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"An organism's astonishing gift of concentrating a 'stream of order' on itself and 
thus escaping the decay into atomic chaos - seems to be connected with the presence 
of the 'aperiodic solids', the chromosome molecules, which doubtless represent the 
highest degree of well-ordered atomic association we know of - much higher than 
the ordinary periodic crystal - in virtue of the individual role every atom and every 
radical is playing here". 
Schrodinger, E. (1944). What is life? Cambridge University Press. 
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ABSTRACT 
Lines of mice carrying an ovine f-lactoglobulin (BLG) transgene secrete 
large quantities of BLG protein into their milk. To explore the stability of transgene 
expression, a systematic study of expression levels in three BLG transgenic mouse 
lines was performed. Unexpectedly, two of these lines exhibited variable levels of 
transgene expression. Copy number within lines appeared to be stable and there was 
no evidence of transgene rearrangement. Studies on the most variable line showed 
that BLG production levels were stable within individual mice in two successive 
lactations. Backcross experiments demonstrated that the genetic background did not 
contribute significantly to the variation of expression levels. Tissue in situ 
hybridisation experiments revealed mosaic patterns of transgene expression within 
individual mammary glands from the two variable lines; in low expressing animals, 
discrete patches of cells expressing the transgene were observed. The concentration 
of transgene protein in milk reflected the proportion of mammary epithelial cells 
expressing BLG mRNA. Furthermore, in situ hybridisation to metaphase 
chromosomes indicated that the transgene arrays in both these lines are situated 
close to the centromere. These experiments suggest that variable mosaicism of 
transgene expression among individuals within a transgenic line is a consequence of 
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ABBREVIATIONS AND CONVENTIONS 
The following abbreviations are used throughout this work: 
AAT human alpha- 1 -anti trypsin 
BLG -lactog1obuIin 
bp base pair(s) 
cDNA complementary DNA 
CsC1 caesium chloride 
DAPI 4, 6-diamidino-2-phenylindole 
dATP 2'-deoxyadenosine 5 '-triphosphate 
dCTP 2' -deoxycytidine 5' -triphosphate 
DEPC diethyl pyrocarbonate 
dGTP 2'-deoxyguanosine 5'-triphosphate 
DNase deoxyribonuclease 
DTT dithiothreitol 
dUTP 2'-deoxyuridine 5'-triphosphate 
ECM extracellular matrix 
EDTA ethylenediami ne- tetra- acetic acid 
EtBr ethidium bromide 
FCS foetal calf serum 
FISH fluorescence in situ hybridisation 
FITC fluorescein isothiocyanate 






IU international unit(s) 




LMP low melting point 
M Molar (moles/litre) 
Mb megabase(s) 







MOPS 3-N-(morpholino) propanesulfonic acid 
mRNA messenger RNA 
nt nucleotide(s) 
OD optical density 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate-buffered saline 
pcp post-coitum plug 
PCR polymerase chain reaction 
PEV position-effect variegation 




rpm revolutions per minute 
r.t. room temperature 
SDS sodium dodecyl sulphate 
sec second(s) 
SSC standard saline citrate (0.15 M NaCl, 15 mM tn-sodium 
citrate, pH 7.0) 
STAT signal transducer and activator of transcription 
TCA trichioroacetic acid 
TE 10 mM Tris-HC1 pH 7.5, 1 mM EDTA 
TEA triethanolamine 
TEB terminal end buds 
TR Texas Red 
Tris 2-amino-2-(hydroxymethyl)- 1,3-propandiol (C4H1 1NO3) 
TTP thymidine 5'-triphosphate 
UV ultraviolet 
V volt(s) 





Advances in recombinant DNA technology and embryo manipulation has 
enabled the introduction of genes into the germline and expression of the foreign 
DNA (Gordon etal., 1980; Wagner et al., 1981; Brinsterer al., 1981; Gordon & 
Ruddle, 1981). The introduced DNA sequences were termed "transgenes" and the 
mice generated from viable embryos that contained the transgenes within their 
genome termed "transgenic" mice. The advent of transgenic technology has 
spawned a vast and ever-growing list of investigators utilising transgenic animals. 
The possibility of altering the genome of animals by introducing new gene variants 
has provided the opportunity foraddressing fundamental questions of development, 
immunology, neurobiology, endocrinology, cell biology, oncogenesis, chromosome 
architecture, and the genetic engineering of farm animals. However, as the list of 
applications for transgenic technology has grown, it has become apparent that there 
are many examples of unstable transgene expression. Such expression has 
implications for investigators using this technology and it is clear that a better 
understanding of the regulation of transgene expression is required. 
This project dealt primarily with factors involved in the expression of an 
ovine f3-lactoglobulin (BLG) transgene in mouse mammary gland. The following 
section reviews mammary gland development and function, applications of 
mammary-specific transgene expression and the stability of transgene expression in 
general. 
1.1. DEVELOPMENT OF THE MOUSE MAMMARY GLAND 
The mammary gland undergoes morphological changes in size, 
structure and activity during the lifetime of the animal. These changes start during 
foetal life and continue even after the gland has reached maturity, as it goes through 
cycles of cellular differentiation / apoptosis during successive lactations. This tissue 
has been utilised to address numerous fundamental questions in different disciplines 
because of the complex developmental cycle (see 1.1.1. to 1.1.4.), the complex 
hormonal regulation of growth and function (1.2.1.), the interaction of growth 
factors and extracellular matrix (1.2.2.), the prevalence of human mammary tumours 
(182,000 new cases and 46,000 deaths each year in the USA alone [Boring et al., 
1992]) and the function of the mammary gland (i.e., milk production [ 1 .3.]). 
Systems utilised to study the mammary gland range from complex three-
dimensional in vitro tissue culture systems to in vivo transgenic experiments. There 
are many differences (e.g., hormonal regulation) in mammary development between 
species (Cowie et al., 1980; Topper & Freeman, 1980; Knight & Peaker, 1982). 
However most work examining mammary development and its regulation has been 
performed in rodents (reviewed by Imagawa et al., 1994; Medina, 1996). Whenever 
possible, this review will concentrate on mouse mammary gland development. Even 
so, there are some differences in development between mouse strains. 
The mammary gland comprises the parenchyma (or epithelial portion) and 
the adipose stroma. The parenchyma forms a system of branching ducts from which 
secretory structures develop and the adipose stroma provides a substrate within 
which the parenchyma develops and functions. The development of the mammary 
gland can be divided into five main stages: foetal, postnatal, gestation, lactation and 
involution. 
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1.1.1. Foetal and postnatal development 
The earliest sign of mammary-specific progenitor cells or 
"mammary buds" (spheres of ectodermal cells sunken into the dermis) is at day 10-
11 (vaginal plug = 0 day) of foetal development (Sakakura, 1987; review). Bilateral 
ectodermal thickenings form the mammary lines within the underlying stroma and 
establish the position of the glands relative to one another between days 11 to 16 
(i.e., inguinal and thoracic [pectoral] groups; Cook, 1965). From days 16 to 21 rapid 
proliferation of mammary epithelial cells occurs in females. Canalisation (cell 
death) within the core of the mammary lines results in a primary open duct in each 
gland. The ducts are lined by a two-cell thick epithelial layer. The primary ducts 
branch to form secondary ducts lined by a single layer of epithelial cells. In male 
mice, mesenchymal condensation occurs around days 13 to 15, due to secretion of 
testosterone from the foetal testis (Kratochwill, 1971; Durnberger & Kratochwill, 
1980), resulting in a vestigial gland. X-ray-induced destruction of the testis in 13-
day male embryos results in female-like development of the mammary gland and 
conversely, injection of testosterone into pregnant mothers or embryos results in the 
regression of mammary development in female offspring (reviewed by Imagawa et 
al., 1994). 
In newborn female mice (18-21 days after fertilisation), the mammary gland 
consists of only 2-4 orders of branching, connected to the outside via the nipple (one 
duct per nipple). These ducts serve as a framework from which the mammary gland 
proper develops along with all the ancillary structures (i.e., blood vessels, nerves, 
lymphatics, connective tissue and myoepithelial cells) under the influence of 
pituitary and gonadal hormones during puberty and adolescence (see 1.2.1.). This 
differentiation establishes the mammary fat pad which provides the support for 
lobulo-alveolar proliferation. Bresciani, (1971) produced autoradiographs showing 
3 
that DNA-synthesising cells were present only at the terminal end buds (TEB) at the 
tips of the ducts, illustrating that these are the major sites of growth in the virgin 
mouse. Elongation of the ducts occurs by mitotic activity in the TEB and results in 
a highly organised system of ducts within the fat pad in the juvenile mouse 
(Williams & Daniel, 1983; Daniel & Silberstein, 1987). Mitotic activity remains 
high until the ducts have reached the periphery of the mammary fat pads, at which 
time the TEB regress to blunt-ended structures containing a single layer of luminal 
epithelial cells with low mitotic activity. Sexual maturity is reached by 6-8 weeks 
by which time ductal development is complete. With each oestrous cycle, 
oestrogens cause the lateral buds to differentiate progressively, thus giving rise to 
small alveolar buds but without lobulo-alveolar formation (see 1.2.1.). 
1.1.2. Development during gestation 
Further development and differentiation of the gland requires 
fertilisation and is induced by the hormones of pregnancy (Topper & Freeman, 
1980). It is estimated that 78% of mouse mammary growth takes place during 
gestation (Brookreson & Turner, 1959) with the number of cells doubling (measured 
as DNA content) every 6 days (Munford, 1963). The highest rates of epithelial cell 
proliferation occur between day 4 and day 12 of gestation (Traurig, 1967). Between 
day 8 and day 10 of gestation, the mammary alveoli start to form true lobulo-
alveolar tissue with growth occurring from the ducts as well as at the end buds. A 
rapid increase in the number and size of alveoli occurs during the second half of 
gestation and can continue into lactation, resulting in the development of fully 
differentiated secretory lobules which are the functional secretory unit of the 
mammary gland (Pitelka et al., 1973; Cowie et al., 1980). The lobule comprises 
several alveoli around a single ductule which collects the secreted milk. Towards 
rd  I 
the end of gestation the secretory epithelial cells enlarge, perhaps due to increased 
secretory activity (Foster, 1977). The pups are usually born at day 19 of gestation / 
day 1 of lactation. 
1.1.3. Development during lactation 
Lactogenesis begins by the 17-19th day of pregnancy. 
Between the last day of pregnancy and the 5th day of lactation the cell population 
doubles and the milk yield increases correspondingly (Knight & Peaker, 1982). 
Lactational performance (measured as milk yield and percentage composition with 
respect to total solids, lipid, and protein) increases linearly from day 8 to day 12 of 
lactation (Hanrahan & Eisen, 1969). The mature gland comprises specialised 
secretory epithelial cells that are surrounded by a layer of contractile myoepithelial 
cells (Fig. 1) and supporting connective and adipose tissue. 








Figure 1. Diagrammatic representation of a cluster of mammary alveoli. 
Taken from Mepham, (1987). 
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It is the myoepithelial cells that contract and force the milk out of the alveolar 
spaces into the ducts and eventually to the nipple. 
1.1.4. Involution 
The gland begins to involute following the peak milk yield at 
mid-lactation (day 11-12 of lactation) and the milk yield correspondingly declines 
until the pups are weaned at about day 21 of lactation (40 day pcp). Involution is 
essentially an autolytic process, with lysosomes playing a major role, while an influx 
of phagocytic cells aided by disruption of the tight junctions completes the 
degenerative process (Strange et al., 1992; Boudreau et al., 1995). Progressively, 
parenchymatous tissue is replaced by connective and adipose tissue. Little is known 
about whether cells "carry-over" from one lactation to the next. Involution does not 
return the gland to a virgin state as administration of [ 3H] thymidine to rats suggests 
that there is appreciable persistence of mammary cells from one lactation to the next. 
This finding is consistent with the increased lactational performance in cows (e.g., 
the lactational performance in cows increases until the fourth lactation [Oldham & 
Friggens, 1989]). 
1.2. FACTORS INTRINSIC FOR MAMMARY GLAND DEVELOPMENT 
Development, differentiation and function of the mammary gland is 
influenced by the developmental lineage and the microenvironment. The 
microenvironment comprises hormonal influences and the extracellular matrix 
(ECM). 
1.2.1. Hormonal regulation 
The development of the gland is controlled to a large extent by 
the influence of several different hormones including progesterone, oestrogen, 
prolactin and placental lactogen (Cowie et al., 1980; Topper & Freeman, 1980; 
Forsyth, 1986). The varied hormonal control is necessary because of the complexity 
of mammary gland development throughout the lifespan of the animal and the 
various constituents within milk (Wiens et al., 1987). 
Early embryonic development of the mammary tissue does not appear to be 
influenced by hormones, but is highly dependent on stromal factors (e.g., 
transforming growth factor beta [TGF3]; Imagawa et al., 1994). Later stages of 
foetal development (days 13 to 15) are influenced by testosterone, which suppresses 
mammary gland development in males (see 1.1.1.). During puberty the gland is 
influenced by the cyclic release of oestrogen which results in a cyclic extension of 
the ductal system but without lobular-alveolar development (Fig. 2). During 
pregnancy, oestrogen in association with pituitary hormones (e.g., prolactin), 
promotes ductal development, while progesterone is additionally required for 
lobulo-alveolar development (mammogenesis [1.1.2.]). Later in development, the 
foetal/placental unit may take over the role of the pituitary, placental lactogen 
replacing or augmenting the action of prolactin. 
The mammary growth in early lactation is associated with a quite different 
hormonal milieu. Parturition is associated with an abrupt fall in progesterone and 
placental lactogen levels. Instead, the mammary growth may be maintained by 
blood prolactin, ovarian steroids (e.g. oestradiol), prostoglandins and/or local growth 
factors (e.g., epidermal growth factor, TGF(x) in the ECM, all of which increase 
during this period (Imagawa et al., 1994). The actions of some of these factors are 




FIRST CONCEPTION FIRST PARTURMON SECOND CONCEPTION 
4 4 4 
PT ,X 
I,sming voIum 
of ti.— o milk 
OV + Pr * PP 
Ll-
ALVEIRAR 





PRENATAL I 	 I POSTPUBERTY I PREGNANCY 	I 	LACTATION 
Figure 2. Schematic representation of mammary growth in mice. 
OV, ovarian hormones (e.g., oestrogen); PT, pituitary hormones (e.g., prolatin); FP, foetal placental 
hormones (e.g., placental lactogen); X, other factors (e.g., TGF(x); L, local factors (e.g., 
metalloproteases); INV, involution. Adapted from Mepham, (1987). 
via the protein tyrosine kinase Jak2 (Campbell et al., 1994; David et al., 1994; 
Dusanter-fourt et at., 1994; Gilmour & Reich, 1994; Rui et al., 1994) and one of its 
substrates, the transcription factor MGF / STAT5 (Wakao et al., 1994; Gouilleux et 
al., 1994; DaSilva et at., 1996). 
1.2.2. Extracellular matrix components 
Epithelial cell growth and development is dependent on the 
ECM which comprises the basement membrane and a variety of polysaccharides and 
proteins secreted by the cells (Bissell & Hall, 1987; Imagawa et al., 1994). ECM 
molecules interact with each other and with their specific receptors on the cell 
surface (Fig. 3). Such interactions now are believed to play an important role in the 








Figure 3. ECM-signalling and mammary epithelial cell differentiation. 
C, CCAA1T/enhancer binding protein; FAK, focal adhesion kinase; MAPK, mitogen-activated 
protein kinase; API, transcription factor; BCE-I, a 160 bp enhancer element 5' of the bovine - 
casein gene; STAT5, signal transducer and activator of transcription (5). Adapted from Roskelley et 
al., (1995). 
modifications of the ECM influence ductal branching, end-bud development and 
epithelial proliferation (Silbertein et al., 1992). During pregnancy and lactation, an 
intact basement membrane is required for the emergence of differentiated function 
(Sympson et al., 1994). 
The general model for the ECM-mediated differentiation is as follows: 
Extracellular signals are transmitted across the cell membrane via the 
transmembrane receptors (e.g., integrins) which recognise ECM molecules (e.g., 
laminin). The changes in these receptors, triggered by the ligand binding, cause an 
intracellular cascade of signal transduction leading to changes in gene expression, 
and therefore the growth and differentiation state of the cells. 
1.3. MILK COMPOSITION 
The function of the mammary gland is to synthesise and secrete the 
milk that is essential for the nourishment of mammalian young. Milk is an 
extremely complex biological fluid composed predominantly of water, fat, protein, 
carbohydrate (mainly lactose), calcium and salts as well as minor constituents such 
as several vitamins, enzymes, cellular metabolites, dissolved gases and trace 
elements (Davies et al., 1983). The major constituents are the same in all species 
examined (Jenness, 1986) although the relative quantities vary considerably between 
species (Table 1). 
Table 1. The major components of milk 
Species Fat (g/l) Protein (gil) Lactose (mM) Calcium (mM) 
Sheep 74 55 133 58 
Pig 68 48 153 104 
Cow 37 34 133 30 
Mouse NA 97* NA NA 
Human 38 10 192 7 
Adapted from Davies el al., (1983); NA: not available; * from the thesis of Kumar, S. (1993), 
University of Edinburgh 
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1.3.1. Milk fat. 
Milk fat is composed of triacyiglycerols (the major fraction), 
di- and monoacyiglycerols, cholesterol and its esters, phospholipids and free fatty 
acids (long, medium and short-chain) and is of nutritional value (Davies et al., 1983; 
Dils, 1986). The presence of these in the milk is a result of de novo synthesis in the 
mammary gland itself and from blood lipids (from the diet or from other body 
tissues). 
1.3.2. Milk carbohydrate 
Lactose is the predominant carbohydrate in the milk of most 
species (Davies et al., 1983) but glucose, galactose and oligosaccharides are also 
present at much lower concentrations. Lactose maintains the osmotic balance of the 
milk and facilitates the absorption of calcium in the intestine. 
1.3.3. Milk protein 
Milk comprises two major classes of protein, namely the 
caseins and the milk serum or whey proteins (Table 2). The caseins and whey 
proteins are defined by acid precipitation and the relative abundance of each varies 
considerably between species (Jenness, 1986). All of the caseins and four of the 
whey proteins ((x-lactalbumin, BLG, WAP and lactoferrin) are expressed and 
synthesised in the mammary gland whereas serum albumin, lysozyme and the 
immunoglobulins are present in milk due to transfer from the blood. 
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Table 2. Milk protein composition of sheep and mouse milk 
Milk Protein 	Concentration in milk (g/L) 
Sheep 	Mouse 
Caseins 
asl -casein 12.0 28.0 
as2-casein 3.8 NA 
3-casein 16.0 21.0 
ic-casein 4.6 2.4 
Whey Proteins 
a-lactalbumin 0.8 trace 
BLG 2.8 none 
WAP none 2.0 
serum albumin NA NA 
lysozyme NA NA 
lactoferrin NA NA 
immunoglobulins NA NA 
Adapted from Lathe et al., (1986) and the thesis of Kumar, S. (1993), University of Edinburgh; NA: 
not available 
The caseins are thought to have a nutritional role as well as serving to 
transfer calcium and phosphorous from the mother to the neonate (Schmidt, 1982; 
Mepham, 1987) although pups suckling from mice lacking fI-casein develop 
normally (Kumar et al., 1994). 
The whey proteins also appear to have functional and nutritional roles. a-
lactalbumin acts as a cofactor in the synthesis of lactose by the enzyme, 
galactosyltransferase (Kuhn, 1983). Lactoferrin binds iron (Masson & Heremans, 
1971) and is thought to transfer iron from the mother to the offspring (Saarinen & 
Siimes, 1979) and perhaps also inhibit the growth of serveral bacteria (Stuart et al., 
1984). The function of WAP (Hennighausen & Sippel, 1982) and BLG is unknown 
although the 3-dimensional crystal structure of bovine BLG is consistent with a role 
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in vitamin A transport (Papiz et al., 1986; see 1.6.). WAP expression reaches levels 
as high as 15 mg/ml in the rabbit (Grabowski et al., 1991) due to a high rate of 
transcription and a high degree of mRNA stability (Chen & Bissell, 1989). 
Overexpression of WAP in transgenic mice can result in incomplete lobulo-alveolar 
development and loss of milk production, implying a role in mammary development 
(Burdon et al., 1991). The immunogiobulins confer passive immunity to the 
offspring (Mepham, 1987). 
Several milk protein genes have been isolated and characterised (Rosen, 
1987; review) and many of the cis-acting sequences that are important for milk 
protein gene expression have been identified (see 1.4. & 1.5.2.). 
1.4. FACTORS INTRINSIC FOR MILK PROTEIN GENE EXPRESSION 
The milk protein genes are expressed in secretory epithelial cells. 
Epithelial cell differentiation has been extensively studied in tissue culture by 
following the expression of the milk protein genes lactoferrin, 13-casein and WAP 
(reviewed by Roskelley et al., 1994). These experiments have produced evidence 
for a hierarchy of ECM-dependent signals that regulate mammary gland 
development (Fig. 4). 
Firstly, architectural changes (tier 1) in cell shape (i.e., "rounding" of the 
epithelial cells) are necessary but not sufficient for 3-casein expression (Roskelley et 
al., 1994). This alteration in nuclear architecture appears to "prime" the cells for 
ligand-induced regulation of differentiation, implying that the nuclear architecture is 
altered via the cytoskeleton due to the rounding process. Secondly, laminin or 
prolactin-specific signals (tier 2) can activate an ECM-responsive element (BCE-1) 
and induce endogenous 3-casein expression. Thirdly, morphogenesis (tier 3) results 
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Figure 4. Mammary epithelial cell differentiation, ECM-signalling and milk 
protein gene expression. 
C, CCAATI'/enhancer binding protein; FAK, focal adhesion kinase; MAPK, mitogen-activated 
protein kinase; API, transcription factor; BCE-1, a 160 bp enhancer element 5' of the bovine f3-
casein gene; STAT5, signal transducer and activator of transcription (5). Taken from Roskelley etal., 
(1995). 
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Finally, after weaning, degradation of the ECM by metalloproteases (Talhouk et al., 
1992) triggers the massive programmed cell death that occurs during involution 
(Strange et al., 1992; Boudreau et al., 1995). 
Low levels of milk protein genes are expressed already in virgin mice, but 
their synthesis increases dramatically during pregnancy following a characteristic 
time course that is different for each protein. For example, 3-casein and WAP 
expression are detectable at low levels in the virgin whereas a-lactalbumin is not 
(Fig. 5). -casein expression is detectable in only a few alveolar cells by day 9 of 
gestation and in 30% of the cells by day 11 (Robinson et al., 1995). Mosaic 
expression of WAP is detected by day 14 of gestation. It takes until day 18 of 
gestation before uniform expression of 13-casein and WAP is achieved. 
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Figure 5. Model for the regulation of differentiation of mammary alveolar cells 
during puberty, pregnancy and lactation. 
Lu, lumen; taken from Robinson et al., 1995. 
Mammary gland development and milk protein gene expression is in 
response to placental lactogens, growth factors and the ECM. The signals from 
these extracellular influences are transmitted to the regulatory elements of the genes 
via intracellular signalling. Evidence from cell and organ culture studies and 
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transgenic animals illustrate that the differences in milk protein gene expression may 
be attributed to different regulatory elements in the milk protein genes and their 
interactions with different hormones and/or different ECM factors. For example, 
WAP expression requires the synergistic action of prolactin, insulin and 
glucocorticoids whereas 5-casein expression only requires the presence of prolactin 
(Hennighausen et al., 1988; Pittius et al., 1988; Burdon et al., 1991; McKnight et 
al., 1991; Shamay et al., 1992; Wakao et al., 1994). Response elements within the 
promoters of the two genes have been identified but the mode of the differential 
regulation is not understood (Li & Rosen, 1994 and 1995). 
1.5. TRANSGENICS AS A METHOD OF PRODUCING BIOMEDICAL 
PROTEINS 
The advent of transgenic technology and the cloning of several 
"biomedical" genes (genes that are not expressed or aberrantly expressed in a sub-
population of humans and associated with various genetic disorders) has led to the 
enticing prospect of producing large quantities of these proteins in the milk of farm 
livestock (Lathe, 1985) using recombinant DNA and embryo microinjection 
technology. 
1.5.1. Choice of biomedical proteins 
Several genetically heritable disorders are caused by a 
deficiency in circulating levels of particular proteins. For example, haemophilia B 
(Christmas disease), which afflicts 1/30,000 males (Brownlee, 1987), is caused by a 
deficiency in human factor IX (FIX), an essential component of the blood 
coagulation cascade. Deficiency in human alpha- 1-antitrypsin (AAT), an elastase 
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inhibitor, predisposes to emphysema and related disorders. AAT deficiency is one 
of the most common lethal hereditary disorders to affect Caucasian males of 
European decent (Crystal, 1989; Carlson et al., 1988). 
Conventionally these proteins are purified from the blood of blood donors 
and used in replacement therapy. This is an expensive and time consuming process 
because large quantities are required (e.g., AAT is present at 2 g/l in plasma and has 
a half-life of only 6 days) and the blood has to be screened for the presence of 
viruses such as those that cause hepatitis and AIDS. In the U.S.A. alone there are 
more than 20,000 sufferers of emphysema who require some 200 g of AAT per 
patient per year (Casolaro et al., 1987) making a strong case for an alternative 
method of production. Human sequences encoding FIX and AAT have been cloned 
and characterised (Kurachi & Davie, 1982; Choo et al., 1982; Jaye et al., 1983; 
Ciliberto et al., 1985; Kelsey et al., 1987). 
1.5.2. Choice of expression system 
Large animal production of biomedical proteins has 
several advantages over bacterial (Courtney et al., 1984), yeast (Sleep et al., 1991) 
and mammalian tissue culture systems (Garver et al., 1987). For example, farm 
animals are more likely to supply the correct post-translational modifications 
required for a functional human protein (Casolaro et al., 1987) and they are 
relatively cheap to maintain. Of the three most common farm animals (pig, sheep, 
and cattle), Lathe et al., (1986) argued that sheep would offer the most favourable 
compromise between several important parameters including the technical feasibility 
for the collection of eggs, injection of DNA into embryos and the overall cost of the 
procedures (Table 3). 
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Table 3. Comparison of different farm livestock. 
Pig Sheep Cattle 
Availability of techniques for determining 
time of follicle maturation Yes (Yes) (No) 
Number of ovulations per animal without 
superovulation 10 1-3 1 
Number of ovulations per animal with 
superovulation 15-20 4-10 possibly 6 
Visualisation of pronuclei (Yes) (Yes) (No) 
In vitro culture of early embryo (Yes) (Yes) No 
Seasonal breeding No Yes No 
Relative cost of embryo transfer 1 2 110 
Taken from Lathe et al., (1986). 
The mammary gland was chosen as the tissue for expression of biomedical 
proteins because (i) the tissue is well adapted to high levels of protein secretion into 
milk, (ii) milk production is strictly "inducible" by pregnancy and parturition, (iii) 
there are several tissue-specific milk protein promoters, (iv) collection of milk is 
relatively non-invasive to the animal, (v) milk is renewable. 
Due to the high costs and long time-scales involved in large animal 
transgenics DNA constructs have generally been designed and tested in transgenic 
mice (Table 4). Tissue-specific expression is achieved by fusing the 5' regulatory 
regions from milk protein genes with the sequences encoding the biomedical protein 
(either genomic or cDNA). Expression is generally limited to the mammary gland 
and the protein products secreted into the milk. Expression levels are highest using 
BLG or WAP promoters whereas levels achieved with casein gene promoters have 
been surprisingly low, possibly due to limited regulatory sequences within the 
constructs. Constructs designed and tested in transgenic mice have been used to 
W. 
Table 4. Mammary gland-specific transgenic animals 
Source of promoter 	Amount of promoter 	To express 	 Animal 	Protein levels 	Reference 
WAP-rat Entire gene Rat WAP Mice 27% of endogenous Bayna, 1990 
WAP-mouse 2.6 kb 5', SV40 Poly A cDNA t-PA Mice 300 ng/mi Gorden, 1987 
WAP-mouse 2.6 kb 5', SV40 Poly A cDNA t-PA Goats 3 J.tg/ml Ebert, 1991 
WAP-mouse Entire gene Mouse WAP Pigs 1 g/L Wall, 1991 
WAP-mouse 2.3 kb 5', 1.6 kb 3' cDNA Human SOD Mice 0.7 mg/ml Hansson, 1994 
WAP-mouse 2.3 kb 5', 1.6 kb 3' cDNA Human Protein C Mice 3 jig/ml Velander, 1992a 
WAP-mouse 2.3 kb 5', 1.6 kb 3' cDNA Human Protein C Pigs 0.001-1 mg/ml Velander, 1992b 
WAP-mouse 4.2 kb 5' gDNA Human Protein C Mice 0.1-0.7 mg/mI Drohan, 1994 
WAP-rabbit 17.6 kb 5' gDNA Human AAT Mice 10 mg/ml Bischoff, 1992 
WAP-rabbit 6.3 kb gDNA Human GH Mice 4-22 mg/ml Devinoy, 1994 
a-iactalbumin-bovine Entire gene Bovine a-lactalbumin Mice 1.5 mg/ml Bleck, 1993 
a-iactaibumin-bovine 750 bp 5', 336 bp 3' cDNA Bovine a-iactalbumin Mice 0.0025-0.45 mg/ml Vilotte, 1989 
a-iactalbumin-bovine 477 bp 5', 336 bp 3' cDNA Bovine a-Iactalbumin Mice 0.1 mg/ml Soulier, 1992 
cz-iactalbumin-goat Entire gene Goat a-iactaibumin Mice 1.2-3.7 mg/ml Soulier, 1992 
BLG-sheep 4 kb 5', 1.9 or 7.3 kb 3' BLG Mice 23 mg/ml Simons, 1987 
BLG-sheep 4 kb 5' Human AAT Mice 0.4-7.3 mg/ml Archibald, 1990 
BLG-sheep 4 kb 5' Human AAT Sheep 35 g/L Wright, 1991 
BLG-sheep 3, 5.5 or 10.8 kb 5', 8 kb 3' BLG Mice 1-8.5 mg/ml Shani, 1992 
BLG-sheep 3 kb 5' gDNA Human SA Mice 2.5 mg/ml Shani, 1992 
BLG-sheep 1.8 kb 5', 4.6 kb WAP 3' cDNA SOD Mice 10 ng/mI Hansson, 1994 
-casein-rat 3.5 kb 5', 3 kb 3' Rat 	-casein Mice 0.01-1% (mRNA) Lee, 1988 
-casein-rabbit 2 kb 5' Human interieukin-2 Rabbits 430 ng/ml Buhier, 1990 
0-casein-goat 3 kb 5', 6 kb 3' Goat 13-casein Mice 12-24 mg/ml Persuy, 1992 
1-casein-goat 4.2 kb 5', 5.3 kb 3' Goat 3-casein Mice I mg/ml Roberts, 1992 
0-casein-goat 6.2 kb 5', 7.1 kb 3' cDNA bovine ic-casein Mice 0.94-3.85 p.g/jii Guterrez, 1996 
aSl -casein-bovine 1.35 kb 5', 1.5 kb 3' cDNA bovine ccsl-casein Mice 0.1% (mRNA) Clarke, 1994 
a5i -casein -bovine 1.35 kb 5', SV40 3' Bacterial CAT Mice 3 ng/mI Clarke, 1994 
aSi -casein -bovine 2.9 kb 5', 3.5 kb 3' cDNA Human IGF-1 Rabbits 1 g/L Brem, 1994 
as 1 -casein-bovine 21 kb 5', 2 kb 3' gDNA Human urokinase Mice 1-2 mg/ml Meade, 1990 
aSi -casein-bovine 21 kb 5', 2 	k 3' cDNA Human iysozyme Mice 0.25-0.71 j.ig/p.i Maga, 1994 
aSl -casein-bovine 6.2 or 14.2 kb 5', 6.5 kb 3' cDNA Human Iactofemn Mice 0.1-36 jig/ml Piatenberg, 1994 
t-PA, tissue-plasminogen activator; SOD, superoxide dismutase; GH, growth hormone; SA, serum albumin; CAT, chioramphenicoi acetyltransferase; IGF-I, insulin-
like growth factor-I; gDNA, genomic DNA; cDNA, complementary DNA; WAP & BLG, see text. Adapted from Maga and Murray, 1995. 
generate transgenic rabbits, goats, pigs, and sheep. The BLG promoter has produced 
levels of AAT as high as 35 g/l (50% of total milk protein) in the milk of transgenic 
sheep (Wright et al., 1991). These levels are the highest yet recorded for any 
biomedical protein in transgenic sheep and exceed all other pharmaceutical methods 
of production. Purification of AAT from sheep milk and analysis of the 
pharmacological activity is ongoing (Clark, A.J. pers. comm.). 
1.6. OVINE -LACTOGLOBULIN (BLG) 
Ovine f-lactoglobulin (BLG) exists as two major alleles (Bell & 
McKenzie, 1967). These encode variants of BLG, termed BLG-A and BLG-B, 
which differ in only one amino acid; Tyr 20 in BLG-A is replaced by His in BLG-B 
(Kolde & Braunitzer, 1983). Four genomic clones were isolated (Ali & Clark, 1988) 
from a sheep genomic DNA library. Two of these clones, termed SS1 and SS12 
have been characterised by restriction enzyme and DNA sequencing analysis. A 
comparison of the two sequences illustrated that they differ by only 1 bp in the 
coding region which accounts for the Tyr/His difference (Ali & Clark, 1988; Harris 
et al., 1988; Ali et al., 1990). Clone SS-1 is a 16.2 kb Sail-Sail fragment that 
comprises 4 kb of 5' sequence, a 4.9 kb transcription unit and 7.3 kb of 3' flanking 
sequence (Fig. 6). 
The transcription unit is transcribed into a 0.8 kb mRNA that comprises 
about 5% of poly(A) RNA (Mercier et al., 1985). This is translated into a 36 kD 
dimeric protein (the dimer is composed of two identical subunits of 162 amino acids 
each) that is secreted into the milk. BLG is found in the milk of a diverse range of 
species (e.g., dogs to dolphins [Jenness, 1982; Pervaiz & Brew, 1985]) and is the 
major whey protein present in the milk of ruminants. However, BLG is not 
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Figure 6. A map of BLG clone SS-1 
BLG exons are indicated (I-Vu) 
limited to the mammary gland where it exhibits tight temporal regulation; in sheep, 
expression starts during mid-pregnancy (Gaye et al., 1986), reaches a peak in 
lactation and tails off as involution commences. 
Despite this information the function of BLG is still unknown. DNA 
sequence comparisons have revealed similar exon and intron arrangements with a 
variety of secretory proteins (mouse urinary protein, alpha-i-acid glycoprotein, rat 
retinol binding protein and apolipoprotein: Au .& Clark, 1988). The 3-dimensional 
crystal structure of bovine BLG (Papiz et al., 1986) is very similar to that of human 
retinol binding protein (Newcomer et al., 1984), suggesting a role in vitamin A 
transport. Indeed, BLG binds a variety of hydrophobic molecules (Lovrien & 
Anderson, 1969; Futterman & Heller, 1972), including retinol (Cogan et al., 1976; 
Fugate & Song, 1980); [ 125 1]-labelled BLG-retinol complex binds to purified 
microvilli from the small intestine from one-week-old calf intestine (Sawyer et al., 
1985), giving further credence to the idea that BLG is involved in vitamin transport. 
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1.7. GENERATION OF TRANSGENIC MOUSE LINES 7,14 & 45 
Since 1980 several methods have been established for introducing 
transgenes into the germline including retroviral vectors and electroporation into 
embryonic stem (ES) cells. The relative merits of each technique for the generation 
of transgenic animals have been reviewed (Lathe et al., 1986; Simons & Land, 1987; 
Clark et al., 1987). The generation of transgenic animals by microinjection of DNA 
into one pronucleus of fertilised eggs is the most favoured method. 
Fertilised eggs are flushed from the oviduct of superovulating female mice 
and immobilised by gentle aspiration using a blunt holding pipette (visualised using 
x400 magnification). The male pronucleus (usually the larger of the two) is injected 
with 2 p1 of DNA solution (containing 40-400 copies of the DNA construct) using a 
microfine pipette and a micromanipulator. Surviving eggs (10-20%) are 
reimplanted into the oviduct of pseudo-pregnant mothers (see chapter 2) and 
allowed to develop. The proportion of offspring with the transgene is laboratory 
dependent; usually some 15-20% of the offspring carry the injected DNA. 
Integration usually takes place at a single site in the genome (for reasons that are not 
understood) and the locus can contain from one to several hundred copies of the 
transgene, usually in a head to tail array. 
Clone SS1 was microinjected into mouse embryos as the full 16.2 kb 
fragment or as a 3' truncated 10.5 kb fragment (Simons et al., 1987; Fig. 6). This 
resulted in three transgenic mouse lines that expressed high levels of BLG mRNA in 
mammary tissue and secreted the protein into the milk. Lines 7 and 14 contain —25 
and <5 copies of the 16.2 kb fragment respectively; line 45 carries —20 copies of the 
10.5 kb fragment (Whitelaw et at., 1992; Dr Bruce Whitelaw, pers. comm.). The 
developmental regulation of BLG transgenes matches that of the endogenous f-
casein gene in mice (Harris et at., 1991). For example, endogenous J3-casein and 
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BLG mRNA expression are observed at day 10 and day 12 of gestation respectively 
in transgenic mice and the expression of both increases until mid-lactation before 
falling to their original levels. During the analysis of BLG transgenic mouse lines it 
was noticed that one line, line 7, exhibited variable levels of mRNA and protein 
expression within the line (see chapter 3). This is an important phenomenon in the 
context of producing biomedical proteins in the milk of farm livestock as well as in 
the broader context of transgenic research in general. 
1.8. UNSTABLE EXPRESSION OF TRANSGENES 
Unstable transgene expression has been described previously; 
Palmiter et al., (1984) reported that the level of HSV thymidine kinase (TK) 
expression could vary by more than an order of magnitude among transgenic 
progeny of the same founder. More recently a number of different transgene 
insertions have been described that express to variable degrees within individual cell 
lines or transgenic mouse lines (Table 5). In these cases, however, there has been no 
common explanation for the instability of expression. 
Unstable expression patterns may be due to a strong selection against 
transgene expression. This had been demonstrated in the failure of sperm fertility 
engendered by testicular TK expression (Wilkie et al., 1991) and in the case of high-
level hepatic expression of plasminogen activator (Sandgren et al., 1991). In both 
these cases there appears to be selection for transgene deletion. A transgene inserted 
into the X chromosome (Tan et al., 1994) or an X-autosome translocation 
(Cattanach, 1974) generates a mosaic pattern of expression due to stochastic 
inactivation of the X chromosome. More commonly, silencing has been observed 
when the transgene integrates into repeat sequence or satellite DNA (Butner & Lo, 
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Table 5. Summary of examples of unstable transgene expression 
Transgene Cause of Unstable Expression Reference 
I-FABP-hGH differences in clonally derived cells Sweetser et al., (1988a). 
L-FABP-hGH 11 Sweetser et al., (1988b). 
Met-HSV tk selection for transgene deletion Wilkie et al., (1991). 
Alb-uPA " Sandgren et al., (1991). 
hsp68-lacZ influence of strain-specific modifier gene(s) McGowan et al., (1989). 
HSV tk-lacZ Allen et al., (1990). 
Met-I-IRD Engler etal., (1991). 
HSV-tk integration into heterochromatin Butner & Lo, (1986). 
HSV-:k " Talarico etal., (1988). 
HMG CoA-lacZ Tan et al., (1993). 
hCD2 " Festenstein etal., (1996). 
tyrosinase-SV40E "phenoclones" Bradi ci al., (1991). 
Met-tyr " Mintz & Bradl, (1991). 
tyrosinase-tyr " Porter & Meyer, (1994). 
mini-white site of integration and/or the transgene per se Dorer & Henikoff, (1994). 
a-globin/LacZ " Robertson et al., (1995). 
brown " Sabi & Henikoff, (1996). 
a-globin/LacZ " Robertson et al., (1996). 
yfl3-geofHS2-FRT " Walters et al., (1996). 
/3-geo 3MRE " Walters et al., (1996). 
MBP mini-gene unknown Katsuki ci al., 1988. 
mLCR5'HS2-huj3 " Enver et al., 1994. 
p.LCR -730 Ay cis-acting regulatory element Stamatoyannopoulos etal., 
(1993). 
The t.ransgene abbreviations are as follows: I-FABP, intestinal fatty acid binding protein gene 
promoter; L-FABP, liver fatty acid binding protein gene promoter, hGH, human growth hormone 
gene; HSV ik, herpes simlex virus thymidine kinase gene; Alb, mouse albumin promoter, uPA, mouse 
urokinase plasminogen activator gene; hsp68, mouse heat-shock protein 68 gene promoter; lacZ, 
Escherichia co!i -galactosidase gene; tyrosinase, mouse tyrosinase (monophenol, L-dopa:oxygen 
reductase) gene promoter; SV40E, simian virus 40 early-region transforming sequences; Met, 
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metallothionein gene promoter; tyr, tyrosinase cDNA; y4-geofHS2-FRT, 3-geo expression is driven 
by the human y-globin promoter and a downstream I kb fragment containing the 5'HS2 element from 
the human -g1obin locus control region (LCR) is flanked between two fip recognition target (FRT) 
elements (note: variegated expression is observed when the 5'HS2 element is removed); y43-geo 
3MRE, as before except the HS2-FRT element was exchanged for three copies of the upstream region 
of the mouse metallothionein (mMT-1) promoter; MBP, mouse myelin basic protein promoter 
followed by the rabbit 3-globin gene carrying the mouse MBP cDNA in the antisense orientation and 
by the polyadenylation sites for rabbit 3-globin and SV40; mLCR5'HS2-huf3, murine f-globin locus 
control region DNase hypersensitive site 2 linked to a 4.8 kb human -g1obin gene-containing 
fragment; itLCR, 2.5 kb locus control region cassette containing DNase hypersensitive sites 1-4 of the 
human 3-globin locus; -730 Ay, -730 nucleotides 5' of the human Ay..globjn  cap site plus the human 
Ay..g lobin  gene. 
1986; Talarico et al., 1988; Festenstein et al., 1996). In other cases different levels 
of transgene expression between animals of the same transgenic lineage have been 
attributed to the influence of strain-specific modifier genes (McGowan et al., 1989; 
Allen et al., 1990; Engler et al., 1991). 
Mosaic patterns of expression were also observed in transgenic animals 
bearing I-FABP-hGH or L-FABP-hGH fusion transgenes (Sweetser et al., 1988a; 
Sweetser et al., 1988b). Here the mosaicism was initially attributed to a deficit of 
cis-acting elements in the transgene. However one of the authors (J.I.G.) and 
colleagues later suggest that the mosaic expression implied subtle differences in 
clonally derived epithelial cells based on evidence that endogenous I-FABP, L-
FABP and cellular retinol binding protein II (CRBP II) were expressed in a transient 
mosaic fashion (Rubin et al., 1989). This transient mosaic expression of 
endogenous villi genes is reminicent of the transient mosaic expression of 
endogenous milk protein genes described by Robinson et al., 1995 (see section 1.4.). 
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Mosaic expression patterns were also observed in mice carrying different tyrosinase 
fusion transgenes (Bradl et al., 1991; Mintz & Brad!, 1991; Porter & Meyer, 1994) 
as well as in non-transgenic mice bearing a chinchilla-mottled mutation at the 
endogenous tyrosinase gene (Porter et al., 1991). In these reports all transgenic 
animals examined, of different lineages, exhibited a similar pattern of light and dark 
transverse stripes of coat colouration, suggesting that the striated coat colour is an 
inherent property of the transgene. 
Recently, mosaic expression of transgenes has been described in Drosophila 
(Dorer & Henikoff, 1994; Sabi & Henikoff, 1996) and mice (Robertson et al., 1995; 
Walters et al., 1996; Robertson et al., 1996) where stochastic transgene silencing has 
been attributed to the site of transgene integration and/or the repetitive nature of the 
transgene per Se. 
1.9. AIMS OF THE PROJECT 
It was with some of these examples in mind that we entered into a 
systematic study of expression levels in three BLG transgenic mouse lines (lines 7, 
14 and 45) in the milk and mammary tissue. The aims of this project were to 
quantitate the variance of BLG in line 7 and to compare this with two other BLG 
expressing lines and subsequently establish the cause of the variable expression. It 
was anticipated that this study would enhance our knowledge about the efficiency of 
transgene expression and therefore contribute to the future avoidance of variable 
transgene expression in mice and farm livestock. 
A1 
CHAPTER 2 
MATERIALS AND METHODS 
2.1. TRANSGENIC MOUSE LINES 
Transgenic lines employed in this study were lines 7, 14 and 45: lines 
7 and 14 harbour an identical transgene (16.2 kb Sail-Sail fragment) while line 45 
carries a 3' truncated transgene (10.5 kb SaiI-XbaI) [see Fig. 6.; chapter 1). 
The generation of these lines is described by Simons et al., (1987). Briefly, 
the BLG clone SS-1 was isolated from a genomic DNA library (Ali & Clark, 1988); 
SS-1 comprises 4 kb 5' of the promoter, a 4.9 kb transcription unit and 7.3 kb of 3' 
flanking sequence. Pronuclear stage eggs were obtained from superovulated 
C57BL/6 x CBA F1 females, after mating with C57BL/6 x CBA F1 males (to induce 
superovulation: pregnant mare's serum is used to mimic follicle-stimulating 
hormone and human chorionic gonadotropin to mimic luteinizing hormone [Hogan 
et al., 1986]). The cloned BLG gene was microinjected into either pronucleus of 
fertilised eggs as the entire 16.2 kb Sail-Sail fragment or as the 10.5 kb Sall-XbaI 
fragment (5.7 kb removed from the 3' end) [Fig. 6].  Cleaved embryos (two-cell 
stage) were transferred to pseudopregnant (females that have been mated with 
vasectomised males) MF1 recipients (generation zero; G0). Transgenic lines were 
established from these and maintained by systematic crossing to C57BL/6 x CBA F 1 
hybrid mice (a line is a group of male and female mice decended from the same G0 
female containing the same transgenic insertion of foreign DNA). 
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2.2. MILKING OF MICE 
All milk samples were collected from 6-8 week old transgenic mice at 
day 11 of lactation. Litters were standardised to 5 pups per mother at birth. Pups 
were separated from their mother 3 hr before milking. Mothers were injected with 
0.3 International Units of oxytocin (Sigma) in 0.1 ml of distilled water into the 
intraperitoneal space (see Hogan et al., [1986] for a description of this procedure). 
After 10 min an injection with anaesthetic was given (Hypnorni/Hypnovel; 10 tl/g). 
The mice were anaesthetised for 10-15 min before gentle massage was applied to the 
mammary glands and milk collected in 50 Rl  capillary tubes. Milk was dispensed 
into 50 j.tl amounts using a Hamilton syringe and stored at -20°C. 
Defatted milk was prepared by adding 200 p.1 of distilled water to 50 p.! of 
thawed mouse milk, brief vortexing to mix, followed by a 12 sec pulse spin in a 
microcentrifuge. Care was taken to resuspend any protein pellet that formed, 
without dislodging the fat around the side of the tube. The supernatant (defatted 
milk) was transferred into a clean microcentrifuge tube, diluted further (1:200 final 
dilution) in reducing buffer (0.5 M Tris-HC1 pH 6.8, 10% v/v glycerol, 10% w/v 
SDS, 5% v/v f-mercaptoethanol [Sigma], 0.1% w/v bromophenol blue) and boiled 
for 4 min to denature the protein. The SIDS in the buffer dissociates all proteins in 
the sample into their individual polypeptide subunits (i.e., the 32 kD BLG dimeric 
protein is dissociated into two 18 kD dimers) and the -mercaptoethano1 cleaves any 
disulphide bonds (there are two in BLG). Samples were stored at -20°C until ready 
for electrophoresis. 
2.3. PURIFICATION OF OVINE f3-LACTOGLOBULIN (BLG) 
Sheep milk was pooled from 12 ewes (4 Black Face, 4 Grey Face and 
4 Black Welsh) and BLG protein purified by the method described by 
Aschaffenburg & Drewry (1957). 
500 ml of pooled sheep milk was warmed to 40°C, 100 g of Na2SO4 added, 
stirred until dissolved, allowed to cool to 25°C and filtered (Whatman No 4). The 
filtrate contained a-lactalbumin, BLG and serum albumin. All the proteins were 
precipitated with the exception of BLG by the addition of 1 ml of concentrated HCl 
(10.3 M) [BDH: specific gravity (1.16 g/ml) x purity (32.25%) / molecular weight 
(36.46)] for every 100 ml of filtrate with vigorous stirring reducing the pH to almost 
2.0. The precipitate was separated from BLG by centrifugation (13,200 g, 30 mm) 
and filtration. BLG was aliquoted into 1 ml amounts and stored at -70°C. The 
purity of the BLG preparation was checked by SDS-PAGE and Western blotting. 
2.4. ESTIMATION OF BLG PROTEIN CONCENTRATION 
Calculation of BLG concentration was performed at The Moredun 
Research Institute, Gilmerton Road, Edinburgh with guidance from Mr Andrew 
Dawson using the micro-Kjeldahl method (Rowland, 1938) essentially as described 
by Davies & Law (1983). The "N" value was multiplied by 6.38 (multiplication 
factor for nitrogen content of bovine BLG). 
2 ml of purified BLG was precipitated with 10% w/v TCA (final 
concentration), the protein pellet was washed in 100% acetone, resuspended in 500 
tl of 2 M NaOH (left at r.t. overnight), made up to 10 ml with distilled water, split 
into several aliquots (2 x 2 ml, 2 x I ml, 2 x 500 tl, and 2 x 250 tl) and hydrolysed 
(to "digest" the protein) by boiling in 3 ml of H2SO4  (nitrogen-free, 98% w/w: 
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BDH) in the presence of 2.0 g of catalyst (100 g of potassium sulphate and 1 g of 
selenium powdered together) in a graduated micro-Kjeldahl flask overnight. This 
converts the carbon in the sample to CO2 and the hydrogen to H20, both of which 
evaporate leaving the nitrogen as NH. The NH4 was converted into NH3 by 
distillation with 10 M NaOH overnight into 5 ml of boric acid indicator (alkalization 
of the acid/protein digest). This was titrated against HC1 until the clear/yellow 
solution turned a brown/red colour (judged by Mr Dawson). The amount of HC1 
required for this colour change was noted. The two samples from each dilution were 
averaged, a blank was subtracted, multiplied by 0.0952 (1 ml of HC1 = 0.0952 
mgN), multiplied by the appropriate dilution, multiplied by 6.38 (see above) and 
divided by two to give the concentration of BLG in mg/mi (see chapter 3). 
2.5. MILK PROTEIN ANALYSIS 
2.5.1. Preparation of SDS-polyacrylamide gels 
Quantitative milk protein analysis was performed using SDS 
polyacrylamide gel electrophoresis (SDS-PAGE) [Laemmli, 19701. 
20 x 20 cm, 20 x 18 cm glass plates and 1 mm gel spacers were cleaned 
using 70% v/v ethanol before being clamped into a vertical position to act as gel 
moulds. 20% resolving gel solution was prepared by mixing 1.66 ml of distilled 
water, 6.66 ml of 1.5 M Tris-HC1 pH 8.8, 266 j.tl of 10% w/v SDS, and 18 ml of 
acrylamide (Sigma) : N, N'-bis methylene acrylamide (Sigma) [30% T, 2.67% C: 
29.2 g acrylamide, 0.8 g N, N'-bis methylene acrylamide]. This solution was de-
gassed under vacuum to aid polymerisation and reduce the chance of bubbles 
forming within the gels. Polymerisation was catalysed by adding 67 0 of 10% w/v 
ammonium persuiphate (prepared fresh) and 13 p.1 of N, N, N', N'- 
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tetramethylethylenediamine (TEMED) [Sigma], mixed and poured immediately into 
the 1 mm space between the glass plates. A 1 cm layer of distilled water was floated 
on top to aid polymerisation and produce a smooth interface between the resolving 
gel and the stacking gel. The resolving gel was allowed to polymerise overnight. 
The water layer on top of the resolving gel was removed and 4% stacking 
gels prepared by mixing 4 ml of distilled water, 1.66 ml of 0.5 M Tris-HCI pH 6.8, 
67 xl of 10% w/v SDS, 866 j.il of acrylamide : bis (see above), 34 jil of 10% w/v 
ammonium persuiphate, 4 jil TEMED and poured on top of the resolving gel. 
Before polymerisation, a comb was placed into the stacking gel to produce the wells. 
The stacking gel was allowed to polymerise for 1 hr. The comb was removed and 
the wells washed with running buffer (25 mM Tris, 0.2 M glycine, 0.4 mM SDS) 
before loading the samples. 
2.5.2. SDS-PAGE 
15 tl of each defatted mouse milk sample in reducing buffer 
was loaded into polyacrylamide gels using a Hamilton syringe. After loading the 
gels were assembled into Bio-Rad Protean II running apparatus (usually two gels at 
a time) with 4.5 1 of gel running buffer surrounding the glass plates (lower reservoir) 
and —250 ml in the upper reservoir. Samples were electrophoresed at 32 mA 
(constant current) while in the stacking gel (1-2 hr) and at 48 mA while in the 
resolving gel (-5 hr). Gels were stained and fixed overnight using a solution of 
Coomassie Blue stain (50% v/v methanol, 7.5% v/v acetic acid, 2% w/v TCA, 
0.04% w/v Coomassie Blue G-250 [BDH]). The mouse milk proteins were fixed 
and the background stain removed by washing the gels for 2 x 30 min in a solution 
of 23% v/v ethanol, 7% v/v acetic acid followed by 2 x 30 min in 30% v/v ethanol. 
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Gels were stored at 4°C and scanned at 585 nm using a Shimadzu CS-9000 
densitometer. 
2.5.3. Western Blotting 
Electrophoresis was performed using 1.5 mm thick, 15% 
polyacrylamide gels. After electrophoresis, proteins were elec trophoretic ally 
transferred to nitrocellulose membranes (Schleicher & Schuell) using the semi-dry 
method described by Khyse-Anderson, (1984). This involved constructing the 
following stack: two sheets of 3 MM paper (soaked in 0.3 M Tris, 20% v/v 
methanol, pH 10.4) onto the lower graphite anode plate, followed by one sheet of 3 
MM paper (soaked in 25 mM Tris, 20% v/v methanol, pH 10.4), one sheet of 
nitrocellulose membrane (soaked in distilled water), the gel, two sheets of 3 MM 
paper (soaked in 25 mM Tris, 40 mM hexanoic acid, 20% v/v methanol, pH 9.4), 
and the upper graphite cathode plate. The stack was sealed with tape to prevent it 
from drying and transfer performed using 7 V/cm at 4°C for 45 mm. 
After transfer the nitrocellulose membrane was washed in 33% v/v horse 
serum (Gibco BRL) in washing fluid B (WFB: 0.05% v/v Tween 20 [Sigma], 0.1 M 
EDTA, 0.5 M NaCl in PBS, pH 7.2) at r.t. overnight, briefly washed in WFB, 
incubated with a rabbit antibody against BLG (a gift from Dr P. Gaye: INRA, Jouy -
en-Josas, France) [1/300 dilution in 10% v/v horse serum, WFB; 20 ml total 
volume] at 37°C for 2 hr, WFB (two quick washes, 3 x 10 min washes, two quick 
washes), incubated with peroxidase-conjugated donkey anti-rabbit immunoglobulin 
(Scottish Antibody Production Unit [SAPU]) [1/300 dilution in 10% v/v horse 
serum, WFB; 20 ml total volume], WFB (as above) and washed briefly in distilled 
water. linmunoblots were developed with 40 mg diaminobenzidine in 40 ml of 10 
mM Tris-HC1 pH 7.9, 0.01% w/v hydrogen peroxide (11202) for 1-10 min until the 
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protein bands were clearly visible. The reaction was stopped by washing the 
membrane in distilled water and dried by blotting on 3 MM paper. Membranes were 
preserved by wrapping them in cling-film. 
2.6. DNA MANIPULATION AND ANALYSIS 
2.6.1. Digesting DNA with restriction enzymes 
All genomic and plasmid DNA was cut using restriction 
enzymes and buffers (Boehringer Mannheim) according to manufacturers' 
instructions except that a 4 to 10-fold excess of enzyme was generally used. 
e. g. 1. 	10 p.g genomic DNA (in 20 41 distilled water) 
1 p1 EcoRI (Boehringer Mannheim: 40 U/jil; 1 unit digests 1 p.g of 
?.DNA in 1 hr at 37°C) 
4 tl buffer (Boehringer Mannheim: enzyme dependent [see Table 6) 
15 41 distilled water 	 incubate at37°Cfors hr. 
e.g. 2. 	1 jtg plasmid DNA (in 5 0 distilled water) 
1p1 EcoRI(1OU/p1) 
2 .tl buffer 
12 jil distilled water 	 incubate at 37°C for 1 hr. 
Table 6 details the enzymes and buffers used in this study. 
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BamHI G/GATCC B 
B gill A/GATCT M 
EcoRI G/AATFC H 
EcoRV GAT/ATC B 
HindIll A/AGCTT B 
NdeI CAITATG H 
PstI CTGCA/G H 
Pvull CAG/CTG M 
Sail G/TCGAC H 
XbaI T/CTAGA H 
XhoI C/TCGAG H 
* Nomenclature (Smith & Nathans, 1973): A three-letter abbreviation for the parent organism (e.g., 
Hin for Haernophilus influenzae or Barn for Bacillus amyloliquefaciens), an additional letter if 
necessary to identify strain or serotype (1-/md or BarnH), followed by a Roman numeral to reflect the 
order of identification or characterisation (1-IindIII or BarnHI). 
1: Buffer B = 10 mM Tris-HC1, 100 mM NaCl, 5 mM MgCl, 1 mM 2-mercaptoethanol. Buffer H = 
50 mM Tris-HC1, 100 mM NaCl, 10 mM MgCl, 1 mM dithioerythritol (DTE), pH 7.5. Buffer M = 
10 mM Tris-HCI, 50 mM NaCl, 10 mM MgCl, 1 mM DTE, pH 7.5. 
2.6.2. Phenol/chloroform extraction of DNA 
Phenol/chloroform extraction is used to extract and purify 
nucleic acids from a variety of sources (Berger & Kimmel, 1987; Sambrook et al., 
1989). The aim of phenol extraction is the deproteinisation of an aqueous solution 
containing the DNA. Mixing phenol with the sample causes the dissociation of 
proteins from DNA. Centrifugation of the mixture yields two phases; a lower 
organic phenol phase carrying the protein (much of which is found in the white 
flocculent interphase) and the less dense aqueous phase containing the DNA. Used 
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in conjunction with phenol, chloroform improves the efficiency of extractions. This 
is principally due to its ability to denature protein, thereby assisting the dissociation 
of DNA from protein. The high density of the chloroform also enhances the 
separation of the phases, facilitating the removal of the aqueous phase with little 
cross-contamination with organic material. 
An equal volume of phenol (equilibrated to pH >7.6 by repeated extraction 
with Tris buffer; Fisher Scientific UK) was added to each sample in microcentrifuge 
tubes (<500 il samples) or glass Corex centrifuge tubes (up to 15 ml per sample), 
mixed by inverting the tubes for 5 mm, centrifuged (12,000 g, 5 mm, r.t.), the top 
aqueous phase was transferred into a clean tube taking care not to disturb the 
interphase and the process repeated using a 1:1 mix of phenol/chloroform followed 
by just chloroform (to remove any residual phenol). The DNA in the aqueous phase 
was precipitated using ethanol. 
2.6.3. DNA precipitation with ethanol 
For recovery of DNA from a typical reaction (e.g., for 1 jig 
DNA in 20 jil): added a 1/10 th volume of 3 M sodium acetate pH 5.5 and 2 volumes 
of 100% ethanol. This was mixed and chilled to -70°C for 15 mm (gives at least 
80% recovery for volumes <1 ml containing at least 10 jig/ml DNA) or overnight at 
-20°C for very low DNA concentrations (1 jig or less in 1 ml). For larger volumes 
precipitations were performed in 15-30 ml glass Corex tubes and the period at -70°C 
was increased to 30 mm. The DNA was pelleted in a microcentrifuge (12, 000 g, 10 
min 4°C). The DNA was visible as a "whitish" pellet at the bottom of the tube. In 
general, pellets of 10 jig were visible whereas 2 jig pellets were invisible. The 
supernatant was removed and the DNA pellet washed twice (centrifuged for 2 mm 
between washes) with chilled 70% v/v ethanol to remove any solute trapped in the 
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precipitate. Pellets were dried in a Gyrovap (Howe) connected to an Edwards 
Freeze Dryer Modulyo for 1-2 min and resuspended in TE (pH 8.0) buffer (10 mM 
Tris-HC1, 1 mM EDTA). The EDTA chelates heavy metal ions which are 
commonly required for DNase activity, while the use of p1-I 8.0 minimises 
deamination. Samples were stored at -20°C. 
2.6.4. Recovery of DNA fragments from low melting point (LMP) 
agarose gels 
This procedure utilised the activity of 13-agarase I (NEB), an 
agarose-digesting enzyme from Pseudomonas atlantica. f3-agarase I acts by 
cleaving the agarose subunit, unsubstitu ted neoagarobiose [3,6-anhydro-a-L-
galactopyranosyl-( 1 -3)-D-galactose] to neoagaro-oligosaccharides (Yaphe, 1957), 
producing carbohydrate molecules that can no longer gel and therefore releasing 
trapped DNA. 
DNA fragments used as probes in Southern and Northern blotting procedures 
and for the construction of the tissue in situ expression vectors were recovered from 
1% LMP agarose (Gibco BRL) gels. LMP agarose gels were allowed to set at 4°C. 
Cooling the gels made them more solid and therefore reduced the chances of the gel 
tearing at the wells when the comb was removed. Samples were electrophoresed 
and the appropriate fragments cut from the gels (visualised using a long-wavelength 
hand-held U.V. lamp) and transferred to microcentrifuge tubes. The weight of 
agarose was determined and a 1/10 th volume of 10 x 3-agarase buffer (10 mM Tris-
HC1, 1 mM EDTA, pH 6.5) [NEB] added. The agarose was melted at 65°C for 10 
mm, the tubes were transferred to 40°C (10 mm), 1 unit of 3-agarase (NEB) was 
added per 200 p.1 of molten agarose. The samples were mixed and then incubated at 
40°C for at least of 2 hr, samples were cooled on ice for 15 mm, microcentrifuged 
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(12,000 g, 15 mm, 4°C), and transferred the supernatant into a clean microcentrifuge 
tube. 2 volumes of isopropanol were added, the samples were chilled to -20°C for 
15 mm, microcentrifuged (12,000 g, 10 mm, 4°C) to pellet the DNA, washed twice 
with 70(% v/v isopropanol, spin-vacuum dried for 5 min before resuspended in 50 p1 
TB buffer. Purity and yield of the fragment was checked on a mini-gel. Samples 
were stored at -20°C. 
2.6.5. DNA ligation 
"Sticky-end" ligation reactions were performed with 1 part cut 
plasmid :3 parts insert (molar ratio) using the following: 
	
—100 ng 	total DNA in 8 p.1 of distilled water 
The solution was warmed to 45°C for 5 min to melt any cohesive termini 
that had reannealed. After chilling on ice (5 mm) the following were added: 
141 	10 x ligation buffer*  (Boehringer Mannheim) 
141 	T4 DNA ligase (1 U/41: Boehringer Mannheim) 
* 20 mmol/1 Tris-HCI, 10 mmol/I M902, 10 mmol/1 dithioerythritol, 0.6 mmol/1 ATP, pH 7.6. 
Ligations were performed at 14°C for 1-4 hr. 1-2 p.1 of the ligation reaction 
were used to transform competent cells (see 2.6.7.). 
2.6.6. DH5a cells 
E. coli DH5a competent cells (Genotype: F, 
hsdR17(rk, mk),  jE44,thi-1, ?c, recAl, gyrA96, relA1, A(rgF-lacZYA)U169, 
080diZ[\M15]) were purchased from GIBCO BRL and stored at -70°C. The 
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080dZ[LM15] marker provides a—complementation of the p-galactosidase gene, 
therefore enabling blue/white screening of colonies on bacterial plates containing X-
gal and IPTG (see 2.8.2.). 
2.6.7. Transformation of DH5a cells with plasmid DNA 
DH5a cells were thawed on ice and the cells gently mixed 
using a blue tip. 1-2 p.1 (0.1-0.5 ng/p.l) of ligated plasmid DNA was added to 100 p.l 
of cells in an microcentrifuge tube, placed on ice for 30 mm, heat shocked (42°C for 
90 sec) and returned to ice for 2 mm. 900 p.1 LB medium (without antibiotic) were 
added and incubated at 37°C for 1 hr (tape microcentrifuge tube to the top of a 15 ml 
glass tube) with vigorous shaking. Spread 50-100 j.tl of each sample onto agar plates 
(see 2.8.1.) using a sterile glass spreader. Incubated the plates overnight at 37°C. 
2.6.8. Preparation of plasmid DNA 
2.6.8.1. Small-scale preparation 
Single white colonies were transferred into 15 ml glass 
tubes containing 2 ml of LB medium (Sambrook et al., 1989) and 50 jig/ml of 
ampicillin (Sigma). Tubes were incubated at 37°C overnight with vigorous shaking. 
1.5 ml of each culture was transferred into microcentrifuge tubes and 
microcentrifuged (12,000 g, 30 sec, r.t.) to pellet the cells. The supernatant was 
poured off and any excess liquid was blotted and removed using a pipette. The cells 
were resuspended in 100 p.1 of chilled TGE solution (50 mM glucose, 25 mM Tris-
HC1 pH 8.0, 10 mM EDTA). 200 p.l of freshly prepared 0.2 N NaOH, 1% w/v SDS 
was added, mixed gently by inverting the tubes 5 times, placed on ice, 150 0 of 
chilled 3 M potassium! 5 M acetate solution was added and vortexed inverted tubes 
for 10 sec. Cell debris was pelleted by centrifugation (12,000 g, 5 mm, 4°C), the 
supernatant was transferred to fresh tubes and DNA isolated by phenol/chloroform, 
ethanol precipitation. The DNA was resuspended in 50 tl TE solution. 
2.6.8.2. Large scale preparation 
2.6.8.2.1. Maxiprep Method 
Plasmid DNA from large-scale bacterial culture (250-
500 ml) was prepared using a MagicTM  Maxipreps DNA purification system 
(Promega) following suppliers instructions. A typical yield was 400-500 jig of 
plasmid DNA. This was the method employed to generate plasmids for routine 
analysis of recombinant DNA sequences. 
Overnight bacterial cultures were decanted into 3 x 150 ml vessels, cells 
were pelleted by centrifugation (14,000 g, 15 mm, 4°C), cells were resuspended in 1 
ml of cell resuspension solution (CRS: 50 mM Tris-HC1, pH 7.5, 10 mM EDTA, 
100 4g/ml RNase) using a wide bore pastette, another 15 ml of CRS and 15 ml of 
cell lysis solution (0.2 M NaOH, 1% SDS) was added and the solution was mixed 
gently but thoroughly by inverting several times. The cell suspension should 
become clear and viscous (can take up to 20 mm). 15 ml of neutralising solution 
(2.55 M KAc, pH 4.8) was added and mixed immediately by inverting several times. 
The solution was centrifuged (14,000 g, 15 mm, 4°C) and the clear supernatant 
carefully decanted into clean centrifuge bottles. 0.6 volumes of isopropanol was 
added, the solution was mixed by inversion and centrifuged (14,000 g, 15 mm, 4°C) 
before the supernatant was discarded. The DNA pellet was resuspended in 2 ml of 
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TE buffer. 1 41 of the DNA solution was checked by electrophoresis in a 1% w/v 
agarose gel. 
2 ml of DNA/FE solution was transferred into a 10 ml universal. 10 ml of 
Magic Maxiprep DNA Purification Resin (mix well; if necessary, warm the resin to 
25-37°C [5-10 mm] to dissolve any crystals. N.B. It is important not to use the resin 
until it is below 30°C) was added and mixed by inverting several times. A 
Maxicolumn tip was inserted into a vacuum manifold and the DNA/resin mix was 
transferred into the column. A vacuum was applied to suck the liquid through the 
column. 13 ml of column wash solution (200 mM NaCl, 20 mM Tris-HC1 pH 7.5, 5 
mM EDTA) was added, the solution was allowed to pass through the column, 
another 12 ml of column wash solution was added, the solution was allowed to pass 
through the column, 5 ml of 80% v/v ethanol was added and the resin was allowed 
to dry (10 mm). The column was removed from the vacuum manifold and placed 
into a 50 ml universal (reservoir). 1.5 ml of preheated TE buffer was added to the 
column, after 1 min the column/reservoir was centrifuged (2.5 K, 5 mm), the DNA 
solution was retained in the reservoir and the column was discarded. The DNA 
solution usually contained some resin. The resin was removed by transferring the 
solution into an microcentrifuge tube and microcentrifugation (12,000 g, 5 mm). 
The supernatant which contained the dissolved plasmid DNA was removed 
carefully. The DNA concentration was estimated by 0D260 or in a gel. The DNA 
was stored at -20°C. 
2.6.8.2.2. CsCl-EtBr gradient method 
The caesium chloride (CsCl)-ethidium bromide (EtBr) 
gradient centrifugation method described by Sambrook et al., (1989) was used to 
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purify plasmid DNA. A high degree of purity was necessary when generating the 
riboprobe expression vectors for the tissue in situ experiments (see 2.10.1.). 
Plasmid DNA was produced using the Maxiprep method described above. 
Each gradient contained —100 jig of plasmid DNA, 4.75 g of CsC1, 250 p.1 of EtBr 
(stock = 10 mg/ml) in a total volume of 5.6 ml of TE buffer. The solution was 
mixed gently to dissolve the CsC1 and transferred into Beckman Quick-Seal tubes. 
Enough liquid was added to make each tube weigh 9.7-9.8 g. The tubes were heat-
sealed, placed into a NVT 65.2 vertical rotor (Beckmann) and ultracentrifuged 
(50,000 rpm, 16-18 hr, 20°C, zero deceleration) in an L8-M ultracentrifuge 
(Beckmann). The lower plasmid band was removed (see 2.9.4) and made up to 5 ml 
with distilled water. The following steps were performed 2-4 times (EtBr 
extraction) until the top phase was completely clear [5 ml of butan-1-ol was added, 
the tubes were inverted several times and centrifuged (2,500 rpm, 3 mm, r.t.), the top 
phase was carefully removed]. The clear solution was transferred into Corex tubes 
and the DNA was precipitated out of solution (see 2.6.3.) except that 2 volumes of 
70% v/v ethanol was used instead of 2 volumes of 100% ethanol (the water in the 
ethanol prevents the CsC1 precipitating). The DNA pellet was resuspended in TE 
buffer and stored at -20°C. 
2.6.9. Preparation and analysis of mouse mammary genomic DNA 
High molecular weight genomic DNA was prepared by 
avoiding vigorous pipetting or vortexing. 
Mammary tissue (0.5-1.5 g) was frozen in liquid nitrogen immediately after 
dissection from the animal. Frozen tissue was pulverised and ground to a fine 
powder under liquid nitrogen in a pestle and mortar (precooled), the powder was 
transferred into a 50 ml universal containing 6 ml of lysis buffer (10 mM Tris-HC1 
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pH 8.5, 400 mM NaCl, 2 mM EDTA, 0.5% w/v SDS), 0.5% w/v SDS and 2 ml of 
pronase solution (1 mg/ml pronase [Sigma], 1% w/v SDS, 2 mM EDTA), the 
solution was inverted several times to disaggregate any lumps of powdered tissue 
and incubated at 55°C overnight with gentle agitation. The solution became clear 
due to proteinase digestion. 2 ml of 6 M NaCl was added, the solution was mixed 
well for 15 sec and centrifuged (3,000 rpm, 15 min,r.t.). The supernatant was 
decanted into a clean tube, phenol/chloroform extractions were performed (see 
2.6.2.), 5 ml of isopropanol was added and mixed gently by inverting to precipitate 
the DNA. DNA is seen as fine "stringy" white material floating in the solution. 
DNA was hooked out using a pasteur pipette (melted and shaped into a hook), air 
dried for 5 mm, washed twice in 70% v/v ethanol, air dried for 5 min and dissolved 
in microcentrifuge tubes containing 500 p1 of 1/10th TE buffer. The samples were 
stored at -20°C once the DNA was dissolved (the DNA can take up to 24 hr to go 
into solution). The DNA concentration was determined by measuring the 
absorbance at 260 nm (1/100 th dilution of each sample in TE buffer). 
10 .tg of mouse mammary DNA was restriction enzyme digested for 5 hr at 
37°C, a 1/4 volume of loading buffer (40 mM EDTA pH 7.9, 0.1% w/v SDS, 30% 
w/v ficoll 400, 0.1 mg/ml bromophenol blue) was added and the solution was heated 
to 60°C for 5 mm. The samples were cooled to r.t. and loaded into 0.8% w/v agarose 
gels. Gels were usually run overnight at 20 V or for 6 hr at 100 V (constant 
voltage). 
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2.6.10. Southern blotting 
2.6.10.1. Transfer onto Hybond-N membrane 
The aim is to transfer the DNA from the gel onto a 
membrane so that the DNA can be examined for the presence of specific sequences 
(Southern, 1975). This is achieved by the flow of liquid through the gel and 
membrane and UV crosslinkage of DNA with a membrane as described by 
Sambrook et al., (1989). 
Gel was soaked in 500 ml of 0.25 M HC1 for 2 x 15 mm (termed 
depurination: fragmentation of the DNA to ensure transfer of all DNA, 
independently of initial size [essential if fragments >8 kb are to be transferred]), 
briefly in distilled water (to remove excess acid), 500 ml of 0.5 M NaOH/1.5 M 
NaCl for 2 x 15 mm (hydrolysis of the phosphodiester backbone at the site of 
depurination), briefly in distilled water, 500 ml of 0.5 M Tris-HC1 pH 7.4/3 M NaC1 
for 2 x 15 mm (neutralise and hence terminate hydrolysis), briefly in distilled water. 
The gel was placed onto a sheet of 3 MM paper (moistened with 20 x SSC) 
with the ends of the paper resting in a reservoir of 20 x SSC, Saran wrap (Dow) was 
placed around the edges of the gel so that capillary action could only occur through 
the gel, a sheet of Hybond-N (Amersham) [cut to the size of the gel and moistened 
with 2 x SSC] was placed onto the surface of the gel taking care to avoid trapped air 
bubbles (bubbles block transfer; if they occurred a glass pipette was used to "roll" 
them out), 2 sheets of 3 MM paper (moistened with 2 x SSC) were layered on top of 
the Hybond-N, a stack of paper towels was placed on top of the 3 MM paper and 
finally an -500 g weight was placed on top of the stack to keep all layers 
compressed. Transfer was allowed to occur overnight. 
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After transfer the stack was disassembled down to the Hybond-N membrane, 
the wells were marked using a soft pencil, the membrane was washed briefly in 2 x 
SSC and the DNA cross-linked with the membrane by UV irradiation (Stratalinker). 
The membrane was air-dried and wrapped in cling-film until ready for hybridisation 
(blots can be stored indefinitely like this but care must be taken not to chip or crack 
the now fragile membrane). 
2.6.10.2. Transfer onto Zeta-Probe GT membrane 
The procedure was identical to that described for 
transfer Onto Hybond-N membranes except for the following steps. The acid 
depurination step was performed using 0.25 M HC1 for 10 mm. After depurination 
the gel was rinsed briefly in distilled water (no further treatment of the gel was 
necessary) before being incorporated into the gel stack as described above except 
that Zeta-Probe membranes (Bio-Rad) were used instead of Hybond-N membranes 
and 0.4 M NaOH was used instead of 20 x SSC. Transfer was complete after 4-6 
hours. 
2.6.11. Preparation of radio-labelled DNA probes and hybridisation to 
Southern blot membranes 
Both methods described below are based on the method 
described by Feinberg & Vogeistein (1983, 1984). The cDNA strand is synthesised 
by the Klenow fragment of E. coli DNA polymerase I using the 3'-hydroxyl 
terminus of random oligonucleotides as primers. Modified deooxyribonucleoside-
triphosphates present in the reaction are incorporated into the newly synthesised 
cDNA strand. The first method utilises the Multiprime DNA Labelling Kit 
VJII 
(Amersham); the second method utilises a pre-mixed High Prime solution 
(Boehringer Mannheim). 
2.6.11.1. Multiprime DNA labelling method 
10-50 ng of probe DNA was made up to 27 p1 with 
distilled water. The DNA was denatured by placing the microcentrifuge tube in 
boiling water for 2 min followed by placing the tube on ice for at least 5 mm. To 
this was added: 
	
38.0 p1 	distilled water 
10.041 	Multiprime buffer solution* 
5.0 j.tl Primer solutiont 
2.0 J.tl Enzyme solutiont 
5.0 i.tl [a32P]dCTP (Amersham) 
* 100 lLM of each dATP, dGTP, and dTTP in 0.3 M Tris-HC1 pH 7.8, magnesium chloride and 2-
mercaptoethanol [Amersham] 
t random hexanucleotides in an aqueous solution containing nuclease-free BSA [Amersham] 
t 1 U/pi DNA polymerase I "Klenow" fragment in 50 mM potassium phosphate pH 6.5, 10 mM 2-
mercaptoethanol, and 50% v/v glycerol [Amersham] 
This was gently vortexed and microcentrifuged (5 sec pulse) to bring all the 
liquid to the bottom of the microcentrifuge tube. The reactions were incubated in a 
37 °C water bath for 30 mm. 
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2.6.11.2. High Prime DNA labelling method 
"High Prime" operates on the same principle as the 
Multiprime labelling system except that all the constituents are within a single 
reaction mixture. One vial containing 200 j.tl of random primer mixture contains: 1 
U/j.il Klenow polymerase, 0.125 mM dATP, 0.125 mM dGTP, 0.125 mM dTTP, 5 x 
reaction buffer and random oligonucleotides in 50% v/v glycerol (Boehringer 
Mannheim). The High Prime DNA labelling system therefore reduces pipetting 
steps which is advantageous in enzymatic reactions. 
25 ng of probe DNA was made up to 11 il with distilled water and denatured 
(see above) before 4 j.tl of High Prime solution was added followed by 5 p1 of 
[a32P]dCTP. The samples were incubated at 37°C for 10 mm. 
2.6.11.3. Quantifying 32P-labelled DNA probes 
The following method utilises a trichioroacetic acid 
(TCA)/filter assay to separate unincorporated [a32P]dCTP's from labelled DNA 
probes. See Berger & Kimmel (1987) and references therein for a description of 
Cerenkov radiation detection. 
1 .tl of the reaction mix was spotted onto a filter (Watmann). Another 1 jil of 
the reaction mix was added to 1 ml of chilled 10% w/v TCA (to precipitate the 
labelled macromolecules [probe]), the tube was chilled on ice for 10 mm, a clean 
filter was placed in a vacuum clamp, 1 ml of TCA/probe DNA was pipetted onto the 
filter within the vacuum clamp, the filter was washed with 10 ml of chilled 10% w/v 
TCA followed by 5 ml of 100% ethanol (to dry the filter). Each filter was placed in 
a 20 ml scintillation vial (without scintillation fluid) and the specific activity was 
measured using a Minaxi Tri-Carb 4000 series (United Technologies Packard) 
scintillation counter (programme seven and a 60 sec sample time). Generally >60% 
incorporation was achieved using this method. If the incorporation was satisfactory 
13 tl of 2 M NaOH was added to denature the probe DNA. If incorporation was 
unsatisfactory another 1 p1 of Kienow was added to the sample and the reaction 
allowed to proceed for a further 15 min before the incorporation was re-checked. 
Generally the addition of an extra 1 p.1 of Kienow brought the incorporation up to 
>60%. However, if this failed, the whole process was repeated. If incorporation 
was still poor, fresh DNA probe was prepared. 
2.6.11.4. Hybridisation and washes 
Pre-hybridisation of membranes was performed in 
revolving glass cylinders using 50 ml of hybridisation solution (0.5 M disodium 
hydrogen orthophosphate [Na2HPO4], 7% w/v SDS, 1 mM EDTA) in a Techne 
Hybridiser HB-1D oven set at 65°C for 30 min. Hybridisation of probe to 
membrane-bound material was performed in the same cylinders using all of the 
denatured probe and 20 ml of hybridisation solution at 65°C overnight. 
Membranes were washed to remove unhybridised probe and background 
signal. First wash was 2 x 20 min in revolving glass cylinders using 50 ml of low 
stringency wash (2 x SSC, 0.1% SDS) followed by 2 x 20 min using 50 ml of high 
stringency wash (0.2 x SSC, 0.01% SDS), briefly in 2 x SSC and air dried before 
being exposed to X-ray film (AGFA; CURIX RP1) between intensifying screens in 
autoradiography cassettes at -70°C (2 hr - 2 weeks) or in Storage Phosphor Screens 
(Molecular Dynamics) at r.t. (30 mm - 72 hr). X-ray film was developed 
automatically using an X-ograph Compact x2 and Phosphor Screens were processed 
using a Phosphorlmager (Molecular Dynamics). If necessary, membranes were 
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stripped by placing them in boiling 0.1% w/v SDS and allowed to cool to r.t. before 
the membrane was removed. It was then ready for re-probing. 
2.6.12. Polymerase chain reaction (PCR) analysis of tail biopsy DNA 
A PCR assay was used for rapid screening of mice for the 
presence of the transgene during the backcross experiments. Primers and methods 
were essentially as described by Whitelaw et al., (1991). The bench and pipettes 
were wiped with 100% ethanol and a separate bottle of distilled water was used for 
PCR reactions to minimise the risk of DNA contamination leading to false positives. 
Tail-tip biopsies were taken from 6-8 week old mice and digested overnight 
at 37°C with proteinase K (200 mg/ml) in 0.3 M sodium acetate, 10 mM Tris-HC1 
pH 7.9, 1 mM EDTA, 1% w/v SDS. Samples were vortexed before being frozen at - 
20°C. Tissue debris and SDS were pelleted by microcentrifugation (12,000 g, 15 
mm, 4°C), 1 jil of the supernatant was pipetted under a drop of mineral oil (Sigma) 
in PCR microcentrifuge tubes and the DNA denatured by heating to 95°C for 15 mm 
before being cooled to 65°C in a Hybaid Omnigene PCR thermocycler. 50 41 of 
PCR reaction mix was added to each sample under the oil. The PCR reaction mix 
comprises the following: 
29.75 jil distilled water 
5.0 41 10 x buffer*  (Boehringer Mannheim) 
8.0 p.1 1.25 mM dNTP mix (Pharmacia) 
5.0 p.l dimethyl suiphoxide (DMSO) 
0.5 p.1 10 mM BLGI primer 
0.5 p.l 10 mM HPRT§ primer 
0.2541 Taq DNA polymerase (Boehringer Mannheim) 
48 
* 10 x buffer (10 mM Tris-HCI pH 8.3, 50 mM KCI, 1.5 mM MgCl, 0.01% gelatin) 
t BLO primers: 5'-GCT TCT GGG GTC TAC CAG GAA-3' and 5'-TCG TGC TFC TGA GCT CTG 
CAG-3 amplify a 246 bp segment of the 5' end of the BLG gene 
§ hypoxanthine-guanine phosphoribosytransferase (HIPRT) primers: 5'-GAG TTC CGG AAC TGC 
CTT TGG TG-3' and 5'-CTG TGC CAC COG GCG CAT GG-3' amplify a 332 bp segment of the 
HPRT gene 
Samples were placed in the PCR thermocycler and given 30 alternating 
cycles at 92°C for 30 sec and 65°C for 5 mm. Once the reaction was complete (3-4 
hr), 10 0 of PCR loading dye (15% w/v Ficoll 400,0.05% w/v SDS, 20 mM EDTA 
pH 8.0, 0.125% w/v orange G) was added to each sample, mixed and 30 41 
electrophoresed in 2% w/v agarose gelst (20 x 20 cm) containing 0.5 jig/ml EtBr at 
100 V for 30 mm. Control positive, negative and blank samples were used in every 
gel. 
Table 7. Range of separation for agarose gels 
tOptimal range 
Agarose 	 of separation 








Taken from Sambrook es al., 1989. 
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2.7. RNA ANALYSIS 
2.7.1. Preparation of total RNA from mouse mammary tissue 
All glassware, pipettes, tips and solutions used for RNA 
analysis were treated with diethyl pyrocarbonate (DEPC) to destroy ribonucleases 
and gloves were changed frequently (Berger & Kimmel, 1987; Sambrook et al., 
1989). 
Mammary tissue (0.5-1.5 g) was frozen in liquid nitrogen immediately after 
dissection from the animal. Frozen tissue was homogenised in 2 ml RNAzo1 B 
(Biogenesis Ltd) for 30 sec using an ultra-homogeniser (Janke and Kunkel). 2 x 1 
ml aliquots were added to 2 ml screw-capped tubes containing 100 jii chloroform. 
These were inverted repeatedly for 15 sec and put in ice for 15 mm, 
microcentrifuged (12,000 g, 15 mm, 4°C), the aqueous phase transferred into a clean 
microcentrifuge and the RNA precipitated using an equal volume of isopropanol 
(4°C for 15 mm). The samples were microcentrifuged (12,000 g, 15 mm, 4°C) to 
pellet the RNA. The pellets were washed twice with 75% v/v ethanol 
(microcentrifuge [12,000 g, 8 mm, 4°C] between washes). The RNA pellet was air 
dried for 10 min and resuspended in 200 .il of DEPC-treated distilled water (stored 
at -70°C) or in 200 p1 of 100% formamide (stored at -20°C; Chomczynski, 1992). 
The RNA concentration was determined by measuring the absorbance at 260 nm of 
a 1/100 th dilution of each sample in TE buffer. 
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2.7.2. Electrophoresis of RNA, Northern blotting and hybridisation 
Messenger-RNAs have secondary structures. Therefore 
denaturing gels are used for RNA electrophoresis (Berger & Kimmel 1987, 
Sambrook et al., 1989). 
10 jig of total RNA per sample was made up to 8 J.Ll with distilled water and 
added to 38 p1 of sample buffer (25 jil formamide, 8 p.1 formaldehyde and 5 p110 x 
MOPS). Samples were incubated at 65°C for 5 min and on ice for 5 min before 5 0 
of running dye (50% v/v glycerol, 0.1 mg/ml bromophenol blue) and 0.5 p1 of EtBr 
(10 mg/ml) was added to each. The samples were electrophoresed in denaturing 
1.5% w/v agarose gels containing 1 x MOPS buffer and 6.8% v/v formaldehyde 
using 1 x MOPS as the gel tank buffer. Northern blots were performed as described 
in section 2.6.10. except that there was no pre-treatment of the gel before blotting 
onto Hybond-N (Amersham) membranes. Preparation of probes and hybridisation 
conditions were identical to those described in section 2.6.11.. 
2.8. PREPARATION OF AGAR PLATES 
2.8.1. Plates containing antibiotic 
LB bottom medium (1% w/v tryptone, 0.5% w/v yeast extract, 
1.5% w/v agar, 0.1 M NaC1) was melted in a microwave and allowed to cool to 
"hand-hot". 1 ml of the appropriate antibiotic (e.g., ampicillin; stock = 50 mg/ml) 
was added to 500 ml LB bottom (final concentration of 100 p.g/ml), swirl mixed and 
poured immediately into petri dishes with a bunsen flame close by to create a 
convection current. Once the plates had set they were placed in a 37°C oven, upside 
down, with the lids half off, for 1 hr to allow excess moisture to evaporate off. 
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Plates were stored at 4°C until ready for use (shelf life of --2 weeks) or used 
immediately. 
2.8.2. Plates for blue/white screening 
Blue/white screening is a method for selecting recombinant 
plasmids that contain a sequence coding for the lacZ ct-peptide, interrupted by a 
multiple cloning site. Nonrecombinant plasmids produce a functional a-peptide 
which, by complementing the product of the host cell lacZ[zM15] gene, leads to the 
production of functional f-galactosidase. Bacterial colonies harbouring the 
lacZ[i\M15] gene on an F' factor and also containing a pGEM-4Z vector (see 
2.10.1.) develop a blue colour when plated on indicator media containing IPTG and 
X-gal. However, when the lac a-peptide is disrupted by cloning into the pGEM-4Z 
multiple cloning region (Fig. 7), the lac cx-peptide is usually not produced and no f-
galactosidase activity is produced. Therefore, bacterial colonies harbouring 
recombinant pGEM-4Z vector constructs are white. 
Agar plates were prepared as in section 2.8.1.. 70 .il of X-gal (stock = 20 
mg/ml in dimethyl formamide), 20 jd of IPTG (stock = 0.1 M) and 50-100 iii of 
transformed cells were pipetted onto the surface of the plates and the liquid was 
spread immediately over the surface of the agar using a sterile glass rod. The plates 
were incubated in an oven (37°C) overnight. 
2.9. PREPARATION OF LAMBDA PHAGE 
Two high titre lysates containing genomic phage clones of the mouse 
c-myc and Pvt-1 loci were a gift from Dr Konrad E. Huppi, Molecular Genetics 
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Section, Laboratory of Genetics, National Cancer Institute, National Institutes of 
Health, Bethesda, U.S.A.. 
2.9.1. XL-1 Blue MRA cells 
E.coli XL-1 Blue MRA cells [Genotype: L(mcrA)183, 
A(mcrCB-hsdSMR-mrr)173, e ndAl, 5ppE44, ihj-I,_gyrA96,  recAllacl were 
purchased from Stratagene. 16 0D600 units (16 0D600 units = an 0D600 of 0.5 in 32 
ml of inoculated medium at 600 nm wavelength) of XL-1 Blue MRA cells were 
used in LBM medium (1% w/v tryptone, 0.5% w/v yeast-extract, 0.5 M NaCl, 10 
MM MgC12) supplemented with 0.2% maltose (3-4 hr). Cells were harvested by 
centrifugation (5,000 g, 10 mm, 4°C), the supernatant was collected, 16 ml of 
chilled 10 MM  MgSO4 was added, the tube was flicked (not vortexed) until all the 
cells were resuspended, the sample was centrifuged (5,000 g, 10 mm, 4°C), the 
supernatant was collected, 8 ml of chilled 10 MM  MgSO4 (two washes with MgSO4 
because LBM medium is inhibitory to phage infection) were added, the cells were 
resuspended and the sample was stored at 4°C overnight. The cells were then ready 
to be used to estimate the titre of phage stocks, preparation of mini-stocks and large 
scale preparation of phage DNA (see below) 
2.9.2. Estimation of titre of phage stocks 
1 p.1 of phage stock was diluted 1,000-fold in SM phage buffer 
(0.1 M NaCl, 10 MM  MgSO4, 20 mM Tris-HC1 pH 7.5, 2% w/v gelatin), 1 p.1 of the 
dilution was added to 200 p.1 of XL-1 Blue MRA cells which were prepared the 
previous day (see 2.9.1.), the cells were incubated at 37°C for 20 mm (to allow 
phage time to attach to cells), 3 ml of molten (42°C) LBM-top agar (LBM with 7% 
53 
w/v agar) was added and the mixture was poured immediately onto LBM bottom-
agar (LBM with 15% w/v agar) plates (15 ml of molten agar poured into 90 mm 
plates). The plates were incubated at 37°C overnight. Lysis of cells causes plaque 
formation in a lawn of non-lysed cells. The number of plaques were counted and 
this number was multiplied by 106  to give the number of plaque forming units (pfu) 
in 1 ml of phage stock. A high titre is 10 8-10 10 pfu/ml. 
2.9.3. Preparation of a mini-stock of high titre phage 
One phage plaque was removed from a plate (as a plug, using 
a blue tip with the end removed). The plug was placed into 500 .il of SM buffer for 
2 hr at r.t. (allowed the phage particles to diffuse into the buffer), 200 p.1 of the SM 
buffer was added to an overnight preparation of cells (see 2.9.1.) which were 
incubated at 37°C for 20 min and poured onto agar plates (see 2.8. [without 
antibiotic, IPTG or X-gal]). Confluent lysis occured after an overnight incubation at 
37°C due to the high concentration of phage used. The plate was chilled to 4°C, 5 
ml of chilled SM buffer added to the surface of the plate, phage particles were 
allowed to diffuse into the buffer for 4 hr at 4°C with gentle shaking. The SM buffer 
was collected and mixed with 100 p.1 of chloroform and centrifuged (4,000 g, 10 
mm, 4°C). The supernatant was removed and mixed with chloroform (0.3% final 
concentration) and stored at 4°C until required. The titre was usually around 1010 
pfu/ml. 
2.9.4. Large-scale preparation of phage DNA 
8 ml of cells in SM buffer (prepared previous day [see 2.9.1.]) 
were inoculated with 1 p.1(1 x 1071010  pfu/pl; this value is dependent on the type of 
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phage) of high titre phage lysate. The cells and phage were incubated at 37°C for 20 
mm. This was added to 500 ml of LMB medium (supplemented with 10 mM 
MgSO4 but without maltose and already warmed to 37°C) and incubated at 37°C in 
a shaking incubator until lysis occured. The aim was to achieve an 0D600 = 1.3 (5-6 
hr) before it crashed down to an 0D600 = 0.3. The progress of cell growth was 
followed by measuring the 0D600 of a 1 ml sample from the culture every half hour. 
Lysis occurred when large lumps of bacterial debris were visible in the medium. 
5 ml of chloroform were added to the flask for 30 min at 37°C (ruptured any 
cells that had not already lysed), 3 mg of DNase I and 3 mg of RNase were added 
and the solution was allowed to stand at r.t. for 40 mm. The samples were 
centrifuged to remove cell debris (5,500 g, 10 mm, 4°C), the supernatant was 
decanted into a 11 flask, 50 g of PEG6000 and 29.22 g NaC1 (to precipitate the 
phage) was added, the solution was swirled to dissolve the PEG and salt. The mix 
was left at 4°C overnight. The phage were pelleted by centrifugation (5,500 g, 15 
mm, 4°C), the supernatant was discarded, 8 ml of SM buffer was used to resuspend 
the phage pellet, 4 ml of chloroform (to extract any protein) was added, the solution 
was inverted to mix and centrifuged (4,000 rpm, 5 mm). The supernatant (contains 
phage) was transferred into a fresh tube. 
CsCI gradients (1.5 ml of 56% CsC1 solution [25.6 g of CsCI dissolved in 20 
ml SM buffer and filtered through a 0.45 j.tm filter], 1.5 ml of 45%, and 2.5 ml of 
31%) were prepared in a 14 x 95 mm clear centrifuge tubes, the interface between 
the 56% and 45% bands was marked with an indelible marker (this is where the 
phage band appears), gently added the phage solution on top of the CsC1, the tubes 
were placed into a Beckman SW 28 rotor (balanced) and centrifuged (23,000 rpm, 
135 mm, 4°C, with zero deceleration) in a Beckman ultracentrifuge to "band" the 
phage particles (appear blue). Once centrifugation was complete the tubes were 
carefully removed and clamped in front of a black background. The blue band was 
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removed (ignored upper bands which are partially degraded phage heads etc.) using 
a 19 gauge needle and syringe. The volume removed was diluted with an equal 
volume of SM buffer, the phage were dialysed against a large excess (at least a 
1000-fold volume) of 50 mM Tris-HC1 pH 7.9, 10 MM M902, 10 mM NaC1 for 1 
hr with several changes of dialysis buffer (to remove the CsC1), the phage heads 
were disrupted in 20 pg/ml proteinase K, 0.5% w/v SDS, 20 mM EDTA (final 
concentration) at 37°C for 45 mm, the phage DNA was gently extracted with 2 x 
phenol/chloroform and 2 x chloroform (see 2.6.2.), and precipitated with 1 volume 
of isopropanol and a 1/10 th volume of 3 M NaAc, pH 4.5 at -20°C for 1 hr. After 
centrifugation, the DNA pellet was air dried and resuspended in TE buffer. 
2.10. TISSUE IN SITU HYBRIDISATION 
Preparation of mouse mammary tissue (fixing and sectioning) was 
performed at The Roslin Institute and the tissue in situ hybridisation experiments 
were performed at the MRC Human Genetics Unit (HGU), Western General 
Hospital, Crewe Road, Edinburgh, U.K. in collaboration with Dr Duncan Davidson 
and Ms Elizabeth Graham using methods described by Monaghan et al., (1991) and 
Angerer & Angerer (1992), and references therein. 
2.10.1. Construction of BLG expression vectors 
Riboprobes of between 200 bp and 1 kb are recommended for 
tissue in situ hybridisation experiments utilising 35 S-labelled probes and paraffin 
embedded tissue. Probes <200 bp give a reduced hybridisation signal and probes >1 
kb penetrate less effectively into fixed tissue. Riboprobes of —400 bp were designed 
because of convenient PstI restriction sites in both the DNA probe templates and as 
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a compromise between probe penetration and signal. This strategy also negated 
alkaline hydrolysis to alter the length of the probes. 
A 424 bp PsrI BLG cDNA fragment (originally from pLac-931: Gaye etal., 
1986) comprising all of exons 3, 4, 5, 6 and 6 bp of exon 2 and 81 bp of exon 7 was 
subcloned from pGEM-3 into a PstI site in pGEM-4Z (Fig. 7: Promega) in both 
orientations. 
Figure 7. pGEM-4Z vector circle map 
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Cloning the inserts in both orientations enabled synthesis of anti-sense (probe) and 
sense (control for non-specific background) riboprobes from the same promoter. 
The pGEM-4Z vector enabled ampicillin selection of transformed cells, blue/white 
screening for recombinants and a convenient cloning site close to a T7 RNA 
polymerase promoter that enabled highly efficient synthesis of mRNA in vitro. An 
off-centre internal Pvull site was used to check the orientation of the 424 bp PsrI 
fragment. It is important to have very clean expression vector preparations for in 
57 
vitro mRNA synthesis (aids precursor incorporation). Therefore large quantities of 
plasmid DNA was prepared by the method described in section 2.6.8.1.1., followed 
by CsC1-EtBr gradient centrifugation (see 2.6.8.1.2.). Expression vectors were 
linearized using the BamHI site (a site just downstream of the inserts and the Ti 
promoter) so that the transcripts were free from vector sequences (wastes isotope 
and increases the chances of background hybridisation), phenol chloroform 
extracted, ethanol precipitated and stored in DEPC-treated distilled water at -20°C. 
2.10.2. Construction of -casein expression vectors 
A 417 bp PsrI -casein cDNA fragment (originally from 
pCM13; Rosen, J., unpublished; Gupta etal., 1982) comprising 5 bp of exon 6 and 
412 bp of exon 7 was subcloned from pBR322 (a gift from Dr Bert Binas; current 
address : Max-Deibruck Centre, Berlin, Germany.) into a PstI site in pGEM-4Z in 
both orientations. An off-centre internal NdeI site was used to check the orientation 
the 417 bp PstI fragment. 
2.10.3. Coating slides with TESPA 
The tissue sections need to be fixed onto the slides, otherwise 
they float off during processing. This is achieved by coating the slides with TESPA 
(3-aminopropyltriethoxysilane [Sigma]) which acts as a tissue adhesive. The 
hydrophobic silane moiety of TESPA binds to glass, while its amino group, 
activated by aldehyde, is crosslinked to tissue. 
Slides were generally processed in batches of 10 or 20 with the slides lying 
horizontal in glass racks and subsequent washes and incubations performed in 200 
ml glass troughs. Batches of slides were washed in 10% v/v HC1, 75% v/v ethanol 
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for 10 sec, distilled water for 10 sec, 100% acetone for 10 sec and air-dried. The 
slides were coated with TESPA by immersing them in a solution of 2% v/v TESPA 
in acetone for 10 sec before two 10 sec washes in 100% acetone, distilled water for 
10 sec and air-dried. Slides were stored in a slide box with silica gel. 
2.10.4. Preparation of tissue 
Tissue was fixed in 4% w/v paraformaldehyde (PFA) in PBS, 
pH 7.2 overnight at 4°C with gentle agitation and washed in PBS for 30 min at 4°C 
with gentle agitation. PFA is a cross-linking fixative used to retain mRNA in 
sections during hybridisation and wash procedures. This fixative proved to be 
adequate for tissue fixation and preservation of morphology and yet enabled 
sufficient penetration of probe to target mRNA (methods that retain RNA and 
preserve morphology are usually not the same as those that afford high hybridisation 
efficiency). 
The following procedures were performed at room temperature with gentle 
agitation. The tissue was dehydrated in 30% ethanol for 15 mm, 2 x 30 min in 70% 
ethanol, 2 x 30 min in 100% ethanol and 60 min in fresh 100% ethanol. The ethanol 
within the tissue was substituted with CNP 30 (Pentone) by performing a set of 
washes in CNP 30 for 2 x 30 min and overnight in fresh CNP 30. The CNP 30 was 
subsequently substituted with paraffin (freshly melted; it deteriorates when stored in 
the melted form) by performing two washes in molten paraffin wax for 1 hr at 60°C 
(i.e., CNP 30 acts an intermediate solvent). The tissue was finally embedded in a 
mould containing fresh molten paraffin which was allowed to set. These tissue wax 
blocks were stored at 4°C (tissue can be kept in this way for at least several years). 
Paraffin embedding was used because it is simple, cheap and generally preserves 
tissue morphology better than frozen sections (mouse embryos). 
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2.10.5. Tissue sectioning 
The paraffin blocks with the embedded tissue were chilled to 
4°C. All instruments that would come into contact with the tissue including the 
rotary microtome (Leitz, Wetzlar), steel blades (Tissue-Tek III), manipulation 
utensils and empty histological water bath were wiped down with 100% ethanol. 
The water bath was filled with DEPC-treated distilled water and heated to 55°C. 4 
m sections were cut to generate a "string" of abutting sections which were floated 
onto the water. The paraffin wax was allowed to melt slightly (-1 mm) so that the 
tissue sections expanded to their original dimensions. Tissue sections were arranged 
onto slides in sets of abutting sections, usually four per slide. The slides were put 
into an oven (60°C) to dry overnight. Slides were stored in a slide box with some 
silica gel. 
2.10.6. Pre-hybridisation 
The aim of this step is to treat the tissue with proteinase K to 
partially remove proteins in order to increase target RNA accessibility to probes. 
All prehybridisation dishes were washed with 100% ethanol and each step 
was performed with gentle agitation. The slides were placed in a slide rack and 
treated with the following solutions 100% xylene for 2 x 5 mm (in fume hood) to 
remove paraffin from tissue (residual paraffin traps probe), through 100%, 90%, 
70%, 50% and 30% v/v ethanol solutions for 2 min each to rehydrate the tissue, PBS 
for 2 mm, 4% w/v PFA in PBS pH 7.2 for 10 mm, PBS for 2 x 2 min, proteinase K 
solution for 7.5 mm (50 mM Tris, 5 mM EDTA, 5 pg/ml proteinase K type XXVIII 
[Sigma]), PBS for 1 mm, 4% w/v PFA in PBS pH 7.2, distilled water for 10 sec, 0.1 
M TEA pH 8.0, 200 ml of 0.1 M TEA with 625 jil acetic anhydride for 2 x 5 mm 
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(used to decrease positive charge on the sections [reduce background] and help 
inactivate proteinase K), PBS for 2 mm, 0.85% NaCl for 2 mm, through 30%, 50%, 
70% and 90% v/v ethanol solutions for 2 min each and 100% ethanol for 5 min each 
to dehydrate the tissue. Finally the slides were air-dried and stored in a box with 
silica gel. 
2.10.7. Generation of 35S rUTP labelled riboprobes 
35S rUTP-labelled single-stranded antisense RNA probes and 
control sense RNA probes were synthesised by in vitro transcription from the T7 
promoter essentially as described by Melton et al., (1984). This type of probe is 
easy to generate and because they form a 1:1 duplex with target RNA, they provide 
a consistent and quantifiable measure of temporal and spatial gene expression. The 
following mix was prepared in microcentrifuge tubes at room temperature: 
3.0 111 	 10 x buffer (NEB) 
1.0 .il each 	10 mM rATP, 10 mM rCTP, 10 mM rGTP (Pharm.) 
1.0p.l 	 IMD1T 
3.0 j.tl 	 distilled water 
12.0 tl 	 35S rUTP (> I mCi / 100 ml) [Amersham] 
5.0 gI 	 0.5 - 1 mg/5 ml DNA template 
1.2 tl 	 RNase block (NBC) 
0.8 iii 	 T7 polymerase (NBC) 
The samples were vortexed briefly and pulse-centrifuged before incubating 
at 37°C for 25 mm. Another 0.8 l.tl of T7 polymerase was added and incubated for a 
further 25 min at 37°C. 2 p.1 of tRNA (stock = 10 mg/ml, Sigma) and 1 p.1 of DNase 
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(stock = 10 mg/ml, NEB) was added and incubated at 37°C for 10 mm. 2 p.1 of 100 
mM EDTA and 164 p.1 of 50 mM DTT, TE buffer were added to give a final volume 
of 200 p.1. The riboprobes were purified by phenol/chloroform extraction and 
precipitated overnight with ethanol (see 2.6.2. and 2.6.3.). 
The precipitated riboprobes were pelleted by microcentrifugation (12,000 g, 
30 mm, r.t.). Meanwhile the following solution was prepared to wash the pellets 
with; 100 i1 of 1 M DTT, 1.9 ml TE buffer and 8 ml of 100% ethanol. RNA pellets 
were washed twice with 500 p.1 of the wash solution then once with 100% v/v 
ethanol, allowed to air-dry for 10 min and resuspended in 25 p.1 of 50 mM DTT, TE 
buffer. 
2.10.8. Quantifying 35S rUTP labelled riboprobes 
1 p.1 of the probe was added to 19 p.1 of distilled water and 1 p.1 
spotted onto two 2.5 cm glass microfibre filters (Whatman). One filter was washed 
three times with chilled 5% w/v TCA and once with chilled 100% ethanol. The 
percentage incorporation was measured from the two filters using the counts per 
minute (CPM)B values. Converted CPM values to disintegrations per minute 
(DPM) by assuming 50% counting efficiency; therefore multiplied CPM values by 
two to arrive at the DPM values. An incorporation of 1.0 x 105  dpm per 1 41 of 
probe was the target level of activity. To achieve this value the probe was diluted 
with hybridisation solution. The hybridisation solution was prepared at r.t. and 
comprises the following: 
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50% 	formamide (deionized): to reduce the hybridisation temperature 
10% 	dextran sulphate : increases hybridisation rate 
1 x 	Denhardt's solution : reduces non-specific binding 
20 mM 	Tris-HCL, pH 8.0 
0.3 M 	NaC1: high salt to reduce electrostatic binding of probe to tissue 
5 mM EDTA 
10 mm 	sodium phosphate 
0.5 mg/ml 	tRNA : carrier 
50 mM 	DTT: prevents probe from oxidising and inhibits RNase 
The final solution also contained a 1/10 th volume of 50 mM DTT, TE buffer 
(N.B. It was necessary to calculate the total volume of hybridisation mix required 
for all of the probes before the solution was prepared. For example, four probes 
required about 5 ml of hybridisation solution given an average incorporation value). 
Probes were stored at -20°C in a box clearly labelled "radioactive" and used within 
48 hr of preparation. 
2.10.9. Hybridisation 
The probes were denatured at 80°C for 2 mm, cooled on ice 
and 10 41 of probe added directly onto each desiccated tissue section. An 
appropriately sized cover-slip was placed over the slides and the slides placed into a 
hybridisation box with the cover-slips facing upwards. Some tissue paper soaked in 
50% v/v formamide, 5 x SSC was placed into a slide box which was then sealed 
with tape. The box was placed into two water-tight plastic bags. The water-tight 
slide box was submerged in a water bath (55°C) overnight. 
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2.10.10. Post-hybridisation 
The hybridisation box was removed from the water bath and 
plastic bags and forceps used to transfer the slides into a jar containing 5 x SSC, 10 
mM DTT at 55°C for 30 mm. The cover-slips were removed at this stage. The 
slides were transferred into HS wash (5 ml 1 M DTT and 100 ml 50% v/v 
formamide, 2 x SSC, 0.1 M DTT) for 30 min at 65-68°C (the temperature affects the 
hybridisation and therefore is critical for controlling hybridised probe to background 
ratio), NTE wash (0.2 M NaCl, 10 mM Tris-HC1, 50 mM EDTA) for 2 x 5 min at 
37°C, NTE wash with 20 tg/ml RNase for 30 min at 37°C (the RNase digests any 
non-hybridised probe [single-stranded], therefore reducing background), NTE wash 
for 5 min at 37°C, HS wash for 30 min at 65-68°C. The remaining washes were 
performed at room temperature. 2 x SSC for 4 x 10 mm, 0.1 x SSC for 4 x 5 mm, 
30%, 50%, 70% and 90% v/v ethanol (each with 0.3 M ammonium acetate) for 1 
min each, 100% ethanol for 2 x 5 min and air-dried. 
2.10.11. Coating slides with emulsion 
This step was performed in a darkroom with a safety light on. 
10 ml of Ilford K5 emulsion was melted with 10 ml of distilled water at 42°C 
(melting takes 5-10 mm). Once the "plastic" emulsion had liquefied it was poured 
into a vessel designed for dipping slides. Slides were dipped into the molten 
emulsion and arranged in a light-proof box on their ends to allow excess emulsion to 
run off and enable even drying of the remaining emulsion on the slides. The box 
was sealed from light and stored for 3 hr to allow the emulsion to dry. Once dry, the 
slides were arranged in a slide box, wrapped in foil and stored at 4°C for 2-6 weeks. 
2.10.12. Development of emulsion-coated slides 
The slides were allowed to reach room temperature before 
proceeding (3 hr). The slides were unwrapped in the dark room with the safe-light 
on and immersed in Kodak developer for 4 mm, distilled water for 10 sec, AMP FIX 
for 5 min and distilled water for 20 mm. The slides were carefully wiped to remove 
any remaining emulsion and dipped in 1% w/v methylene blue for 15-30 sec (to 
lightly stain the mammary tissue) and rinsed under a tap and air dried (do not dry in 
an oven as this melts the emulsion). It is important that the slides are dry before 
proceeding. Slides were mounted using DPX and clean cover-slips (any residual 
liquid on the slides crystallises in the DPX). 
2.10.13. Photography of tissue in situ slides 
Tissue in situ slides were examined using bright-field 
illumination on an Olympus BH-2 microscope fitted with neutral density filters 25 
and 6, an Olympus BH2-SC swing-out condenser and an SPlan x4 objective. An 
Olympus U-FT focusing telescope aided sharp focusing of the images which were 
recorded using an Olympus C-35AD-4 camera and Kodak Extachrome 64T film. 
2.11. CHROMOSOME FLUORESCENCE IN SITU HYBRIDISATION (FISH) 
Chromosome fluorescence in situ hybridisation experiments were 
performed at the MRC HGU, Western General Hospital, Crewe Road, Edinburgh, 
U.K. with guidance from Ms Muriel Lee and Ms Judith Fantes using methods 
essentially as described in Fantes et al., (1995) and references therein. 
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2.11.1. Preparation of mouse lymphocyte cells 
Homozygous and hemizygous transgenic mice were 
sacrificed, their spleens removed and placed in petri dishes containing RPMI 1640 
medium supplemented with 10% v/v foetal calf serum (FCS). Cells were 
disaggregated by puncturing the spleen using 26-gauge needles and medium forced 
through the tissue using a syringe, taking care not to take medium containing cells 
up into the syringe as this damages the cells. Cells were transferred into universals, 
centrifuged (600 g, 6 mm), supernatants removed and cell pellets resuspended in 6-
10 ml of fresh medium. Cells were stained by mixing 250 xl of the cell suspension 
with an equal volume of methylene blue. To calculate the cell density 7 p1 of the 
stained cell suspension was placed in a haemocytometer (Weber Scientific 
International Ltd). The haemocytometer has a chamber with a height of 0.1 mm and 
an etched grid of 1 mm 2 (subdivided into 625 smaller squares). The volume defined 
by the grid was 1 x 10 ml. To calculate the number of cells per ml the total 
number of cells over the grid was multiplied by 2 x iOn. Depending on the cell 
density the preparation was diluted or concentrated to a density of 1 x 107  cells/ml in 
RPMI medium, 10% v/v FCS, 50 4g/m1 lipopolysaccaride. 5 ml aliquots were 
incubated at 37°C for 44-46 hr. After this period the cells were arrested at 
metaphase by adding 100 ng/ml colcemid (Gibco BRL), a microtubule poison, and a 
further incubation at 37°C for 45 mm. Cells were harvested by centrigugation (600 
g, 5 mm). 10 ml of 75 mM KC1, a mildly hypotonic solution that swells lymphocyte 
cells and lyses erythrocytes, was slowly added with agitation to resuspend the cell 
pellet. After 10 min the cells were centriguged (600 g, 5 mm), the supernatant 
removed and the cells fixed with a 3:1 mix of methanol: glacial acetic acid prepared 
fresh each time. Cells were left overnight in fixative followed by three more washes 
in fixative. Cells could be stored at -20°C in 8 ml of fixative at this stage. 
RR 
2.11.2. Preparation of slides 
Good quality chromosome spreads are essential for a 
successful FISH experiment. This stage in the protocol is the most difficult to 
control. 
Glass slides were soaked in a dilute solution of HC1 in ethanol and wiped 
with muslin to ensure clean slides. Fixed cells were removed from storage at -20°C 
and allowed to warm to r.t. before centrifugation (600 g, 5 mm). The supernatant 
was removed and cells resuspended in 0.5-2 ml of fresh fixative depending on the 
quantity of cells (one can judge the relative cell numbers by how opaque the solution 
appears). The cells were taken up into a narrow-mouthed pastette and dropped onto 
clean slides from a height of about 30 cm in a humidity of >50% (often aided by 
steam from a boiling kettle). The spreading of the dropped liquid on the surface of 
the slide was aided by breathing first on the slide to coat it with a thin layer of 
moisture and gently blowing on the slide immediately after the drop had landed. 
This process results in metaphase chromosome spreads of differing quality. The 
best slides were selected by examining the chromosomes using a phase contrast 
microscope (Leitz Orthoplan). The region of the slide containing the highest density 
of cells was marked on the edge of the slide using a diamond pencil. The slides 
were put in a vacuum dessicator for 48-72 hr to allow the chromosomes to "age" 
before any further work was performed with them. 
2.11.3. Giemsa banding (G bands) 
Slides were placed in a coplin jar containing pre-heated 2 x 
SSC for 1 hr at 60°C, 0.5% trypsin (DIFCO) in PBS for 5 sec. 4% w/v Giemsa's 
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R66 Stain (BDH) in 1 M Tris-HC1, pH 6.8 for 20 mm, washed with distilled water, 
air-dried and mounted in DPX (BDH). 
2.11.4. Karyotyping 
G-banded chromosomes were visualised using a Leitz 
Ortholux microscope fitted with a CCD camera. Chromosomes were "digitised" and 
partially karyotyped using the MRC HGU Fip-2 (KMR programme) computer 
assisted chromosome analysis system (Piper & Lundsteen 1987; Graham & Piper 
1994), visualised on a Digivision screen and images printed using a Mitsubishi 
video copy processor. The partial karyotypes were completed using >15 good 
metaphase chromosome spreads (for each line) with assistance from Ms Muriel Lee. 
2.11.5. Generation of biotin and digoxigenin labelled DNA probes 
DNA probes were labelled using a nick translation method 
essentially as described by Langer-Safer et al., (1982). Nick translation is used to 
label DNA fragments of >1 kb. The process utilises DNase Ito create single-strand 
nicks in double-stranded DNA. The 5'-3' exonuclease and 5'-3' polymerase actions 
of E. coli DNA polymerase I remove stretches of single-stranded DNA starting at 
the nicks and replaces them with new strands. In doing so, labelled dNTPs are 
incorporated into the probe DNA (can be insert, plasmid, lambda, cosmid or DNA 
from a PCR reaction). The nick translation reaction comprises the following: 
2.0 p.! 	10 x nick translation salts* 
2.5 pJ each 	0.5 mM dATP, dCTP, dGTP 
2.5 p.1 	0.5 mM bio- 1 6-dUTP or (1.0 p.! dig- il -dUTP + 
1.5 p.10.5 mM dTFP) 
1.0111 	DNase (stock =2 p.g/mlt) 
6.0 p.1 	Probe DNM (500 ng, diluted to 6 p.d with ddH20) 
1.041 	DNA polymerase I (1OU/pl) 
* nick translation salts (0.5 M Tris-HCI, pH 7.5, 0.1 M Mg s04 , 1 mM DTT, 500 p.g/ml BSA 
fraction V) (Boehringer Mannheim) 
1 DNase I (1 mg/mI in glycerol) was diluted to 2 .Lg/ml in activation buffer (10 mM Tris-HC1, pH 
7.4, 5 mM MgCl, I mg/mI BSA fraction V) at 4°C 
§ genomic ovine BLG clone pSS1tgXS (Simon et al., 1987) or mouse major satellite DNA (Pietras et 
al., 1983) or minor mouse satellite DNA or mouse genomic probes for Pvt-1 or c-myc 
The mixture was gently vortexed and microcentrifuged (5 see) to concentrate 
the solution at the base of the microcentrifuge tube. The samples were incubated at 
15°C for 90 mm. The reaction was stopped by adding 2 p.1 of 0.2 M EDTA and 1 p.1 
of 5% v/v SDS. 
Labelled DNA probes were separated from unincorporated dNTPs using 
Sephadex G50 columns (Pharmacia). Each column was inverted several times to 
resuspend the gel and placed upright to allow the gel to settle (10 mm). The top and 
bottom caps were removed and the column was allowed to drain. The column was 
washed with 3 x 1 ml of TE buffer and centrifuged (800 g, 4 mm) to drain excess 
buffer. The labelled DNA was added to the top of the column (column is placed in a 
universal to collect the eluate), centrifuged (800 g, 4 mm) and the eluate collected 
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(75-100 p.1). This contains the labelled DNA probe and is ready for use. The probes 
were stored at -20°C. Labelled probes can be stored for years at -20°C. 
2.11.6. Quantitation of label incorporation 
Labelled probes were diluted 1 x 10-3  and 1 x 10 in TE 
buffer. 1 pi of each dilution was spotted twice onto a grided nitrocellulose filters 
(Schleicher & Schuell) [filters were pre-washed in distilled water for 2 mm 
followed by a 20 min wash in 20 x SSC and air dried. This preliminary wash in 
high salt helps to keep the dots small. The filters can be stored at r.t. for several 
months], each spot was allowed to dry and a further 1 p.1 of each dilution was spotted 
onto just one of the previous spots to give labelled probe ratios of 20:10:2:1. On the 
same membrane 20, 10, 2, and 1 pg of labelled lambda DNA (Boehringer 
Mannheim) was spotted as a comparison. The spots were air-dried and the probes 
were cross-linked to the membrane by exposure to 30 mJ of UV irradiation. 
Filters were soaked with gentle shaking at r.t. for 5 min in 100 ml of buffer 1 
(0.1 M Tris, 0.15 M NaCl, pH 7.5), 60°C for 40 min in 100 ml of buffer 2 (0.1 M 
Tris, 0.15 M NaCl, 3 % w/v BSA fraction V, pH 7.5), r.t. for 15 min in 10 ml of 
buffer 1 plus 10 p.l of streptavidin alkaline phosphatase (Gibco BRL) for biotin 
detection or with 10 p.1 of anti-digoxigenin alkaline phosphatase (Boehringer 
Mannheim) for digoxigenin detection (both can be done together if there are two 
probes on the same filter with different labels). Filters were washed for 2 x 10 mm 
in 200 ml of buffer 1 and in 100 ml of 0.1 M Tris-HC1, pH 9.5 for 5 mm. The filters 
were sealed in polythene bags containing 5 ml of 0.1 M Tris-HC1, pH 9.5 and 2 
drops each of solutions 1, 2, and 3 from the BCIP/NBT alkaline phosphatase 
substrate kit IV (Vector). The bags were stored in the dark for 1 hr. This process 
results in a colour reaction that is proportional to the amount of labelled probe DNA 
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on the filter and allows a comparison with the lambda standards on the same 
membrane. For example, a matching set of spots indicated a probe concentration of 
10 p.g/ml. 
2.11.7. Pre-hybridisation 
All further treatments of slides were performed in glass racks 
and immersion in 200 ml of the appropriate solution (with gentle agitation) in glass 
troughs at r.t. unless otherwise stated. Slides were immersed in 100 ig/m1 RNase in 
2 x SSC for 1 hr at 37°C (this step is only necessary when the slides have not 
already been through Geimsa staining), briefly washed in 2 x SSC, through 70%, 
90%, and 100% ethanol (freshly prepared) for 2 min each to dehydrate the 
chromosomes and dried under vacuum. Slides were transferred into a pre-warmed 
metal rack and put in an oven set at 70°C for 5 mm. Slides were immediately 
denatured in 70% v/v formamide, 2 x SSC for 3 min at 70°C (2 min if the slides 
have been Geimsa stained), quickly transferred into ice-cold 70% v/v ethanol, into 
90% and 100% ethanol solutions for 2 min each to dehydrate the chromosomes and 
dried under vacuum. The slides were then ready for the addition of the probe. 
2.11.8. Preparation of probe for hybridisation 
25 ng of probe was added to 0.5 ng of Cot I DNA (Gibco 
BRL) and 5 gg of salmon sperm DNA (Sigma). Two volumes of 100% ethanol 
were added to this, mixed and spun down under vacuum until all the liquid had 
evaporated leaving the precipitated DNA. Probes were resuspended in 10 41 of 
hybridisation solution (50% v/v deionised formamide*,  2 x SSC, 1% v/v Tween 20, 
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10% v/v dextran sulphate) by leaving it on the bench for 1 hr. Pre-hybridisation and 
preparation of the probe was performed concurrently. 
* 
Deionize 50 ml of formamide with 5 g of Amberlite monobed NB-i resin (BDH) by stirring for an 
hour in a fume hood. Store frozen in aliquots of 0.5 ml. For hybridisation mix only. 
2.11.9. Hybridisation 
The probe was denatured at 70 °C for 5 min followed by 15 
min at 37°C. The slides were warmed to 37°C on a hot-plate. 10 JIl of probe was 
spotted onto the region with the highest density of cells (marked earlier). A clean 20 
x 20 cover-slip was placed on top of the probe and the cover-slip was sealed using 
rubber cement (TipTop). The slides were placed in a metal tray in a 37°C water 
bath overnight. 
2.11. 12. Post-hybridisation 
The rubber seal was peeled off and the slides washed in 50% 
v/v formamide in 2 x SCC at 45°C (4 x 3 mm), 2 x SSC at 45°C (4 x 3 mm), 0.1 x 
SSC at 60°C (4 x 3 mm) and transferred into 4 x SSC, 0.1% v/v Tween 20 at r.t.. 
2.11.13. Preparation and hybridisation of antibodies 
Biotin-labelled probes were detected using sequential layers 
of avidin-FITC (AVFITC) or avidin-Texas Red (AVTR), biotinylated anti-avidin D 
(BAA, Vector) and another layer of fluorochrome-conjugated (the second and third 
layers were not always necessary). Digoxigenin-labelled probes were detected using 
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sequential layers of FITC anti-digoxigenin (Boehringer Mannheim) or Rodamine 
anti-digoxigenin, FITC anti-sheep (Vector) or TR anti-sheep (Vector). Antibodies 
were diluted in 5% w/v skimmed milk (Marvel) in 4 x SSC as follows: AVFITC and 
AVTR (1:500), BAA, FITC anti-sheep and TR anti-sheep (1:100), FITC anti-dig 
(1:40), Rodamine anti-dig (1:15). 
The antibodies and skimmed milk were centrifuged (12,000 g, 15 mm, 4°C) 
and the slides were "blocked" by incubating them on the bench with 40 j.tl of 
skimmed milk (5 mm). Each antibody was added directly to the slide, a cover-slip 
placed on top and incubated at 37°C for 30 min in a moist chamber. The slides were 
washed in 4 x SSC, 0.1% v/v Tween 20 (3 x 2 mm) at 45°C (for biotin detection) or 
37°C (for digoxigenin detection) between each incubation step. After the last 
incubation with antibody the slides were drained of excess liquid and 20 41 of 
antifadent containing propidium iodide (P1) or 4', 6-diamidine-2-phenylindole 
dihydrochloride (DAPI) was added and a clean cover-slip placed on top. The cover-
slips were sealed using a rubber cement (Pang). The slides were then ready to be 
analysed using fluorescence microscopy. 
2.11.14. Analysis of fluorescence images 
2.11.14.1. The confocal microscope 
All the P1-stained / FITC-labelled slides were analysed 
using a BioRad MRC600 confocal laser scanning microscope. This was fitted with 
a dual Al and A2 filter set which allowed simultaneous visualisation of P1 and FITC 
images. 
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2.11.14.2. The Zeiss microscope with CCD 
All DAPI-stained / FITC or TR-labelled slides were 
analysed using a Zeiss Axioplan fluorescence microscope. This was fitted with a 
triple band-pass filter set (Chroma) and a computer-driven excitation filter wheel 
which allowed sequencial visualisation of DAPI, FITC and TR images. 
Chromosomes were imaged using a cooled CCD camera fitted with a KAF 1400 
chip (Photometrics). Separate images of the chromosomes and probes were merged 
using an Apple Mackintosh Quadra 900 computer with software developed by 
Digital Scientific. Images were stored on SyQuest disc and printed using a Kodak 
ColourEase dye sublimation printer. 
2.12. PREPARATION AND ANALYSIS OF "NATIVE" CHROMOSOME 
SPREADS 
Immunofluorescence experiments were performed at the MRC HGU, 
Western General Hospital, Crewe Road, Edinburgh, U.K. with guidance from Ms 
Linda Nicol and Dr Peter Jeppesen using methods essentially as described in Nicol 
& Jeppesen (1994) and references therein. The CREST patient serum was a gift 
from Dr Peter Jeppesen. 
Lymphocyte cell culture and fixation procedures were performed as 
described in section 2.11.1.. Cells were resuspended in 4 ml of 75 mM KC1 
hypotonic solution and incubated for 10 min at 37°C, 20 il were transferred into 10 
ml of isotone (optimised sheath fluid for use in Flow Cytometry Instrumentation) 
and the cell density calculated using FACs flow (Becton Dickinson apparatus). 
Cells were diluted to a density of 2 x 10 5 cells/ml, 500 jil aliquots dispensed into 
Ames Cyto-Tek centrifuge buckets (Miles Scientific), centrifuged (2,000 rpm, 10 
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mm, r.t.), slides were removed from holders and allowed to air-dry (5 mm), 
immersed in KCM chromosome medium (KCM: 120 mM KC1, 20 mM NaCl, 10 
mM Tris-HC1 pH 8.0) for 10 min at r.t., the slides were transferred onto the bench 
and the area around the cells was dried. The slides were then ready to have 
antibodies applied. 
CREST patient serum was diluted 1/100 in 10% v/v normal goat serum in 
KCM (prevents background), centrifuged (12,000 g, 5 mm, r.t.), 40 p.1 of CREST 
antibody was applied to each slide, the chromosomes were covered with a small 
square of parafilm, the slides were incubated in a moist chamber at r.t. for 1 hr, 
slides were washed in KCM for 10 mm, 40 p.1 of anti-human IgG (Sigma Immuno 
Chemicals [F-0132]: ,y-chain specific) FITC conjugate (1/20 dilution in KCM) was 
added to each slide, the above incubation was repeated for 30 min,KCM for 10 mm, 
4% PFA for 10 min to fix the chromosomes, distilled water for 10 mm, air dried, 
counter stained with DAPI (see 2.11.13.) and examined using the Zeiss microscope 
with CCD (see 2.11.14.2.). Images were stored and the slide co-ordinates of each 
image noted before proceeding to perform FISH analysis using DNA probes (see 
2.11). 
Slides with native chromosomes were treated with xylene for 30 sec, with 
DNA ligase for 1 hr at 37°C (to repair any damage induced by the earlier 
fluorescence analysis), 10 mM EDTA for 5 mm, o.i M NaOH for 30 sec and 10 m 
Tris-HC1, pH 8.0 for 30 sec. An uncrosslinking step was performed (30 sec in 0.1 M 
NaOH, 30 sec in 10 mM Tris-HC1 pH 7.0, distilled water for 30 sec and a 10 sec fix 
3:1 methanol/acetic acid) before performing FISH experiments with BLG, c-myc 
and Pvr-] probes using methods described in section 2.11.. 
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CHAPTER 3 
TRANSGENE EXPRESSION LEVELS AND RELATIVE COPY 
NUMBER IN THREE TRANSGENIC LINES 
3.1. INTRODUCTION 
A genomic clone encoding ovine BLG was used to generate 
transgenic mice (Simons et al., 1987). Three lines of transgenic mice were 
established (lines 7, 14 and 45) that express the BLG protein at high levels in the 
milk. A study of lines 7 and 14 demonstrated that transcription was initiated at the 
BLG promoter and that the protein was limited to the secretory epithelial cells of the 
mammary gland (Harris et al., 1991). Expression of the transgene in line 14 
reflected the temporal regulation of 3-casein, an endogenous mouse milk protein 
gene. The expression profile of BLG during gestation was similar in sheep and in 
line 14 mice after compensation for the different lengths of pregnancy in the two 
species. Therefore the 5' cis-regulatory region of the transgene is capable of 
directing the correct temporal and spatial regulation of ovine BLG in mice. 
During this study (Harris et al., 1991) it was noticed that there were 
significant fluctuations in mRNA levels during a lactation cycle and significant 
variations in protein levels at mid-lactation (day 11) among animals of line 7 
(McClenaghan, M.; pers. comm.). Despite the vast amount research in transgenic 
technology there were few examples of unstable transgene expression in the 
literature by 1991 (Table 5, chapter 1). Though hypervariable expression of an 
HMGCR transgene had been docummented previously (Mehtali, M., Ph.D. thesis, 
University of Strasbourg, 1988; McClenaghan, M. and Lathe, R.; pers. comm.), this 
76 
project was initiated to investigate the cause of variable BLG transgene expression 
in mice. 
As part of a systematic study of BLG expression levels in lines 7, 14 and 45 
the following questions were addressed: (i) what are the precise levels of BLG 
protein in milk of each transgenic line?; (ii) do mRNA levels reflect protein levels?; 
(iii) are transgene arrays rearranged or deleted?; (iv) what is the nature of BLG 
mRNA expression in the mammary gland? 
To address these questions a BLG protein standard was prepared from 
pooled sheep milk (see 3.2.1.). Milk samples were taken (mid-lactation) from 
approximately 30 mice of lines 7, 14 and 45. Some differences have been described 
between the thoracic and inguinal glands of the mouse (e.g., a-lactalbumin 
expression in response to hormonal stimulation; Bolander, 1990). Therefore all 
samples were collected from the upper left or right inguinal glands which are 
regarded as equivalent. The mouse milk was collected from the upper left inguinal 
gland and used in SDS-PAGE analysis (3.2.3.). The mouse was then sacrificed and 
the same gland removed and dissected in half. Each half (always the same region of 
the gland for all the animals) was frozen in liquid nitrogen and used to prepare RNA 
(3.2.4.) or DNA (3.2.5.). By this means it was possible to obtain milk, RNA and 
DNA systematically derived from the same gland of the same animal. The upper 
right inguinal gland was not milked so as to preserve tissue morphology. This gland 
was removed and dissected in half before being. prepared for tissue in situ analysis 
(see chapter 5). 
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3.2. RESULTS 
3.2.1. Preparation of a BLG protein standard 
Quantitative analysis of BLG expression levels in the milk of 
transgenic mice required a BLG protein standard of known concentration. Although 
purified BLG is commercially available from a number of suppliers the purity is 
variable and the precise concentration is unreliable (due to variable quantities of 
water within the crystallised protein). Therefore it was necessary to generate a BLG 
protein standard and determine the exact concentration. 
BLG was purified from sheep milk following a method described by 
Aschaffenburg & Drewry, (1957). SDS-PAGE demonstrated that the BLG 
preparation contained only one detectable protein that co-migrated with the BLG 
present in sheep and transgenic mouse milk (Fig. 8A). Western blot analysis using a 
rabbit antibody against BLG confirmed the identity of the protein (Fig. 813). 
An accurate method for determining the nitrogen content and hence the 
protein content of a small sample is the micro-Kjeldahl method (Rowland, 1938; 
Davies & Law, 1983). This method was employed to determine the concentration of 
protein in the BLG preparation (Table 8). Four measurements (1.172, 1.167, 1.159, 
and 1.230 mg/ml) derived from replicate assays were averaged to 1.2 mg/mi. This 
value was used to calculate and prepare the BLG standards for quantitative SDS-
PAGE analysis of the milk samples collected from lines 7, 14 and 45. 
1 	2 	3 	4 	5 
Mkimm 
UQ 
B. 	1 	2 	3 	4 	5 	6 
Figure 8. SDS-PAGE and western blot analysis of purified ovine BLG 
(A) A 15% SDS-polyacrylamide gel stained with Coomassie Blue G-250. Equivalent 
amounts of defatted milk (0.16 p.1) were loaded. Lane 1: 5 p.1 of control mouse milk; lanes 2 
and 3: 1 jig and 2.5 jig of sheep BLG respectively; lane 4: 5 p.1 of pooled sheep milk; Lane 5: 
5 p.! of Iransgenic mouse milk (iNSt 89.2; Whitelaw et al., 1992). (B) A western blot of a 15% 
SDS-polyacrylamide gel. Lane 1: 5 p.1 of 1/125 defatted control mouse milk; lanes 2-4: 250, 
100 and 20 ng of sheep BLG respectively; Lane 5: 5 41 of 1/125 defatted BLG mouse milk 
(tSt 89.2); Lane 6: 5 p.! of 1/250 defatted pooled sheep milk. 
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Table 8. Calculation of the concentration of the BLG protein standard 
S ample* mean mean - ct x 0.09641 	x Dilutionl x 6.38* 	mg/ml- 
c1 0.227 
C2 0.210 0.218 
11 0.980 
120.980 0.980 0.762 0.073 0.367 (x5) 2.343 1.172 
21 0.600 
22 0.595 0.598 0.380 0.037 0.366 WO) 2.334 1.167 
31 0.410 
32 0.403 0.407 0.189 0.018 0.363 (x20) 2.319 1.159 
41 0.307 
420.329 0.318 0.100 0.010 0.386 (x40) 2.460 1.230 
2 x I ml of ovine BLG were combined and made up to a total volume of 10 ml with distilled water. 
This 10 ml was divided into 2 x 2 ml (sample 1), 2 x I ml (sample 2), 2 x 500 lii (sample 3), and 2 x 
250 jil (sample 4). is a distilled water control and therefore the baseline for samples 1-4; the 
values are the volumes of HCI added in each titration (see materials and methods), tthe mean of each 
sample minus the mean of c, Ii ml of HCI = 0.0952 mgN, ¶ fraction of the total 10 ml, §6.38 is the 
multiplication factor for the nitrogen content of bovine BLG, 'concentration of BLO for each 
dilution in mg/ml (the dilutions were prepared from 2 ml of BLG stock solution) 
Each quantitative SDS-polyacrylamide gel contained a 1 p.g and a 2 p.g BLG 
standard. These concentrations of BLG were within a linear range that went through 
the origin (Fig. 9). By comparing the BLG levels in transgenic mouse milk samples 
with ovine BLG standards enabled the calculation of the absolute BLG expression 
levels in milk samples. Each gel contained eight transgenic mouse milk samples 
and two BLG standards (1 j.tg and 2 jig). Therefore the BLG expression levels in the 
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Figure 9. Quantitation of BLG standards in five gels 
The area of the Coomassie blue-stained BLG peaks recorded by absorbance were calculated by 
weight. Measurements for I tg and 2 pg BLG standards in five SDS-polyacrylamide gels were 
generated at different stages of destaining. The BLG standards with the lowest peak measurements 
had been destained for the longest period (several hours). 
3.2.2. A quantitative assay for BLG expression levels in transgenic 
mouse milk 
SDS-PAGE analysis was employed to measure the BLG 
protein expression levels in >300 mouse milk samples. The results from this 
analysis were the basis of every experiment in this project and therefore exhaustive 
efforts were made to determine the most accurate and reproducible method for 
measuring BLG protein levels. The reproducibility of the assay was tested by 
repeatedly loading a pooled transgenic mouse milk sample into gels of differing 
thickness and polyacrylamide concentration, at different dilutions and under 
different gel scanning conditions. The following protocol was necessary to obtain 
F:.' 
reproducible BLG values for the same sample loaded in an identical fashion within a 
gel. Optimal results were obtained with 1.0 mm thick gels. Mouse milk samples 
were loaded as 1/200 dilutions (1/250 for some of the highest expressors in line 45) 
of the original sample. These dilutions brought the BLG values in the transgenic 
mouse milk* samples into the linear range of the BLG standards. Resolving gels 
were 20% polyacrylamide and the samples were run at 28 MA for 1 hr (stacking gel) 
and at 36 mA for 5-6 hr (resolving gel). This enabled the resolution of BLG and 
WAP (Fig. 10) so that BLG could be scanned as a discrete band. The BLG 
concentrations were determined by scanning densitometry. Each lane was scanned 
separately with the scanning beam set to the exact width of each lane; usually 9 mm 
for the milk samples and up to 12 mm for the BLG standards. For each scan the 
baseline and verticals for each peak were drawn in by hand because the automatic 
settings yielded variable results. From resulting traces, peaks were cut out and 
weighed using a fine balance. The weight of the peak-trace was proportional to the 
size of the peak and hence the concentration of BLG. 
The data presented in table 9 demonstrates that the weight of any one peak 
(and therefore the amount of BLG) within a gel could be expected to lie within ±4% 
of the true value 95% of the time. This was felt to be an acceptable margin of error. 
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Figure 10. SDS-PAGE analysis of mouse milk 
Mouse milk samples were electrophoresed in 20% polyacrylamide gels (1 mm thick) under 
reducing conditions and stained with Coomassie Blue. The lanes were as follows: LMM, low-
molecular-mass standards (phosphorylase b [97.4 kDal,  BSA [68 kDa], ovalbumin [43 kDa], 
carbonic anhydrase [29 kDa], soybean trypsin inhibitor [20.1 kDa], lysozyme [14.3 kDa]);  BLO, 
2 p.g of ovine BLG; lanes 1-5, 1/200 dilutions of defaued transgenic mouse milk samples from 
line 7; C, 11200 dilution of a defatted control non-transgenic mouse milk sample. 
Lane 	BLG* 
Table 9. Reproducibility study of BLG values 
1 550 
2 549 15 tl of a transgenic mouse milk sample (1/125 
3 570 th dilution) was loaded into eight lanes within a gel 
4 550 and the BLG values determined by SDS-PAGE/ 
5 567 Coomassie Blue-staining and scanning 
6 574 densitometry. 
7 557 * The weight of each BLG peak in grams (x 10); 
8 543 n = 8, mean = 557.5, s.d. = 11.43, c.v. = 2% 
3.2.3. BLG protein expression levels in lines 7, 14 and 45 
Variable levels of BLG had been observed (although not 
quantitated) within line 7. Systematic quantitative analysis of lines 7, 14 and 45 was 
performed to determine the range of BLG protein expression levels within these 
lines. The results are presented in Table 10 and Fig. 11. 
Line 14 expressed BLG in a stable fashion with only 3.5 mg/mi separating 
the lowest and the highest expressor (5-8.5 mg/ml). Levels of expression in the two 
remaining lines differed considerably between individual animals. BLG levels in 
milk of line 45 animals ranged from 16 to 30 mg/ml, while in line 7 there was a 8-
fold difference between the lowest and highest BLG expressors (3 to 23.9 mg/ml). 
Table 11 shows the standard deviations (s.d.) and coefficients of variation (c.v.) for 
BLG protein expression in the three lines. Lines 7 and 45 had larger s.d. values than 
line 14. The s.d. values are a measure of the variance within a population. 
Therefore higher s.d. values in lines 7 and 45 was expected, based on the 
distributions presented in the histograms in Fig. 11. The c.v. for line 45 was similar 
Table 10. BLG protein expression levels in lines 7, 14 and 45 
Line 7 BLG (mg/ml) 	Line 14 BLG (mg/ml) 	Line 45 BLG (mg/ml) 
F4 23.9 H8 8.5 E2 30.0 
FlO 21.5 F4 8.3 Dl 29.6 
F5 16.8 110 8.3 A3 29.1 
F7 14.9 16 8.0 J2 28.7 
F2 12.7 114 7.9 GI 28.3 
D5 12.3 14 7.9 E3 28.1 
E3 13.1 H3 7.4 H4 27.0 
Fl 10.1 F13 7.4 Ii 25.7 
D3 11.4 C5 7.3 A2 25.4 
E3 11.3 13 6.8 14 25.1 
F8 11.3 1110 6.7 12 25.0 
F4 10.7 G3 6.7 13 24.9 
F3 9.6 Iii 6.5 El 24.5 
F9 9.4 C2 6.5 D4 23.2 
E2 8.8 F9 6.5 E4 22.9 
El 8.4 B6 6.5 H2 22.6 
G4 8.2 D4 6.4 D3 22.6 
B2 8.1 C8 6.3 F2 22.3 
Gl 7.8 FlO 6.1 113 21.9 
Dl 7.5 C7 6.0 15 21.8 
Al 6.9 H9 5.9 F4 21.2 
B5 6.8 17 5.9 G2 21.1 
G3 6.4 B2 5.8 D2 20.9 
A5 5.9 G7 5.4 A4 20.4 
A4 5.7 G6 5.3 F3 18.8 
B  4.4 Fli 5.0 Al 18.0 
D2 4.2 L14 4.7 J4 17.0 
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Figure 11. BLG expression level profiles in milk collected from line 7, 14 and 
45 hemizygous mice 
to that of line 14; this probably reflects its higher average expression level rather 
than comparable degrees of variation (see table 11 legend). 
[.74 
['lii 
These results demonstrate that line 7 expresses variable levels of BLG within 
the line, line 14 expresses BLG in a stable fashion and that line 45 is an intermediate 
between these two extremes. 
Table 11. BLG protein expression levels within lines 7, 14 and 45 
Line 	mean ± s.d. 	C.V. 
7 	9.5±4.9 	52%(n=30) 
14 	6.6± 1.1 	17%(n=28) 
45 	23.7 ± 3.9 	16% (n = 28) 
BLG protein mean values are absolute values (mg/ml); c.v. = 100 x s.d. I mean; n = number of mice 
3.2.4 Analysis of BLG mRNA levels in lines 7,14 and 45 
Variable levels of BLG protein in the milk could be due to 
variable mRNA stability, variable mRNA translation, variable protein turnover or 
even unusual transcription of the transgene. To determine whether levels of BLG 
mRNA vary in parallel with BLG protein expression, quantitative Northern blotting 
using BLG and control (GAPDH) hybridisation probes was performed on total RNA 
from lactating tissue. 
Table 12 and Figure 12 shows BLG mRNA and protein expression in 
individuals from lines 7, 14 and 45. The correlation coefficients for protein and 
RNA levels were 0.44 and 0.54 for line 14 and 45 respectively (n = 9), 0.54 for line 
7 (n = 8) after the exclusion of F4 and -0.19 for line 7 including F4. These 
correlation values did not indicate strong linear relationships. 
Table 12. BLG protein and mRNA expression levels in lines 7, 14 and 45 
Line 7 





F4 23.9 235530 H8 8.5 82245 Dl 29.6 82813 
F7 14.9 409459 114 7.9 97614 J2 28.7 46936 
B2 8.1 503488 F13 7.4 90737 E3 28.1 79438 
B5 6.8 337695 F9 6.5 83523 Ii 25.7 58881 
G3 6.4 235627 17 5.9 78155 A2 25.4 72744 
A5 5.9 206387 H10 6.7 65304 H2 22.6 55551 
A4 5.7 406947 B6 6.5 70542 Al 18.0 36595 
B3 4.0 75340 C2 6.5 88377 F3 18.8 47694 
A3 3.0 227625 H9 5.9 69808 D5 16.0 70849 
* individual mouse identification and corresponding BLG protein expression level (mg/ml); t BLG 
mRNA levels were normalised to sheep GAPDH; mRNA values are arbitrary and not comparable 
between lines. 
Fig. 13 plots protein levels against RNA values. The outliers in each line 
(e.g., F4 in line 7) made a significant impact on the correlation coefficients due to 
the small RNA sample size. However, BLG mRNA levels did appear to be more 
variable in mammary tissue from animals of lines 7 and 45 than in line 14. 
Quantitative analysis confirmed this, as summarised in Table 13. 
M. 
Protein 
F7 B2 G3 AS 83 A3 S M 
L7 
F7 B2 G3 AS B3 A3 S 









114 F13 17 H10 C2 H9 S 	M 	 114 F13 17 H10 C2 H9 S 
L14 
- 	 Albumin 6696410
BLG ••••O.. 
J2 E3 A2 H2 F3 D5 S M 	 J2 E3 A2 H2 F3 D5 S M 
- - - - - Albumin 
L45_ 	 OSSI.. •GAPDH 
— - BLG 
•.S.S. BLG 
Figure 12. BLG protein and RNA expression in lines 7, 14 and 45 mice, 
shown as SDS-polyacrylamide gels and northern blots 
The protein and RNA samples were from the same individual mice. The samples 
are organised from high BLG protein expression (left) to low BLG expression 
(right). Protein controls, 1/200 dilution of defatted sheep milk (S) and control 
mouse milk (M). RNA controls, 10 jig of sheep mammary RNA (S) and non-







5 10 15 20 25 30 
Line 14 
5 10 15 20 25 30 
BLG protein (mg/ml) 
Figure 13. BLG protein expression levels plotted against BLG mRNA levels 
RNA values are from Table 12, rounded up to the first two digits; Y-axis are not comparable between graphs; BLG values are absolute 
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Table 13. The coefficient of variations for BLG mRNA expression within lines 






RNA values were measured in arbitrary units 
following normalisation (within a line) to 
endogenous GAPDH mRNA determined by 
separate hybridisation to a GAPDH probe; 
for this reason mean values for RNA are not 
comparable between different lines and are 
not shown. 
The results indicate that variable expression is present at the mRNA level in 
lines 7 and 45, and the relationship between protein and RNA is similar in all three 
lines (see also chapter 5). These experiments do not rule out variable mRNA 
stability within lines 7 and 45. However results presented in chapter 5 make this 
unlikely. Therefore variable BLG expression is probably not due to variable mRNA 
stability, translation or protein turnover. Instead, the most likely explanation for 
variable expression is that aberrant transcription of the transgene locus is occuring 
within lines 7 and 45. 
3.2.5. Analysis of BLG transgene arrays in lines 7, 14 and 45 
The formation of a transgene array in the genome is the result 
of a variable number of DNA fragments joining together and integrating into a 
single (usually) chromosomal site. Variable expression of the lransgene within lines 
7 and 45 could be due to two classes of effects. Firstly, variable transgene 
expression could be caused by gross or minor modifications to the structure of the 
transgene locus. For example, the transgene array may be rearranged due to 
breakage and rejoining before integration, the array may be partially or fully deleted 
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due to intrachromosomal recombination (Sandgren et al., 1991) or it could include 
point mutations. Secondly, variable transgene expression could be imposed upon 
the transgene locus due to the chromosomal environment. This second class of 
effects are termed "position-effects" and will be dicussed in chapter 4 while this 
chapter will be concerned with the first class of effects. 
Lines 7 and 14 harbour an identical transgene (a 16.2 kb Sail-Sail fragment 
encompassing the entire ovine BLG transcription unit; Fig. 14) while line 45 carries 
a 3' truncated transgene (10.5 kb SalI-XbaI fragment); the 3' truncation does not 
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Figure 14. A map of the BLG transgene 
BLG exons, I-Vu; restriction enzyme sites, Sail, EcoRI (E), HindIII (H); 1.1 kb BLG DNA 
hybridisation probe, P1. 
To address the possibility of transgene deletion and/or rearrangement, 
Southern blot analysis was performed on DNA prepared from mammary tissue from 
lines 7, 14 and 45. The genomic DNA was restriction enzyme digested using 
EcoRI. The BLG transgene has two internal EcoRI restriction sites that are 4.3 kb 
apart (Fig. 14). An internal 1.1 kb EcoRI-HindIII probe (P1; Fig. 14) was isolated 
from plasmid pBJ14 (a gift from Dr Bruce Whitelaw; Roslin Institute) and used as a 
hybridisation probe to detect the 4.3 kb internal transgene fragment in EcoRI-
digested mammary DNA samples. A whey acidic protein (WAP) hybridisation 
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probe (pBS-WAP; a gift from Dr Thomas Burdon; Centre for Genome Research, 
Edinburgh) or a total genomic DNA hybridisation probe was used as a control for 
DNA loading between lanes. 
In all samples from lines 7, 14 and 45 the BLG probe identified a 4.3 kb 
band as predicted; there was no evidence of variations in the banding pattern that 
might suggest rearrangement of the transgene array in lines 14 and 45 (Fig. 15). 
There were 2 smaller bands (2.7 kb and 3.4 kb) present in all the line 7 individuals 
and one larger band (10 kb) present in five (F4, F7, F8, D2 and A3) out of nine line 
7 individuals (Fig. 16A and B). The 10 kb band was equivalent to —2 copies and the 
2.7 kb and 3.4 kb bands were equivalent to <1 copy (compare with the 2 copy signal 
from the endogenous sheep BLG sample) indicating that they were probably due to 
hybridisation to fragments of the transgene at the edge of the transgene array and/or 
a small internal rearrangement. Nothing is known about the internal structure of the 
transgene array in line 7 although it is thought that lines 14 and 45 contain both 
head-to-head and head-to-tail arrangements of the transgene within the array (Dr 
Bruce Whitelaw, pers. comm.). The 10 kb band is probably present in some samples 
because of incomplete digestion (see the top of the lanes containing F9, B 1 and 133) 
or partial degradation (see just below the 10 kb region in lane Fl and Bi) of the 
DNA (Fig. 16). The extra bands were present in both high and low expressors, 
consistant with the interpretation that transgene rearrangement is not responsible for 
variable expression. 
A previous estimate of copy number indicated lines 7 and 45 carried 25 and 
17 transgene copies respectively (Whitelaw et al., 1992), while line 14 harboured <5 
copies (Dr Bruce Whitelaw, pers. comm.). Fig. 15 appears to confirm these copy 
numbers. Certainly line 45 has a higher copy number than line 7 and these two lines 
have a higher copy number than line 14. Hybridisation using BLG and control 
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Figure 15. Southern blot analysis of the transgene array in lines 7, 14 and 45 
Total genomic mouse mammary DNA from lines 7, 14 & 45 was hybridised with a 
WAP and a BLG probe. The samples are organised from high BLG protein 
expression (left) to low BLG protein expression (right). S. sheep mammary DNA; 
M, control mouse mammary DNA. See Table 10 for the protein expression levels. 
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Figure 16. Southern blot analysis of the transgene array in line 7 
(A) Total genomic mouse mammary DNA from line 7 was hybridised with the P1 
probe. The samples are organised from high BLG protein expression (left) to low 
BLG protein expression (right). S, sheep mammary DNA; C, control mouse 
mammary DNA. See Table 10 for the protein expression levels. 
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Figure 16. Southern blot analysis of the transgene array in line 7 
(B) The same membrane as in (A), over-exposed to film (24 hr). 
we 
probes revealed that the transgene copy number was indistinguishable within lines, 
even among mice from line 7 exhibiting an 8-fold range of BLG levels (Fig. 16). 
Despite efforts to provide a precise quantitation of relative BLG copy number in 
mammary gland DNA, the c.v. values for the BLG transgene were consistently high 
for all three lines. The high c.v. values reflects the inherent variability in the 
procedure (Table 14). Even line 14, which has only <5 copies of the transgene 
exhibited a high DNA c.v. value. Normalising the BLG signals to WAP (L7 c.v. = 
26%, n = 9; L14 c.v. = 45%, n = 9; L45 c.v. = 38%, n = 9) or total genomic DNA 
(table 14) gave similar c.v. values, ruling out a possible transfer problem due to the 
size of the EcoRI WAP fragment (7.3 kb) in the Southern blotting procedure. All 
lines had similar c.v. values for DNA, even in line 14 which is a stable BLG 
expressing line. This contrasts with the protein and RNA data where the s.d. and 
c.v. values differed considerably for the three lines (Table 14). Furthermore the line 
7 protein and RNA c.v. values are higher than the DNA c.v. value. 
Table 14. BLG expression levels and copy numbers within lines 7, 14 and 45 
Protein RNA DNA 
Line mean ± s.d. 	C.V. C.V. C.V. 
7 9.5 ± 4.9 	52% (n=30) 47% (n=9) 36% 0=18) 
14 6.6± 1.1 	17% (n=28) 13% (n=9) 41% (n=13) 
45 23.7 ± 3.9 	16% 0=28) 26% (n=9) 42% 0=13) 
DNA values are measured in arbitrary units following normalisation (within a line) to endogenous 
total DNA determined by separate hybridisations to a total genomic probe (see materials and 
methods); for this reason mean values for DNA are not comparable between different lines and are 
not shown. 
The 1fld1flnhr\ '_'land CoMPI ie inin\ cell I\ pc (cc.. stromal tosue, blood vesseL, 
myoepithelial cells) that do not express BLG. However these tissues presumably 
harbour the transgene array. Though the secretory epithelial cells are the most 
abundant cell type within the day 11 lactating mammary gland, the precise 
proportion of secretory epithelial cells within the mammary gland has not been 
determined. Therefore measurements of DNA copy number from the whole gland 
will include the transgene copies in the other, non-expressing cells. Given the 
inherent variability in the technique, secretory epithelial cell-specific deletion of the 
transgene array may not be detected using Southern blotting. Therefore it was not 
possible to rigorously exclude the possibility that the variable expression in lines 7 
and 45 could be due to epithelial cell-specific transgene deletion. This point will be 
expanded in chapter 7. 
The Southern blot analysis described in this chapter would not reveal subtle 
changes (e.g., a point mutation[s]) within the transgene array. To investigate this 
possibility it would probably have been necessary to sequence the entire transgene 
array in lines 7 (-400 kb), 14 (<90 kb) and 45 (--275 kb). Because of the repetitive 
nature of the insertions, even this would probably not have detected key point 
mutations. Despite extensive literature searches I have found no evidence for 
spontaneous point mutations within transgene arrays. Therefore although still 
formally possible, a point mutation that drastically affects transgene transcription is 
an unlikely mechanism; a more plausible mechanism that is based on past and 
current literature as well as the collective results presented in this study is presented 
in chapter 6. 
These results argue that variable BLG expression is probably not due to 
stochastic loss or rearrangement of the transgene array in different individual line 7 
and 45 mice and is instead probably due to variable mRNA transcription between 
individuals within a line. 
3.2.6. BLG expression levels across two lactat ions in line 7 mice 
Variable lactational performance can be due to numerous 
factors; none of which can explain the variable levels of BLG protein in lines 7 and 
45 (Table 15). 
Table 15. Sources of variability in lactational performance 
Factor 	 Relevance to variable BLG expression 
Intrinsic factors 
Genetic background Standardised to (C57BL/6 x CBA*) 
Litter size Litters were standardised to 5 pups per mother 
Reproductive state Samples were collected at day 11 of lactation 
Environmental factors 
Thermal environment Same for all the individuals in the population 
Nutrition it 
Work, exercise of 
Health status All animals appeared healthy 
Milk withdrawal The litter sizes were standardised and milk was 
collected as close to 1 pm as possible for all 
the samples and by identical procedures 
Time related factors 
Age Standardised to 6-8 weeks 
Season Breeding is not seasonal in mice 
Stage of lactation Day 11 of lactation for all the samples 
The sources of variability were adapted from Oldham & Friggens, 1989; * for an investigation of the 
contribution of genetic background see chapter 4 
However, variable expression could be due to fluctuating expression levels 
within lactations, perhaps due to fluctuating levels of mammotrophic hormones. 
Ideally this possibility could be addressed by performing serial milking within one 
lactation cycle. However this approach would be unduly invasive to the mother and 
the suckling offspring. Furthermore Zippelius and Schleidt, (1956) demonstrated 
that young rodents emit ultrasounds when in stress conditions, to which the dam 
responds by exhibiting maternal care patterns (e.g., time spent in nursing position). 
These responses may vary between individuals and therefore make serial milking 
within a lactation an unpredictable experiment (e.g., numbers of mice required). 
Instead, to determine whether expression levels exhibit temporal variation within 
individual animals of transgenic line 7, milk protein levels were measured in a large 
population of mice at day 11 of two successive lactations. This approach was far less 
invasive to the mice, enabled a large sample size (29) and addressed whether the 
expression level was fixed within the individual at mid-lactation. The results are 
presented in Table 16. Commencing with a group of 40 animals, 29 milk sample 
pairs were obtained from two successive lactations. 25% of the sample pairs were 
lost because (i) the mouse did not become pregnant (ii) the litter died, and (iii) the 
mother did not produce enough milk from the upper left inguinal gland. Milking a 
large population across two lactations enabled a comparison of BLG expression 
levels within an individual and between individuals at the same stage of lactation. 
The average difference between the two lactations (L2-Ll) was 2.4 mg/ml 
(±0.6) or 2.0 mg/ml (±0.4) if sample 37 is omitted. These differences were 
significantly greater than zero (paired t-test, p < 0.05). Thus the mice produced 
significantly more BLG on their second lactation (24 mice produced more, two the 
same and three produced less). This result might be expected because mouse milk 
yield and pup weight gain increase with successive lactations (Knight et at., 1986) 
and improvement in lactational performance with successive lactations is a general 
phenomenon in the dairy industry (see chapter 1). 
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Table 16. BLG protein expression levels in line 7 mice across two lactations 
BLG expression levels (mg/ml) 
Mouse First lactation (Li) 	Second lactation (L2) L2-L1 
1 14.9 ND / 
2 4.0 2.5 -1.5 
3 ND ND / 
4 10.6 15.3 +4.7 
5 17.8 22.1 +4.3 
6 15.4 22.2 +6.8 
7 10.3 16.1 +5.8 
8 15.3 15.5 +0.2 
9 ND ND / 
10 4.8 7.4 +2.6 
ii 10.5 ND / 
12 12.2 12.2 0.0 
13 11.4 ND / 
14 8.1 9.7 +1.6 
15 12.2 ND / 
16 5.8 6.2 +0.4 
17 11.4 14.2 +2.8 
18 15.6 13.1 -2.5 
19 13.0 18.1 +5.1 
20 5.0 5.3 +0.3 
21 ND ND / 
22 ND ND / 
23 14.5 16.6 +2.1 
24 ND ND / 
25 4.1 5.3 +1.2 
26 5.9 8.7 +2.8 
27 6.9 9.9 +3.0 
28 4.7 4.7 0.0 
29 10.5 12.6 +2.1 
30 14.0 17.3 +3.3 
31 10.9 12.6 +1.7 
32 13.5 13.4 -0.1 
33 10.1 11.1 +1.0 
34 11.0 11.4 +0.4 
35 9.1 10.4 +1.3 
36 16.0 17.8 +1.8 
37 9.8 24.2 +14.4 
38 3.8 ND / 
39 5.9 9.5 +3.6 
40 3.0 ND / 
ND: not determined 
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The BLG expression levels in the two lactations were plotted together with 
respect to each mouse in a bar diagram and ordered from lowest to highest 
expressors using the first lactation results (Fig. 17; sample 37 was omitted). This 
demonstrated that there was a close correlation between BLG levels measured at the 
first and second lactations. For example, the low expressors remained low 
expressors and high expressors remained high expressors; there was no evidence of 
the wide range of expression observed within the population being reiterated in the 
individual. 
Albumin levels are the least affected by variations in the levels of BLG in the 
milk (McClenaghan et at., 1995) and therefore serve as the best control for loading 
of samples in SDS-PAGE. The c.v. measurements for BLG protein were the same if 
calculated from absolute values or those normalised for the endogenous protein 
albumin (Table 17). Therefore the variations in BLG levels were not due to 
variations in sample loading. 
Table 17. Coefficient of variation values for BLG protein expression in milk of 
line 7 animals 
c.v. measurements 
Sample* 	Absolutel 	Albumin correctedt 
1 	 23% 	 25% 
2 	 13% 	 13% 
3 	 15% 	 14% 
4 	 16% 	 16% 
* Each sample comprises seven individuals; a measure of the c.v. values for the weight of the BLG 
peak-traces in line 7 transgenic mice at day 11 of the second lactation; t absolute values were 





Figure 17. BLG expression levels in milk of line 7 animals over two consecutive lactations. 
BLG was quantitated in milk collected at the same time point (day 11 of lactation) in two successive lactations 
in C57BL6 x CBA hemizygous mice. The average difference between the first and second lactations was 2 (± 
0.4) mg/ml (paired t-test, p  <0.05). 
While the line 7 population shows wide variation in the level of expression, 
individual levels appear to be fixed by day 11 of the first lactation. 
3.3. CONCLUSIONS 
A considerable amount of effort was invested into (i) 
purifying a pure BLG protein standard, (ii) determining the precise protein 
concentration of the BLG standard, and (iii) establishing a quantitative SDS-PAGE 
assay for the measurement of BLG concentration in transgenic mouse milk. 
Collectively, this enabled the accurate determination of BLG protein expression 
levels in several hundred samples (in this and in subsequent chapters). 
Quantitative SDS-PAGE analysis of mouse milk demonstrated that the BLG 
protein expression levels were variable in lines 7 and 45 and stable in line 14. In 
line 14 levels of expression of the transgene-encoded protein are stable, while line 7 
(harbouring the identical transgene) levels are highly variable; thus the DNA 
construct employed does not have an inherent deficiency that leads to variation in 
expression levels. The correlation values between BLG protein expression levels 
and mRNA levels were not sufficiently high to indicate strong linear relationships. 
However, these values did demonstrated that the relationship between protein and 
RNA was similar in all three lines. Furthermore, a comparison of c.v. values show 
that variation was present at the RNA level in lines 7 and 45. Though not rigorously 
proven, these results lead to the conclusion that the variation in protein levels is 
principally due to variations in transcription of the transgene insertion. Because 
lines 7 and 14 harbour the identicle transgene construct, it may be concluded that the 
particular transgene insertion locus determines variation in the levels of expression 
of BLG protein and mRNA levels. 
FEI1 
While the Southern blot analysis would not reveal subtle changes in the 
structure of the transgene array, the data suggest that variable expression is not due 
to stochastic loss or rearrangement of the transgene array in different individual line 
7 and 45 mice. Once established, the expression level remains relatively fixed 
within the individual. This result argues that, while the population shows wide 
variation in the level of expression, individual levels are fixed by day 11 of lactation. 
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CHAPTER 4 
VARIABILITY IS NOT DUE TO THE GENETIC 
BACKGROUND 
4.1. INTRODUCTION 
Expression levels of randomly integrated transgenes usually differ 
between lines of transgenic animals (Spradling & Rubin, 1983; Palmiter & Brinster, 
1986). These quantitative differences, known as "position-effects", have been 
attributed to the different chromosomal integration events which characterise the 
different lines. Transgene integration results in differing numbers of the transgene 
in the array (copy number) and different transgene integration sites between lines. 
Copy number dependent (or position-independent) levels of expression are 
indicative of a transgene array that is "insulated" from epigenetic influence due to 
the presence of a locus control region (LCR) within the construct (Grosveld et al., 
1987; Lang et al., 1988; Talbot et al., 1989; Greaves et al., 1989; Bonifer et al., 
1990; Palmiter et al., 1993; Diaz et al., 1994; Krnacik et al., 1995; Jones et al., 
1995; Aronow et al., 1995; May & Enver, 1995). Position-effects can be caused by 
cis- (local chromosomal domain; e.g., promoters, enhancers and silencers) and 
trans- (epigenetic modifiers; e.g., transcription factors) acting factors that can act 
together or independently to produce variations in expression between lines 
(Kothary et al., 1988; Allen et al., 1988; Wilson et al., 1990). For example, 
differences in expression levels between lines for an identical transgene can be due 
to integration (i) into an endogenous gene (Fig. 18), (ii) close to the enhancer of an 
endogenous gene, (iii) close to a CpG island (Bird, 1986) and the ubiquitous 
106 
I. 





- 	 — 




Figure 18. Possible mechanisms for transgene position effects 
Open boxes (i-vu), endogenous loci; stippled boxes, transgene array; hatched box (v), imprinted 
region; E, enhancer; CpG, CpG island; LCR, locus control region, TF, transcription factor(s); 
Modifier, genotype-specific modifier locus. Taken from Kothary et al., 1989. 
transcription factors thought to be associated with them, (iv) within a domain that is 
regulated by an LCR, (v) into a region in the genome that is imprinted (Surani et at., 
1988), (vi) into a region in the genome that is subject to the influence of a genotype-
specific modifier(s) and (vii) into or close to heterochromatin (see chapter 6). 
Unstable expression occurs when the transgene is expressed in a fashion that 
is different from the expected temporal or spatial pattern of expression, resulting in 
qualitative differences concurrent with the quantitative (position effect) differences 
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between lines. Unstable expression comprises two categories; (1) degrees of 
expression that differ between lines while remaining stable within a line and (2) 
variable levels of expression within a line. While there are several examples of 
aberrant transgene expression between lines in the literature (see chapter 1, section 
1.8) to my knowledge there are only three examples of variable transgene expression 
within a line of mice (McGowan et al., 1989; Allen et al., 1990; Porter & Meyer, 
1994). The latter phenomenon may be rarely reported because the integration site 
and copy number are normally identical within a line and therefore the transgene 
array is under the same epigenetic influences in all individuals. Porter and Meyer 
(1994) did not investigate the cause of variable degrees of mosaic expression within 
line TgUPT9 although they did suggest that the transgene expression may be under 
the influence of genetic modifier loci. Allen and colleagues described variable 
expression of an HSVtk-/acZ transgene; in this study the variable expression was 
due to variable levels of uniform expression between individual mice rather than 
variable degrees of mosaic expression. Conversely, McGowan and colleagues 
describe variable degrees of mosaic expression of a hsp68-lacZ transgene within a 
line. In both studies the variable expression was shown to be due to the influence of 
a genotype-specific modifier gene(s) and the expression level was inversely related 
to the methylation status of the transgenes; low expressors exhibited 
hypermethylation whereas high expressors showed hypomethylation. The 
epigenetic modification (gain or loss of methylation) of the transgene locus was 
cumulative through successive backcrosses to a parental hybrid strain (Allen et al., 
1990). Furthermore, the transgene locus was susceptible to the influence of a 
genotype-specific modifier(s) in other non-parental genetic backgrounds. The effect 
of the modifier(s) was dependent upon the sex in one strain (BALB/c) therefore 
demonstrating a genomic imprinting effect. 
Evidence for DNA methylation constituting the imprinting mark includes 
differential methylation of imprinted transgenes (Reik et al., 1987; Sapienza et al., 
1987; Swain et al., 1987; Chaillet et al., 1991) and imprinted endogenous genes 
(Table 18). It is thought the silencing of a locus (containing endogenous genes or 
transgenes) due to genomic imprinting is an all or nothing process. Therefore 
integration of the BLG transgene into a region of the genome that was imprinted 
would result in complete silencing of expression within a line. Hence, integration of 
the BLG transgene into an imprinted locus can be ruled out as the mechanism for 
variable expression within lines 7 and 45. 
Inactivation of expression as a consequence of methylation could result from 
the methyl adduct in the major groove interfering with the binding of transcription 
factors directly or indirectly through the presence of methyl-DNA binding proteins 
or specific repressor proteins that render the DNA inaccessible to transcription 
factors (Iguchi-Ariga & Schaffner, 1989; Meehan et al., 1989; Boyes & Bird, 1991; 
Ehrlich & Ehrlich, 1993), causing heritable gene repression (Holliday & Pugh, 
1975). Conversely, it is possible that DNA methylation is a consequence of gene 
inactivation. In the context of variable transgene expression in lines 7 and 45, a 
study of the methylation status of the transgene would not reveal the cause of 
unstable expression. Instead, a genetic backcross was performed to founder lines to 
investigate whether a genotype-specific modifier gene(s) was involved in variable 
expression. 
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Table 18. Imprinted endogenous genes 
Maternal Allele E xpression* 	Paternal Allele Expression* 
Gene 	Reference 	 Gene 	Reference 
1g/2 	DeChiara et al., 1991 
Mas 	Villar & Pedersen, 1994 
Snrpn Leff et al., 1992 
U2afbp-rs Hayashizaki et al., 1994 
insl/ins2 Giddings et al., 1994 
IPW Wevrick et al., 1994 
Pegi/Mest Kaneko-Ishino et al., 1995 
IgJ2r 	Barlow et al., 1991 
H19 	Bartolomei et al., 1991 
Mash2 	Guillemot et al., 1995 
p57KIP2 	Hatada & Mukai, 1995 
* Imprinted genes display parent-specific monoallelic expression (Surani, 1994; Barlow, 1995), 
although often not at all developmental stages (Szabo & Mann, 1995). Igf2r, insulin-like growth 
factor 2 receptor; H19, encodes an RNA with unknown function; Mash2 , achaete-scute homology 2; 
57KIP2, a potent tight-binding inhibitor of several Gi cyclin/Cdk complexes; 1gJ2, insulin-like 
growth factor 2; Mas, a protooncogene; Snrpn, small nuclear ribonucleoprotein; U2ajbp-rs, human 
U2af (a snrpn) binding protein-related sequence; insi and 2, mouse insulin 1 and 2; IPW, imprinted 
gene in the Erader-Willi syndrome region; Pegi (also known as Mest), paternally expressed gene 1. 
4.2. RESULTS 
4.2.1. A backcross from line 7 mice into founder strains 
The transgenic mice studied (lines 7, 14 and 45) were of a 
C57BL/6 x CBA hybrid genetic background. The differential levels of expression 
observed among individuals in a particular line may be due to segregation of alleles 
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of a modifier gene(s) that modulate transgene expression. This type of phenomenon 
has been and described and examined by McGowan et al. (1989) and Allen et al. 
(1990). Engler et al. (1991) also characterised strain-dependent methylation of a 
transgene and were able to map the position of the modifier to a specific locus Ssm-
1. 
To address the possibility of a strain effect, line 7 (the most variable line) 
mice were successively backcrossed to pure-bred CBA and C57BL/6 animals for 
four generations (Fig. 19). 














Figure 19. Breeding line 7 mice to CBA and C57BL/6 founder strains 
The first cross from mixed background animals involved 8 homozygous line 
7 female mice and 8 CBA male animals; similarly 8 homozygous line 7 female mice 
were crossed to 8 C5713L/6 male animals (16 matings in total). Hemizygous 
transgenic female offspring were mated once they were 6-8 weeks old and milk was 
collected at day 11 of lactation. This provided the first set of milk samples 
(backcross population: 75% CBA or 75% C57BL/6) and established 6 hemizygous 
sub-lines in the CBA background and 8 sub-lines in the C57 background (Tables 19 
and 20). Each of the founder mothers was allocated a number (CBA 1-8 and C57 9-
16) and the subsequent female offspring were designated numbers (1-5) after their 
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mothers number (e.g., CBA 3 produced four transgenic females: 3.1, 3.2, 3.3 and 
3.4.). 
The backcross experiment proceeded for another three crosses and all 
subsequent progeny were screened by PCR analysis to identify offspring carrying 
the transgene. On average 50% of progeny carried the transgene from a cross 
involving a transgenic (hemizygous) female with a non-transgenic inbred male. 
Each backcross population was maintained in sufficient numbers so as to provide 
approximately 20 milking females per group, with the exception of the fourth 
backcross populations which were deliberately scaled down in preparation for line 
maintenance. Due to limiting numbers and poor breeding of the inbred lines, some 
sub-lines were lost. However BLG protein expression levels were obtained from 11 
third and 7 fourth backcross sub-lines. Therefore BLG protein expression levels for 
an individual mouse in the fourth backcross population could be compared with the 
levels from its ancestors (e.g., CBA 3.1.2.3.1. to CBA 3.1.2.3. to CBA 3.1.2. to 
CBA 3.1. [Table 19]). 
In theory the genetic background of each backcross is 75%, 87.5%, 93.75%, 
and 96.9% either CBA or C57BL/6. This experiment resulted in >150 mouse milk 
samples which were analysed by SDS-PAGE as described in chapter 3. The results 
are presented in tables 19 and 20. The BLG expression levels from a C57BL/6 x 
CBA mixed genetic background (taken from the first lactation data in chapter 3) 
were plotted beside those from successive backcross populations to give the relative 
distribution of BLG expression ranges in successive backcross populations (Fig. 20). 
There appears to be a trend towards higher expression in the C57 background and 
lower expression in the CBA background implying a slight genetic background 
effect. However there is still a considerable range of expression levels in both the 
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Table 19. BLG expression levels in line 7 animals in a CBA backcross 
B*.1 BLG 	B*.2 	BLG 	B*.3 	BLG 	B*.4 	BLG 
1.1. 9.6 1.1.1. 8.3 1.1.1.3. 9.4 
1.2. 5.4 1.1.4. 5.9 1.2.1.1. 5.0 
1.3. 3.0 1.2.1. 5.0 1.2.1.2. 75 
1.4. 5.7 1.3.1. 5.3 1.3.3.1. 6.6 
1.3.3. 7.2 1.4.1.3. 5.7 
1.4.3. 9.3 
2.1. 7.6 2.1.1. 6.8 2.1.3.1. 2.1 
2.3. 6.0 2.1.3. 4.0 2.3.5.4. 5.0 
2.4. 11.7 2.3.5. 6.4 2.3.5.5. 9.0 
2.5. 5.9 2.5.4. 6.7 2.5.4.3. 8.2 
3.1. 7.3 3.1.2. 14.4 3.1.2.3. 9.7 3.1.2.3.1. 12.0 
3.2. 6.0 3.2.3. 5.9 3.1.2.4. 8.6 3.2.3.3.1. 9.2 
3.3. 3.5 3.3.3. 4.7 3.2.3.3. 35 3.2.3.3.2. 5.0 
3.4. 4.8 3.2.3.4. 1.7 
6.1.4. 6.0 3.3.3.1. 6.1 
6.1. 11.2 6.2.2. 6.5 
6.2. 5.7 6.3.1. 10.6 6.1.4.1. 10.9 7.2.2.1.1. 4.1 
6.3. 7.0 6.3.2. 6.7 6.3.1.2. 115 7.2.2.1.2. 5.4 
7.2.2.1.3. 12.2 
7.1.1. 4.8 7.1.1.4. 7.4 7.2.2.1.6. 17.5 
7.1. 3.3 7.1.3. 4.2 7.2.2.1. 5.4 7.2.2.1.8. 7.6 
7.2. 3.8 7.2.2. 7.0 7.2.2.1.10. 6.6 
7.3. 11.3 7.3.1. 3.2 7.2.2.1.11. 4.3 
8.1.1.1. 2.5 
8.1. 4.7 8.1.1. 2.3 8.1.2.1. 4.5 8.1.2.1.2. 4.3 
8.2. 6.1 8.1.2. 4.4 8.1.2.2. 4.4 8.1.2.2.1. 9.2 
8.2.1. 2.9 8.2.1.2. 3.4 8.1.2.2.4. 21.0 
*B, backcross; B1-4, mice of four successive crosses into CBA parental strain (parental genetic 
background contributions are respectively 75%, 87.5%, 93.75% and 97%); BLG, BLG protein 
expression levels in mg/mt. 
113 
Table 20. BLG expression levels in line 7 animals in a C57BL/6 backcross 





















































14.2 .5 .2.2. 	11.3 
15.1. 	3.5 	15.1.4. 	6.0 
15.2. 10.0 15.2.1. 9.2 
15.3. 	8.0 	15.2.2. 	4.4 	 16.1.3.1.1. 	13.6 
15.3.1. 13.7 16.1.2.1. 	14.0 	16.1.3.1.2. 16.1 
16.1. 	13.7 	 16.1.3.1. 21.7 16.1.3.2.2. 23.1 
16.2. 10.7 16.1.2. 	11.7 	16.1.3.2. 4.8 16.1.3.2.3. 19.5 
16.1.3. 11.0 16.2.1.1. 10.9 16.2.1.1.1. 17.8 
16.2.1. 	9.4 	16.2.1.2. 7.3 16.2.1.2.2. 11.7 
* B, backcross; B14, mice of four successive crosses into C57BL/6 parental strain (parental genetic 
background contributions are respectively 75%, 87.5%, 93.75% and 97%); BLG, BLG protein 
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Figure 20. BLG expression levels in milk of line 7 animals; effect of genetic 
background. 
Line 7 (C57BL/6 x CBA) animals were separately backcrossed to the two parental strains; BLO 
levels were recorded. CBA/C57 group (centre), individual BLG levels in mice of C57BL/6 x CBA 
background (50% genetic contribution from each parental strain); CBA 1-4 (left) and C57 1-4 (right) 
are mice of four successive crosses to each parental strain (parental genetic background contributions 
are respectively 75%, 87.5%, 93.75% and 97%). 
C57BL16 and CBA inbred populations, even after the fourth backcross. Others have 
described strain effects after only one cross into a strain exerting a modifier 
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influence (McGowan et al., 1989; Allen et al., 1990; Engler et al., 1991). In this 
study there was no evidence of a clear segregation into high and low expressing 
groups, a result that would be consistent with the presence of a modifier gene(s). 
The first backcross towards a C57 genetic background resulted in a 
significant reduction in the variance (p < 0.05) when compared with the mixed 
C57BL/6 x CBA population (Tables 21 and 22); the mean was not significantly 
different (p> 0.05). Neither the variance or the mean were significantly different in 
the second and third C57 backcross populations. There was still no significant 
difference in the variance between the fourth C57 backcross population and the 
mixed C57BL/6 x CBA population although there was a significant increase in the 
mean. In the CBA backcross experiment both the variance and the mean were 
significantly different (p <0.05) between the first, second and third backcross CBA 
populations and not significantly different (p> 0.05) in the fourth backcross 
population when compared with the C57BL/6 x CBA population (Tables 21 and 22). 
The striking difference in distribution of expression levels between the third and 
fourth CBA backcross populations could be a true effect of the backcross or it could 
be due to a limited number of samples, i.e., some high expressors would arise in the 
third backcross population if more samples were measured. Because the 
backcrosses that preceeded the fourth cross introduced a far greater theoretical 
genetic difference without such a large effect on the expression level distribution it 
was concluded that the difference is more likely to be due to a limited number of 
samples. 
Major alterations in transgene expression level have been documented after 
just one cross into an inbred line (McGowan et al., 1989; Allen et al., 1990; Engler 
et al., 1991). It was predicted that the presence of a single or multiple loci would be 
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Table 21. BLG expression levels within eight backcross populations 
First backcross (75%) 	Second backcross (87.5%) 	Third backcross (93.75%) 	Fourth backcross (97%) 
Strain 	mean ± s.d. 	C.V. 	 mean ± s.d. 	C.V. 	 mean ± s.d. 	C.V. 	 mean ± s.d. 	C.V. 
C57 	9.2±2.8 30%(n=20) 	9.8±3.9 40%(n=21) 	9.7±5.3 	54%(n=20) 	13.8±4.5 33%(n= 14) 
CBA 	6.5±2.6 41%(n=20) 	5.8 ± 2.0 34% (n = 24) 	6.3 ± 2.8 	45% (n = 22) 	9.1 ± 5.3 	58% (n = 13) 
s.d. = standard deviation; c.v. (coefficient of variation) = 100 x s.d. / mean; n = number of mice; BLG mean values are absolute 
values (mg/ml) 
C57BL/6 x CBA mixed background: mean ± s.d. = 10.1 ± 4.2, c.v. = 41% (n = 35) 
revealed by major alterations in both the variance and mean values for expression 
levels over three generations. Because no such alterations were observed by the 
fourth bachcross, it was concluded that the variable expression of the transgene 
within line 7 is not due to the influence of a genotype-specific modifier(s). 
Table 22. Comparison of the variance and mean values between the mixed 
C57BL/6 x CBA genetic background and successive backcross populations 
C57BL/6 CBA 
Backcross variance mean variance mean 
1 p <0.05 p > 0.05 p <0.05 p <0.05 
2 p > 0.05 p > 0.05 p <0.05 p <0.05 
3 p > 0.05 p > 0.05 p <0.05 p <0.05 
4 p > 0.05 p <0.05 p > 0.05 p > 0.05 
4.2.2. BLG expression levels through the backcross 
The maintenance of sub-lines through the backcross enabled a 
comparison of BLG expression levels through sub-lines within each backcross. 
There were no clear trends in expression levels through the backcross. Expression 
levels in female progeny of high or low expressing mothers appeared to be randomly 
distributed and there was no evidence of an association between maternal and filial 
expression levels; for example, a parent expressing BLG protein at 11 mg/mi (C57 
16.1.3.) gave rise to siblings with expression levels of 4.8 mg/ml (C57 16.1.3.2.) and 
22 mg/ml (C57 16.1.3.1.) [Table 20].  Another striking example of the 
unpredictability of expression levels through the backcross is the CBA 7.2.2.1. to 
CBA 7.2.2.1.1-11 pedigree (Table 19). In this case the mother was expressing BLG 
at only 5.4 mg/ml, below the average for this backcross population (Table 21). She 
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produced offspring exhibiting almost the complete range of expression levels within 
the fourth backcross population (4.1 to 17.5 mg/ml; Table 19) and a range of 
intermediate expressors. 
The data demonstrates that although the expression level is fixed within the 
individual (chapter 3) the level of expression is not predictable through the germline. 
A mechanism that fulfils these criteria is proposed in chapter 6. 
4.3. CONCLUSIONS 
A backcross into 97% CBA or 97% C57BL/6 genetic backgrounds 
had no significant effect on variance of BLG expression in either background; there 
was no clear segregation into high and low expressors. Furthermore, the expression 
levels were not predictable through the backcross. In conclusion, while there is a 
slight strain effect on the mean BLG expression level, the variable expression of the 
transgene within line 7 is not explained by heterogeneity of genetic background. 
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CHAPTER 5 
BLG AND 3-CASEIN EXPRESSION IN MID-LACTATION 
MOUSE MAMMARY GLAND 
5.1. INTRODUCTION 
Previous results confirmed that levels of BLG protein and mRNA 
varied extensively between different line 7 females. At the cellular level one can 
envisage two modes of variation. First, there could be a uniform level of expression 
in all the secretory epithelial cells of an individual mammary gland: the overall level 
of expression varies between individuals (Allen et al., 1990). Second, the level of 
expression could vary from cell to cell within an individual gland giving rise to a 
mosaic pattern of expression, the degree of mosaicism varying between individuals 
(McGowan et al., 1989). 
In situ hybridisation to cellular mRNA with 35S-labelled complementary 
single-stranded ("antisense") RNA probes (Angerer & Angerer, 1991, 1992; 
Wilkinson, 1992) was employed to discriminate between the above possibilities. 
In situ hybridisation was utilised rather than immunohistochemistry for 
several reasons. Immunohistochemistry using antibodies for BLG has been used to 
localise BLG protein in the mouse mammary gland (Harris et al., 1991), however 
the resolution was poor. Also, as milk is secreted (unlike mRNA), contamination 
within the sections could have been a problem using antibody detection. In situ 
hybridisation allows one to distinguish the cells in a complex tissue that express 
specific mRNAs. Furthermore, measuring mRNA levels provides a more accurate 
estimation of gene activity because mRNA accumulates before the protein it 
120 
encodes; stable proteins may persist long after the gene is repressed and the mRNA 
has decayed. Protein antigenicity varies after fixation with different fixatives, and 
detection of different antigens (i.e., BLG and -casein) may therefore require 
different tissue preparations (efficiency of hybridisation of different probes is similar 
with the same tissue fixation procedures). 
The synthesis of single-stranded RNA probes is convenient if one is aufait 
with molecular biology and the precise length of probe can be controlled (an 
important consideration for probe penetration into the tissue) if the appropriate 
restriction enzyme sites are available (see materials and methods). Single-stranded 
probes are more sensitive than double-stranded probes because they do not re-
anneal. Most importantly, RNase digestion (see 2.10.10. in chapter 2) of any probe 
sticking to the tissue (specific hybridisations are not affected because RNase does 
not digest double-stranded complexes) reduces non-specific background signal. 
Labelled oligonucleotides are less sensitive because they are shorter than nucleic 
acid probes. 
For my purposes 35 S-dUTP was the best labelling method. At present 
radiolabelled probes are more sensitive than hapten-labelled probes. The increased 
safety and high stability of hapten-labelled probes was not significant as the tissue in 
situ hybridisation experiment was performed twice only. Although 311-labelled 
probes give better resolution of signal they require longer autoradiographic 
exposures. 35S-labelled probes give about a one cell diameter resolution which was 
sufficient and required an exposure of 1-2 weeks. 32P-labelled probes have a shorter 
half-life than 35S-labelled probes (14 days vs. 87 days), give poorer resolution and 
offer no advantage of speed of results. 
In situ hybridisation studies using BLG and -casein mRNA probes (see 
materials & methods) were performed on abutting sections from tissue collected at 
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day 11 of lactation from hemizygous individuals of lines 7, 14 and 45 (see chapter 3) 
and non-transgenic mice. 
The structure of mid-lactation mammary gland tissue is shown in Fig. 21A. 
The secretory tissue is represented by the alveolus. This has a lining of secretory 
epithelial cells that express and secrete the milk proteins into the alveolar space. 
The myoepithelial cells around the outside of the alveolus then contract to squeeze 
the milk out into the ducts and eventually to the nipple. Therefore, when a cross 
section is taken through the mammary gland at mid-lactation the main features are 
cross sections of alveoli and the ductal systems (Fig. 21B). 
5.2. RESULTS 
5.2.1. Tissue in situ hybridisation analysis of mouse mammary tissue 
sections 
As expected, endogenous 13-casein mRNA was detected in 
non-transgenic tissue (Fig. 22A) whereas BLG mRNA was absent (Fig. 22B). 
Importantly, this demonstrated that the BLG mRNA probe did not bind in a non-
specific fashion with the tissue or other mRNA's. Likewise, all sections from lines 
7, 14 and 45 probed with BLG and 3-casein sense probes (control for non-specific 
hybridisation) had no radioactive signal associated with them (Fig. 21B) 
Endogenous 3-casein mRNA was detected throughout the mammary 
epithelium in all three transgenic lines, demonstrating that essentially all secretary 
epithelial cells of the gland have the capacity to express a milk protein gene (Fig. 
23A, Fig. 24A, Fig. 25A, Fig. 26A). Robinson and colleagues (1995) described 
mosaic expression (30%) of 13-casein up to day 11 of gestation in mice; not until day 
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Figure 21. Tissue morphology of the mammary gland. 
(A) Diagrammatic representation of a cluster of mammary alveoli 
(adapted from Mepham, 1987). (B) Section taken through a mid-
lactation mouse mammary gland probed with a -casein sense 
(control) RNA probe and stained with methylene blue. The main 
structural features are the rings of secretory and myoepithelial cells 
surrounding each alveolar space (a) and the ductal systems (d). Each 
image in Figs. 21 to 26 is at x4 magnification and is representative of 


















Figure 22. In situ hybridisation analysis of mRNA expression 
patterns in non-transgenic mouse mammary tissue. 
(A) 0-casein, (B) BLG 
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18 of gestation was uniform expression achieved. My study demonstrates that 
uniform 3-casein expression is also present at day 11 of lactation. 
In gland sections from individuals of line 7 expressing the BLG protein at 
low levels (e.g., 133: see Table 10 in chapter 3), small clusters of cells strongly 
expressing BLG mRNA were observed, surrounded by non-expressing cells (Fig. 
23B). However some individual alveoli contained both expressing and non-
expressing cells (e.g., lower left and top right region in Fig. 2313). High expressors 
from line 7 (e.g., F5) had the opposite pattern of expression showing small regions 
of cells and even individual alveoli negative for BLG mRNA, surrounded by cells 
abundantly expressing the transgerie (Fig. 2413). Abutting sections probed for BLG 
and 13-casein identified regions and specific alveoli that only expressed 13-casein. 
Due to the complex 3-dimensional arrangement of the mammary epithelium no 
precise quantification was possible (note, Robinson et al., [1995] do not mention 
how they quantitated the 13-casein expression within the gland). Nonetheless, it did 
appear that the proportion of positive cells in any one section correlated with the 
level of BLG in the milk; highest expressors clearly had a greater proportion of cells 
positive for transgene mRNA. This demonstrated that variable expression was 
present at the mRNA level in line 7 and that it was differing degrees of mosaic 
mRNA expression that resulted in the high c.v. value (47%) measured by northern 
blot experiments (see chapter 3; section 3.2.4.). 
Line 14 (e.g., 16) was distinctly different because BLG expression appeared 
to be uniform throughout all the epithelial cells within any one section, in a way that 
matched the pattern of 13-casein expression (Fig. 25A and B). Line 45 (e.g., 12) also 
exhibited mosaic expression of BLG, although less so than in line 7 (Fig. 2613) 
which may reflect the higher average expression level in line 45. 
The tissue in situ hybridisation results from lines 7 and 45 demonstrate that 
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Figure 23. In situ hybridisation analysis of mRNA expression 
patterns in line 7 (low). 
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Figure 24. In situ hybridisation analysis of mRNA expression 
patterns in line 7 (high). 
(A) f3-casein, (B) BLG (17 mg/ml). White arrows indicate regions 





























Figure 25. In situ hybridisation analysis of mRNA expression 
patterns in line 14. 
(A) 3-casein, (B) BLG (8 mg/ml). 
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Figure 26. In situ hybridisation analysis of mRNA expression 
patterns in line 45. 
(A) 3-casein, (B) BLG (25 mg/mI). 
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5.3. CONCLUSIONS 
Although the tissue in situ analysis did not permit precise quantitation 
of per-cell expression levels, the results suggest that variations in the level of BLG 
protein and mRNA expression in individuals of lines 7 and 45 (described in chapter 
3) are due principally to variations in the proportion of mammary epithelial cells 
expressing the transgene. 
Transgene expression was mosaic in animals of line 7 (and to a lesser extent 
in line 45) but uniform in all line 14 animals examined. In lines 7 and 14 the 
introduced transgene is identical, arguing that mosaic expression is due to the 
location and/or nature of the transgene array. 
II] 
CHAPTER 6 
CHROMOSOMAL LOCALISATION AND MOSAICISM OF 
TRANSGENE EXPRESSION 
6.1. INTRODUCTION 
The results presented in chapter 5 demonstrated that BLG mRNA 
was expressed in a mosaic fashion in the mammary gland in lines 7 and 45. BLG 
was expressed uniformly throughout the gland in line 14, as was 3-casein in all three 
lines. There are two possible explanations for the lack of BLG expression in some 
mammary epithelial cells in lines 7 and 45. First, somatic inactivation of the 
transgene can occur due to rearrangement or deletion of the locus in some cells but 
not in others (Wilkie etal., 1991; Sandgren et al., 1991). Just such a possibility was 
addressed in chapter 3 and was demonstrated to be unlikely. Second, the transgene 
locus could be subject to transcriptional inactivation in some cells but not in others. 
Transcriptional inactivation is often associated with methylation and 
heterochromatic condensation of a locus, best exemplified by the phenomenon of X-
inactivation. However, heterochromatinisation is not restricted to the inactive X 
chromosome; the DNA component of autosomes can be sub-divided into 
euchromatic and heterochromatic DNA. Euchromatin decondenses during 
interphase and contains most of an organism's genes. The classical definition of 
heterochromatin is the region of the chromosome that remains condensed (or 
heterochromatinised) throughout the cell cycle (Verma, 1988). Constitutive 
heterochromatin is located near the centromeres, telomeres and the whole of the Y 
chromosome whereas facultative heterochromatin is associated with the inactive X 
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chromosome. The centromere is defined cytologically as the primary constriction 
on the chromosome at a fixed position for a given chromosome. 
Transcriptional inactivation of the BLG transgene locus could be due to 
heterochromatic silencing, since this mechanism fulfills the following relevant 
criteria: (i) The inactivation process is capable of inactivating a large region of 
DNA; the transgene array in line 7 is >400 kb (-25 copies of a 16.2 kb fragment). 
Heterochromatinisation is a process thought to be involved in maintaining the 
inactive state of the inactive X chromosome (150 Mb) in female eukaryotic cells 
(Lyon, 1961; Barr & Can, 1962; Kanda, 1973; Rastan et al., 1980). (ii) The 
inactivation process is stable within the individual; expression levels are fixed across 
two lactation cycles (chapter 3). Once inactivated the X chromosome remains 
heterochromatinised in a permanent fashion and is heritable in a clonal fashion 
(Gartler & Riggs, 1983; Lyon, 1991; Brown & Willard, 1994). (iii) The expression 
level in a parent mouse is not transmitted to her offspring (chapter 4); therefore the 
fixed level of expression within the individual may be determined through the 
germline or during stem cell development. The state of X chromosome inactivation 
(heterochromatinisation), although stable within an individual, is not transmitted 
through the germline (Gartler et al., 1975; Kratzer & Chapman, 1981; McMahon et 
al., 1981; Monk & McLaren, 1981). (iv) The inactivation process is not 100% 
efficient (some degree of mosaicism was always present); abolition of expression 
was never observed within line 7 (chapter 5). Finally, mosaic or "variegated" 
expression of endogenous genes (Muller, 1930; Lewis, 1950; Baker, 1968; Spofford, 
1976; Karpen, 1994) and transgenes (Dorer & Henikoff, 1994; Wallrath & Elgin, 
1995; Sable & Henikoff, 1996) has been described in Drosophila and is termed 
position-effect variegation (PEV). The phenomenon involves a rearrangement of 
the chromosome which brings a locus (the first and best documented is the dominant 
allele of the white [w} gene) close to the centromere. The rearrangement is thought 
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to cause the heterochromatinisation of the w locus in some cells but not in others 
resulting in a mosaic pattern of white (mutant) and red (wild type) areas on the eye. 
PEV has also been documented with sequences integrated close to telomeres 
(Gottschling et al., 1990; Sandell & Zakian, 1992) or within centromeres (Alishire et 
al., 1994) in yeast. Similarly, X-autosome chromosome translocations in mouse 
result in silencing of autosomal genes in proximity to the breakpoint (Cattanach, 
1963; Russell, 1963; Eicher, 1970; Cattanach, 1974) implying that PEV may be a 
ubiquitous silencing phenomenon. The silencing process can affect genes up to 20 
kb away from the heterochromatin/euchromatin breakpoint in yeast (Gottschling et 
al., 1990) and up to 2 Mb in Drosophila (Weiler & Wakimoto, 1995). In summary, 
PEV involves a chromosomal disruption, proximity of the locus to constitutive 
(centromere or telomere) or facultative (inactive X chromosome) heterochromatin, 
heterochromatinisation of the locus and mosaic expression of the locus. 
Mouse chromosomes are acrocentric (with the exception of the Y 
chromosome), with centromeres located at one end of the chromosome arms (Evans, 
1981; Roberts et al., 1988). The centromeric regions of mammalian chromosomes 
contain tandemly repeated satellite sequences and display characteristics of 
constitutive heterochromatin (e.g., late replicating and a paucity of genes). Satellite 
sequences in Mus musculus are relatively AT rich and are methylated at their CpG 
dinucleotides, indicative of the lack or low level of transcriptional activity. Two 
classes of centromeric repetitive sequences have been characterised in mouse, the 
minor and major (gamma) satellite sequences (Hastie, 1996). In Mus musculus, the 
minor satellite is organised as tandem repeat arrays of a 120 bp monomer sequence, 
may constitute up to 0.2% of its genome (the haploid copy number has been 
estimated to be at least 50,000) and an average of --300 kb of satellite sequence per 
chromosome (Pietras et al., 1983, Wong & Rattner, 1988; Kipling et al., 1991). 
Minor satellite sequences are found at the primary constriction on the autosomes and 
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the X chromosome, but absent from the Y chromosome. These sequences are 
thought to be organised in largely uninterrupted blocks of tandem repeats (Kipling et 
al., 1991). Cytologically, minor satellite sequences appear to be localised at the 
kinetochore (Wong & Rattner 1988). Closely related species of Mus differ in the 
amount and type of satellite sequence present in their centromeric heterochromatin 
(Wong et al., 1990; Kipling et al., 1994; Aker & Huang 1996). Major satellite DNA 
comprises a 234 bp element that is tandemly repeated 106 times and is localised to 
the region of the chromosome that immediately flanks the kinetochores (Singer, 
1982; Pietras et al., 1983; Lica et al., 1986; Radic et al., 1987; Wong & Rattner, 
1988; Joseph et al., 1989; Moens & Pearlman, 1990; Wong et al., 1990; Matsuda & 
Chapman, 1991). The heterogeneity of the amount of heterochromatic DNA 
between closely related species (e.g., Mus musculus, Mus caroli and Mus spretus) 
and the repetitive nature of the sequences has led to speculation that satellite DNA 
has no essential function and is "junk" DNA. However studies on Drosophila 
demonstrate that many essential functions reside in heterochromatin including the 
sequences required for faithful chromosome pairing and segregation during mitosis 
and meiosis (i.e., the kinetochore/centromere; Murphy & Karpen, 1995b). 
Functional analysis of the Drosophila centromere suggests that the kinetochore is 
involved in spindle attachment and the flanking sequences are required for sister-
chromatid cohesion and for the generation of anti-poleward forces during mitosis 
and meiosis (Murphy & Karpen, 1995a,b). The precise function(s) of mouse 
centromeric regions have yet to be dissected although regions may be structurally 
and/or functionally conserved between higher eukaryotes (Nicklas, 1989). 
In this study there was a disruption of the normal chromosomal architecture 
due to transgene integration and mosaic expression of the transgene locus was 
observed in two out of three lines. I was therefore interested in determining whether 
the transgene array had integrated at or close to a centromere in lines 7 and 45 and 
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whether the array exhibited heterochromatinisation, akin to the observations 
described for PEV in Drosophila. 
6.2. RESULTS 
6.2.1. G-band and FISH analysis of lines 7, 14 and 45 
Fluorescent in situ hybridisation (FISH) analysis was 
performed on chromosome spreads prepared from line 7, 14 and 45 female animals 
to determine the chromosomal localisation of the BLG transgene integration site. 
Mouse chromosomes are acrocentric and are smaller than human 
chromosomes which makes them more difficult to karyotype. Furthermore, several 
mouse chromosomes are difficult to distinguish (e.g., chromosomes 9 and 13), even 
from very good chromosome preparations. Fifteen good quality G-banded 
metaphase chromosome spreads were analysed from each line. Karyotyping was 
performed partly by specialised software (see materials and methods) and partly by 
eye (with assistance from Muriel Lee, MRC Human Genetics Unit, Edinburgh). 
Digitized chromosome images were stored and the slide coordinates of each 
metaphase spread noted. These images were duplicated; one was used to karyotype 
the chromosomes and the other retained for comparison with the FISH image. The 
chromosome G-bands were removed by acid/alcohol hydrolysis and FISH analysis 
was performed using a BLG probe (see materials and methods). Fluorescent 
chromosome images were captured using a confocal microscope. 
The BLG probe did not hybridise with chromosomes prepared from non-
transgenic mice (Fig. 27). The BLG probe did hybridise with one or two 
chromosomes (depending on if the mouse was hemizygous or homozygous for the 
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Figure 27. FISH analysis of non-transgenic mouse metaphase chromosomes. 
Chromosomes from non-transgenic C57BL6 x CBA mice were hybridised overnight 
with a biotinylated BLG probe and incubated with avidin-FITC. Chromosomes 
were stained red using propidium iodide. 
ir.i 
transgene) in 100% of chromosome spreads prepared from transgenic mice. This 
enabled a comparison of the FISH images with the recorded 0-banded images, the 
construction of karyotypes and hence the identification of the chromosomes carrying 
the transgene (Figs. 28-30). The process was repeated 15 times with the best G-
banded chromosome spreads for each line. Karyotype analysis systematically 
identified the same chromosome harbouring the transgene within each and 
demonstrated that the transgene had integrated into a different chromosome in each 
line. The BLG transgene locus was located on chromosome 15 in line 7, 
chromosome 7 in line 14 and on chromosome 5 in line 45. Interestingly, the BLG 
locus had integrated mid-arm in line 14 but was close to the centromere in lines 7 
and 45 (Figs. 28-30). 
6.2.2. Position of the transgene array relative to satellite DNA 
To refine the localisation of the transgene array relative to the 
centromere a double in situ hybridisation was performed using a BLG probe in 
conjunction with a major satellite (196) DNA probe. Major satellite DNA can 
comprise as much as 10% of the mouse genome and is the main DNA component of 
the centromeres (Singer, 1982). Therefore by combining both probes in an in situ 
hybridisation study it was possible to locate the position of the transgene integration 
site in these two lines relative the centromeres. 
The major satellite DNA probe hybridised to the centromeric regions of 
metaphase chromosomes (Fig. 31). In all line 7 chromosome spreads the BLO locus 
was close to but outwith major satellite DNA (Fig 31A). The BLG signal was 
quenched to determine if any translocated satellite DNA was present at the BLG 
locus (Fig 31B). There was no evidence of translocated satellite DNA at the BLG 
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Figure 28. FISH/G-band analysis of metaphase chromosomes from line 7. 
(A) Chromosomes from homozygous line 7 mice were stained red using propidium 
iodide. Biotinylated BLG probe was visualised indirectly using avidin-FITC 
(green). (B) G-banding in conjunction with FISH enabled the identification of the 
G-banded chromosomes with the integrated transgene (arrows). (C) Karyotype of 
line 7 0-banded chromosomes. The chromosomes harbouring the transgene 
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Figure 29. FISH/G-band analysis of metaphase chromosomes from line 14. 
(A) Chromosomes from hemizygous line 14 mice were stained red using propidium 
iodide. Biotinylated BLG probe was visualised indirectly using avidin-FITC 
(green). (B) G-banding in conjunction with FISH enabled the identification of the 
G-banded chromosomes with the integrated transgene (arrow). (C) Karyotype of 
line 14 G-banded chromosomes. The chromosome harbouring the transgene 
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Figure 30. FISH/G-band analysis of metaphase chromosomes from line 45. 
(A) Chromosomes from hemizygous line 45 mice were stained red using propidium 
iodide. Biotinylated BLG probe was visualised indirectly using avidin-F1TC 
(green). (B) G-banding in conjunction with FISH enabled the identification of the 
G-banded chromosomes with the integrated transgene (arrow). (C) Karyotype of 
line 45 G-banded chromosomes. The chromosome harbouring the transgene 
(chromosome 5) is indicated with a black arrow. 
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Figure 31. Localisation of BLG and major satellite (196) DNA sequences in line 
7 by chromosomal FISH to metaphase chromosomes. 
(A) Chromosomes from homozygous line 7 mice were stained blue with DAPI. The 
BLG probe incorporated digoxigenin- ll -dUTP, the major satellite DNA probe 
incorporated biotin-16-dUTP. The BLG probe (arrow) was detected with rhodamine 
conjugated anti-digoxigenin and Texas red conjugated anti-sheep (red). The major 
satellite probe was detected using successive layers of avidin-FITC, biotinylated anti-
avidin and avidin-FITC (green). Each chromatid of metaphase chromosome 15 can 
be seen labeled with the BLG signal in these examples. (B) As above except the 
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the satellite DNA by taking optical readings along 56 different chromatids (Fig. 32). 
The edee of the satellite DNA signal was taken from two points (Fig. 32B); Cl was 
at the leading edge of the satellite DNA signal and C2 was half way between the 
edge (Cl) and the middle of the satellite DNA signal. The true edge of the satellite 
DNA was most likely to be towards Cl because the area to which the satellite DNA 
probe hybridised remained essentially the same as when the signal was quenched. 
The BLG transgene locus signal was taken from one point (TI; Fig. 3213) which was 
the middle of the signal. The results are presented in Table 23. 
Table 23. Measurement of the distance between the BLG transgene locus and 
major satellite DNA 
Chromosome l engt h* 	Ti to Clt 	Ti to C2 
mean ±s.d. 	mean ±s.d. mean ±s.d. 
41.54 ±5.02 	3.35% ±5.29 	12.10% ±4.76 
* chromosome length was measured in microns (xIO); T the distance between TI and Cl or C2 is 
expressed as a percentage of the total chromosome length (qtel to ptel); n = 56. This analysis was 
performed by Judy Fames; MRC Ilunian Genetic Unit, Edinburgh. 
The estimated distances between the transgene locus and edge of the satellite DNA 
signals were used to position the transgene locus on the G-band map of mouse 
chromosome 15 (Fig. 33). These rough calculations position the transgene locus 
within the first two G-hands after the heterochromatic/euchromatic DNA 
boundaries. 
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Figure 32. Localisation of the BLG locus in line 7 relative to the centromere. 
(A) The preparations with the longest chromosomes with sharp BLG signals were selected for this analysis. Lines were artificially 
drawn from one end of the chromosome to the other through the centromere and chromatids. Optical readings were taken along 
these lines. (B) Optical readings were plotted as distance vs. pixel intensity for each of the three colours, blue for chromatids, green 
for satellite DNA and red for the BLG locus. The ends of the chromatids are marked qtel & ptel. The edge of the centromere was 
measured from two points (Cl & C2). The transgene position was taken from the peak Ti. This analysis was performed by Judy 
Fantes, MRC Human Genetics Unit, Edinburgh. 
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Figure 33. Mouse chromosome 15 and the BLG transgene locus 
The estimated position of the BLG transgenc locus on mouse chromosome 15 is indicated (band A2 
or Bi). The calculation of the position of the BLG locus was based on the presumption that the edge 
of the satellite DNA is the boundary between bands Al and A2 (Akeson & Davisson, 1996). The 
distance between the A1/A2 boundary and C  is 3.35% of the total chromosome length; the distance 
between the A1-A2 boundary and C2 is 12.10% of the total chromosome length (Table 23). Note 
that the edge of the satellite DNA was taken as the fixed point of reference this time instead of the 
center of the transgene signal (Ti) as was the case in Table 23. The 0-banded schematic diagram of 
mouse chromosome 15 was taken from Mouse Genome 94 (1996), pp.  58 and is drawn to scale. 
The total haploid mouse genome is estimated to be 3.3 Gb (Carden, 1994). 
Chromosome 15 is estimated to represent 4.17% of the total haploid genome (Evans, 
1996). Therefore, based on these two presumptions, chromosome 15 is —138 Mb in 
size. 3.35% of chromosome 15 therefore represents 4.6 Mb and 12.1% is equivalent 
to 16.7 Mb. These calculations indicate that the BLG transgene locus could be 
between 4.6 Mb and 16.7 Mb from major satellite DNA. However it is more likely 
that the lower estimate is closest to the true distance. Double in situ hybridisation 
experiments utilising a BLG probe and probes for endogenous genes (e.g., 
interleukin 7 receptor and growth hormone receptor) that are known to map to bands 
A2 or B  (Mouse Genome 94 11996] pp.  58) will be necessary to map the transgene 
integration locus with greater precision. 
In line 45 the resolution of the in situ mapping (estimated at around 0.5 Mb) 
made the BLG signal appear to abut or even overlap with the major satellite DNA 
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signal (Fig. 34A). However the transgene signal can be observed clearly separate 
from major satellite DNA in interphase nuclei where chromosomes are decondensed 
(Fig. 34A). Again, quenching the BLG signal indicated that there is no translocated 
satellite DNA at the BLG locus in line 45 (Fig. 34B). 
Minor satellite DNA is found at the tip of mouse chromosomes. However, 
the possibility that there could be translocated minor satellite DNA at the BLG locus 
still existed. This was examined by performing the experiment described above but 
with a probe for minor satellite (Fig. 35). Results with spreads from line 7 
homozygous transgenic mice demonstrated that the transgene was positioned well 
away from the minor satellite DNA (Fig. 35A) and there was no evidence of 
translocated minor satellite DNA at the BLG locus after the BLG signal was 
quenched (Fig. 3513). 
6.2.3. Immunofluorescent / FISH analysis of line 7 chromosomes using 
CREST antibodies and DNA probes for BLG, c-myc and Pvt-1 
Some 10-15% of Scleroderma/CREST (calcinosis, aynaud's 
phenomenon, oesophageal involvement, sclerodactyly, 1elangiectasia) patients 
produce autoantibodies (known as anti-entromere antibodies [ACAs]) that 
recognise centromeric determinants (Moroi et al., 1980; Saunders et al., 1993). 
More specifically, the ACAs recognise a conserved 52 amino acid domain termed 
the chromodomain (chrorno for chromatin modifier) present in a family of 
centromere associated proteins thought to provide structural support for other 
proteins involved in chromosome pairing and segregation (Kellum & Alberts, 1995). 
"Native" chromosomes can be prepared in a fashion that leaves the chromosome- 
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Figure 34. Localisation of BLG and major satellite (196) DNA sequences in line 45 by chromosomal FISH to metaphase 
chromosomes. 
(A) Chmrnosomes and one interphase nucleus from hemizygous line 45 mice were stained blue with DAPI. The BLG probe 
incoiperated biotin- 11 -dUTP, the major satellite DNA probe incorporated digoxigenin- 11 -dUTP. The BLG probe (arrow) was 
detected with avidin-FITC (green). The major satellite probe was detected using rhodamine conjugated anti-digoxigenin and Texas 
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Figure 35. Localisation of BLG and minor sa1I1if 	 . ' 
chromosomal FISH to metaphase chromoson 
(A) Chromosomes from homozygous line 7 mice C1  Lail ICU 01 U iiii iJAkI. i u-
BLG probe incorporated digoxigenin-11-dUTP, the minor satellite DNA probe 
incorporated biotin-16-dUTP. The BLG probe (arrow) was detected with rhodamine 
conjugated anti-digoxigenin and Texas red conjugated anti-sheep (red). The minor 
satellite DNA probe was detected using successive layers of avidin-FITC, 
biotinylated anti-avidin and avidin-FITC (green). Each chromatid of metaphase 
chromosome 15 can be seen labeled with the BLG signal in these examples. (B) As 










associated proteins associated with the chromosomes. Immunofluorescence 
experiments with native chromosomes and CREST sera demonstrated that the EP 
fraction (Jeppesen & Nicol, 1986) recognises a mammalian homologue of the 
Drosophila heterochromatin-binding protein 1 (HP1; James & Elgin, 1986; Elgin, 
1996) that is specifically associated with pericentromeric heterochromatin in Mus 
musculus and humans (Nicol & Jeppesen, 1994). HP1 shares the chromodomain or 
"HP11Pc box" (Clark & Elgin, 1992) with the Polycomb protein (Pc; Paro & 
Hogness, 1991) which is thought to regulate certain developmental events by 
repressing homeotic gene expression (Moehrle & Paro, 1994). A further correlation 
between PEV and homeotic gene repression has been demonstrated by the fact that 
regulatory regions that respond to Pc group repression can induce variegation of an 
adjacent white gene (Fauvarque & Dura, 1993). PEV can be modified by mutations 
in genes that are then termed suppressors (e.g., Suvar(2)5 [HP1]; Eissenberg et al., 
1990; Eissenberg et al., 1992) or enhancers (e.g., the gene encoding GAGA, a 
protein associated with gene activation; Farkas et al., 1994) of variegation. The 
trithorax-group of genes in Drosophila are general activators of homeotic genes and 
demonstrate structural and functional similarities with the enhancers of variegation. 
Therefore PEV serves as a marker in genetic screens to identify other 
heterochromatin or chromatin-affecting proteins (Reuter et al., 1990; Grazino et al., 
1992). More than 50 suppressor or enhancer loci of PEV have been characterised to 
date and several other candidates have been identified (Weiler & Wakimoto, 1995). 
Results presented in chapters 5 and 6 established that (i) there is mosaic 
expression of the transgene in two lines and (ii) the transgene arrays in the same two 
lines are close to their respective centromeres. These are the two main features 
associated with PEV. Inimunofluorescent analysis using CREST antibodies was 
performed on native chromosomes prepared from line 7 mice to investigate whether 
there was evidence of heterochromatinisation of the BLG locus. 
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Native metaphase chromosomes were prepared from lymphocyte cell 
cultures from low and high BLG expressing individuals from line 7. 
Immunofluorescence experiments using CREST antibodies resulted in the 
characteristic "double-dot" binding to the kinetochores (Fig. 36A). The degree of 
pericentromeric (lighter labeling around the kinetochores; Fig. 37A) varied between 
slides in preparations from the same animal and from different animals. These 
differences are attributable to the inherent technical difficulty of producing 
chromosome preparations of consistent quality. 
The position of the BLG locus was identified by following the 
immunofluorescent analysis with FISH using a BLG and two endogenous 
chromosome 15 probes, c-rnyc and Pvt-1 (Fig. 38). The endogenous probes enabled 
the identification of both chromosome 15's in chromosome preparations from 
hemizygous line 7 individuals (Fig. 36B and Fig. 3713). This strategy enabled the 
comparison of the heterochromatic staining on the chromosome harbouring the 
transgene and its homologue without the transgene. Out of more than 60 metaphase 
chromosome spreads examined from low and high line 7 BLG expressors there was 
no evidence for co-localisation of the BLG and CREST signals (Figs. 36 and 37). 
This result could suggest that the BLG locus is not epigenetically silenced by 
heterochromatinisation of the locus. However there are several other possible 
reasons why there was no evidence for co-localisation of the BLG and CREST 
signals. (i) Crucially, the CREST EP serum is specific for just one heterochromatic 
protein (Nicol & Jeppesen, 1994). The BLG locus may be heterochromatinised by a 
complex of proteins that does not contain this protein. Other proteins that contain a 
chromodomain have been identified in mouse (Singh et al., 1991; Wreggett etal., 
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Figure 36. Native FISH using CREST antibodies and DNA probes for BLG, C-
myc and Pvt-lon line 7 chromosomes. 
(A) Native chromosome spreads from hemizygous line 7 mice were incubated with 
CREST antibody. The CREST antibody was visualised indirectly using anti-human 
IgG-FITC (green). The chromosomes were stained blue with DAPI. Images were 
recorded and the coordinates of each spread noted before proceeding with FISH 
analysis using BLG and endogenous gene probes. The chromosomes harbouring the 
transgene (long arrow) and the homologue (short arrow) are indicated. (B) The 
BLG, c-myc and Pvt-1 probes incorporated digoxigenin- 11 -dUTP and visualised 
indirectly using rhodamine conjugated anti-digoxigenin and Texas red conjugated 
anti-sheep (red). The CREST signal was retained from the previous hybridisation 
(green). The c-myc / Pvt-1 loci are indicated on the chromosome with the transgene 













Figure 37. Native FISH using CREST antibodies and DNA probes for BLG, c-rnyc and P vt-I on line 7 chromosomes. 
(A) The chromosomes indicated (short arrows) exhibited distinctive pericentromeric CREST signals. The two chromosome 15's 
are also indicated (long arrows). (B) The chromosomes with the transgene (lower arrow) and its homologue (upper arrow) without 
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Figure 38. Mouse chromosome 15 and the BLG, c-myc and Pvt-1 loci. 
(A) Schematic representation of a G-banded chromosome 15. The c-myc and Pvt-1 
loci are mapped to band D2 or D3 (Mouse Genome 94 [1996] pp. 58). Also 
illustrated is the estimated position of the BLG transgene locus. (B) Restriction 
maps (incomplete) of the c-myc and Pvt-1 loci. The c-myc and Pvt-1 clones were a 
gift from Dr Konrad Huppi, NIH, USA. 
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1994; Singh, 1994). M31 is a 24.7 kD protein that is thought to be a component of 
constitutive heterochromatin and is the closest homologue to HP1 with 51% 
homology. M32 is more distantly related to HP1 and is thought to be a component 
of silenced chromosomal domains. (ii) The metaphase spreads were prepared from 
lymphocyte cell cultures that were derived from the spleen and not from mammary 
tissue (at present there is no suitable protocol for mammary gland disaggregation 
and cell culture). Silencing of the BLG locus in the two tissues may not utilise the 
same processes. (iii) Finally, the CREST antibody serum may bind to the BLG 
locus but the signal may not be detectable because it is a relatively small target (400-
500 kb). 
6.3. CONCLUSIONS 
The transgene arrays have integrated into chromosomes 15 (line 7), 7 
(line 14), and 5 (line 45). Lines 7 and 45 exhibit variable protein and mRNA 
expression levels, mosaic expression in the mammary gland and the transgenes have 
integrated close to their respective centromeres. Line 14 exhibits stable protein and 
mRNA expression, uniform expression in the mammary gland and the transgene has 
integrated mid - arm on chromosome 7. The BLG locus does not co-localise with 
major or minor satellite DNA and could be as close as 4-5 Mb from major satellite 
DNA in line 7 and even closer in line 45. These results imply that variegated 
expression of the transgene may be associated with the position of the locus relative 
to the centromere, akin to PEV in Drosophila. 
Immunofluorescence experiments provided no evidence for co-localisation 
of the CREST antibody signal with the BLO locus on native metaphase chromosome 
preparations from line 7 animals. However this negative result does not rule out the 
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The introduction of new gene combinations into the mammalian germline by 
pronuclear injection of DNA is widely used in a variety of applications. The 
transgene usually integrates as a tandemly repeated and predominantly head-to-tail 
array at a single random site within the genome and therein segregates as a single 
Mendelian locus (Palmiter & Brinster, 1986). Though the transgene insertion site 
can clearly have an influence upon the tissue-specificity and level of expression, it 
has often been assumed that expression of the transgene, once integrated, is stable 
within a transgenic line. Indeed, some detailed studies have failed to detect 
variations in the level of transgene expression (on average, less than 20% variation 
in the level of reporter gene expression among different individuals of each line 
examined [Al-Shawi et al., 1990J). 
This contrasts with the situation found in Drosophila, yeast and plants where 
transgene expression can be subject to stochastic influences that lead to variegation 
of expression levels. We thus entered into a detailed study of the stability of 
transgene expression in three transgenic lines harbouring the ovine BLG gene. The 
transgene is expressed selectively within the lactating mammary gland and BLG 
protein is exported into milk. Of three lines studied, only one (line 14) expressed 
the transgene in a stable manner and wide variations in the individual level of 
expression were observed among individuals of the other two lines (lines 7 and 45). 
Most other examples of unstable transgene expression describe differences (e.g., 
degrees of mosaic expression) between different transgenic lines. This study 
provides the first detailed evidence for variegated expression of a transgene between 
individuals within transgenic lines. 
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DNA copy number within these lines appeared to be stable and there was no 
significant evidence of transgene rearrangement. Despite variation across the 
population, extensive analysis of the most variable line (line 7) demonstrated that 
the expression levels are fixed within the individual (chapter 3). The genetic 
background of this line, however, does not play a significant role in this variation 
(chapter 4). In this pedigree, as well as in a second line (line 45), mammary tissue in 
situ hybridisation experiments revealed mosaic expression of the transgene (chapter 
5); in low expressing animals, discrete patches of cells expressing the transgene 
were observed. The concentration of the transgene protein in milk reflected the 
proportion of mammary epithelial cells expressing BLG mRNA. In contrast, all the 
secretory epithelial cells within transgenic glands expressed the gene for an 
endogenous milk protein (-casein) uniformly. In situ hybridisation to metaphase 
chromosomes indicated that the transgene arrays in lines 7 and 45 are situated close 
to the centromere. 
7.1. Variable levels of BLG protein expression within lines 7 and 45 
In the experiments described in chapter 3 the ranges of BLG 
protein expression levels were different in lines 7, 14 and 45 (mean [mg/ml] ± s.d. = 
9.5 ± 4.9, 6.6 ± 1.1 and 23.7 ± 3.9 respectively). BLG is thus expressed in an 
unstable fashion in line 7 and in a stable fashion in line 14. Line 45 is more difficult 
to classify in terms of stable or unstable expression. Though line 45 exhibits less 
variability than line 7, this line (45) has a larger mean expression level than line 7. 
A possible explanation is that some factor(s) restricts the range of expression in line 
45, reducing the extent of variation by suppressing transgene product levels at the 
upper end of the range. For example, there may be an upper limit or "ceiling effect" 
to the amount of BLG that can be expressed within the mammary gland. The gland 
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appears to have a finite secretory capacity for milk proteins (McClenaghan et al., 
1995). In chapter 3 the mean BLG expression level was 23.7 mg/ml (n = 28) for 
line 45 hemizygous mice. The data from chapter 3 would predict a mean of 45-50 
mg/nd in homozygous line 45 mice. However, the mean BLG expression level was 
only 33.2 mg/ml (n = 8) in line 45 homozygous mice in a separate study 
(McClenaghan et al., 1995). The large difference between the predicted and 
measured homozygous mean expression levels in the two studies could be due to the 
small sample size (n = 8) in the latter study. Alternatively the homozygous mean 
could be limited to around 30-35 mg/ml by constraints on mammary gland synthetic 
capacity. Moreover, when BLG protein expression is increased (e.g., by crossing 
two hemizygous line 45 mice) the levels of the endogenous milk proteins were 
reduced (McClenaghan et al., 1995). The stage/level of competition for milk protein 
production was not identified. An increase in expression level of one protein at the 
expense of another could be due to competition for transcription factors (e.g., MGF / 
STAT5) involved in milk protein gene expression (Wakao et al., 1994; Gouilleux et 
al., 1994; DaSilva et al., 1996). Interestingly, the compensatory effect is different 
for each endogenous protein; WAP is proportionately reduced more than cx- and P- 
casein (McClenaghan et al., 1995). Alternatively, the gland could exert a limit to 
the amount of BLG expressed by a negative feedback mechanism. 
Tissue in situ hybridisation experiments revealed mosaic expression of BLG 
mRNA in the mammary gland of line 7 and 45 animals. In line 7, the proportion of 
cells positive for transgene mRNA appeared to correlate with protein expression 
levels. In mammary gland sections from the lowest expressors regions of expressing 
cells were surrounded by non-expressing cells. In the highest expressors this 
situation was reversed, with small regions and even single alveoli comprising non-
expressing cells surrounded by expressing cells. While the proportion of mammary 
gland cells expressing the transgene clearly varied between individuals of line 7, 
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individual differences in line 45 were less pronounced. Here the patterns of 
expression were similar to those observed in line 7 individuals expressing the 
transgene in the majority of mammary gland cells. There was little evidence of 
patches of expressing cells surrounded by non-expressing cells. This may be due to 
the higher average expression level in line 45. However, line 45 individuals did 
demonstrate a degree of variegation between individuals within the line that 
corresponded with the protein expression levels. This result suggests that the 
variation of BLG protein levels in line 45 animals was a true measure of the range of 
expression within the line and not a statistical wobble or spread due to the high 
average expression level. 
Unfortunately, it was not possible to accurately quantitate tissue in situ 
hybridisation images. This would require serial sections through the gland (due to 
the complex three-dimentional structure of the gland) and exhaustive estimates of 
numbers of expressing and non-expressing cells in each section. A strategy similar 
to this was described by Munford (1963) and serves to demonstrate that such an 
undertaking would be a separate project in its own right. 
In summary, only line 14 exhibited stable expression akin to endogenous 
milk protein gene expression. This served to demonstrate that the transgene 
construct itself is not responsible for variegated expression. However, the other two 
lines studied (7 and 45) showed considerable variation within the lines. These 
variations were manifested at the level of protein expression within the milk and the 
proportion and mRNA expressing cells within the mammary gland. 
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7.2. Transcriptional versus translational mechanism for unstable 
BLG expression 
Eukaryotic gene expression is regulated at a variety of 
transcriptional and/or the post-transcriptional levels. Chapter one summarised a 
multitude of factors involved in transcription of the milk protein genes within the 
mammary gland including transcription factors (Wakao et al., 1994; Li & Rosen, 
1995; DaSilva et al., 1996), hormones (Topper & Freeman, 1980; Hobbs et al., 
1982; Wiens et al., 1987), cell-cell (Levine & Stockdale, 1985; Chen & Bissell, 
1989) and cell-ECM interactions (Lee et al., 1984; Blum et al., 1987; Chen & 
Bissell, 1989). Some of these influences lead to differential regulation of individual 
milk protein mRNAs (Hobbs et al., 1982). For example, studies using primary 
cultures of mouse mammary epithelial cells maintained on floating collagen gels, 
with or without addition of ECM components, demonstrated that casein mRNAs 
were hormonally regulated while WAP and a-lactalbumin were not expressed (Lee 
et al., 1984, 1985). Steady-state mRNA levels are determined by a variety of 
parameters including initiation and elongation of transcription, 5' cap addition, 
polyadenylation, splicing, transfer from the nucleus to the cytoplasm, subcellular 
targeting of transcripts and the role of mature mRNA degradation. Although little is 
known about the role of extracellular influences on milk protein mRNA stability in 
the mammary gland, there are several well characterised examples of regulation of 
gene expression by control of niRNA stability in other systems (for review, see 
Atwater et al., 1990). For example, oestrogen was reported to have a >30-fold 
stabilising effect on the half-life of vitellogenin mRNA in Xenopus laevis liver 
(Brock & Shapiro, 1983). Milk protein expression is also governed by protein 
targeting to constitutive and regulated secretory pathways that transport the mature 
polypeptide through and out of the secretory epithelial cells (Turner et al., 1992). It 
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is therefore perhaps unsurprising that high correlations between individual BLG 
protein and mRNA expression levels were not observed within lines 7, 14 and 45. 
The correlation coefficients were similar for all three lines (after excluding one 
outlier in line 7) arguing that the relationship between RNA and protein is the same 
in all three lines. The variability of BLG niRNA expression levels reflected the 
variability of protein expression levels; line 7 was the most variable for protein and 
mRNA expression, line 14 was the most stable and line 45 had an intermediate 
range relative to lines 7 and 14. This relationship could be due to variable mRNA 
stability within lines 7 and 45. However the tissue in Situ hybridisation experiments 
demonstrated that there was a good correlation between the BLG protein expression 
level and the number of mRNA expressing cells in line 7. The theoretical possibility 
remains that non-expressing cells transcribe the transgene but degrade the transcript 
to such an extent that it becomes undetectable by in situ hybridisation. However, it 
seems more likely that variable protein levels are more due to variable transcription 
of the transgene. 
7.3. Variable transcription of the BLG transgene 
Unstable transgene expression could be due to stochastic 
deletion or rearrangement of the locus. However no evidence was found for 
significant loss of transgene copies within individuals exhibiting the full range of 
expression within all three lines. Based on the relatively uniform intensity of the 
BLG bands on Southern blots the c.v. values appeared surprisingly high for all three 
lines. This was initially attributed to the preparation of the DNA samples and the 
quantitation of the bands. Exhaustive efforts were made to reduce cumulative errors 
by cleaning the DNA twice (2 x 3 phenol/chloroforms), ensuring complete 
resuspension of the DNA, measurement of DNA concentrations in triplicate, 
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production of blots with low background hybridisation, careful quantitation using a 
phosphoimager and the use of two (total mouse mammary DNA and WAP) internal 
controls for loading. Despite every effort the c.v. values remained high in each line, 
implying that they reflect the inherent variability in the technique. It is doubtful that 
the c.v. values represent variations in transgene copy number that are responsible for 
variable mRNA and protein expression levels. For example, line 14 has c.v. values 
of 41-45% for copy number within the line without demonstrating variations in 
mRNA and protein expression levels. In contrast, line 45 has c.v. values of 38-42% 
for copy number and does demonstrate significant variations in mRNA and protein. 
Unfortunately similar studies have not been performed by others in the laboratory 
and therefore a comparison of "basal" variation for the procedure cannot be made. 
Significantly, the DNA copy number c.v. values were similar in all three lines while 
the protein (s.d.) and mRNA (c.v.) values varied considerably within the three lines. 
Furthermore, the line 7 protein and mRNA c.v. values (52% and 47% respectively) 
were higher than the DNA c. v. values (26-42%), making transgene deletion an 
unlikely explanation for variable expression. 
These results Contrast with a separate study in which unstable transgene 
expression was shown to be due to stochastic deletion of the locus in two lines of 
transgenic mice (Sandgren et at., 1991). In this study expression of an albumin-
urokinase-type plasminogen activator fusion construct in the liver was lethal in 
transgenic mice. However two lines stochastically reverted from an original 10 and 
4 copies of the transgene to 2-3 and I copy respectively, resulting in the abolition of 
expression and subsequent selection for cells exhibiting the deletion. These 
deletions were clearly visible using Southern analysis even though the liver is a 
heterogenous tissue comprising several cell types. Detailed Southern analysis of 
transgene DNA demonstrated that the most likely mechanism responsible for the 
loss of cytotoxic transgene expression was homologous recombination between 
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copies of the transgene within the array. Transgene deletion was manifested as 
changes in liver phenotype because the rearrangements imparted a selective 
advantage on the cells exhibiting the rearrangement and the liver permitted 
amplification of these cells. Similarly, expression of a metal lothionei n/herpes 
simplex virus thymidine kinase fusion construct in embryonic germ cells resulted in 
sperm infertility (Braun et al., 1990). lntrachromosomal recombination between 
duplicated genomic DNA flanking the transgene deleted the array and resulted in 
fertile males due to clones of wild-type sperm (Wilkie et al., 1991). Again, the 
deletions were clearly visible by Southern analysis. 
Line 7 exhibited variable expression and line 14 exhibited stable expression 
even though both lines contain an identical construct. The size of the transgene 
array could be the determining factor; the larger arrays in lines 7 and 45 could be 
more susceptible to intrachromosomal recombination. However an array of only 4 
copies exhibited deletion down to just one copy in the study described by Sandgren 
and collegues (1991). 
The total DNA content of the mouse mammary gland increases 5- to 7-fold 
between the virgin and day 14 of lactation (Brookreson & Turner, 1959; Nicoll & 
Tucker, 1965). Mammary tissue from virgin C3H/Crgl/2 mice comprises about 23% 
mammary parenchymal DNA and 77% stromal DNA (Nicoll & Tucker, 1965). 
While the DNA content of the mammary gland fat pad did not increase between the 
virginal state and day 10 of lactation the parenchymal tissue increased to about 89% 
(a 27-fold increase) of total DNA. However it is not known what percentage of the 
cells within the gland at mid-lactation are of the secretory epithelial type (Prof. 
Barry Gusterson, pers. comm.). Given the inherent variability in the Southern blot 
data and the heterogeneity of cell types within the mammary gland, stochastic 
deletion of the locus in lines 7 and 45 cannot be ruled out as the cause of variable 
expression. However this explanation is hard to reconcile mechanistically. The 
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mammary gland is similar to the liver and testis (Sandgren et al., 1991 and Wilkie et 
al., 1991 respectively) in that the gland exhibits massive cell proliferation (Traurig, 
1967) and cell selection could plausibly operate. However, expression of BLG does 
not appear to be toxic to the mother or offspring (Simons et al., 1987) and the 
secretory epithelial cells appear morphologically normal (Harris et al., 1991). 
Therefore it is unclear whether mammary stem cells exhibiting intrachromosomal 
deletion of the BLG locus could have a selective advantage over those without 
transgene deletion. It is not known for certain whether the mammary gland contains 
a population of stem cells that divide and differentiate to generate the secretory 
epithelial cells. However, the cycles of cell proliferation and involution during 
successive lactations is consistant with the presence of stem cells (for review see 
Daniel & Silberstein, 1987). Autoradiographic studies of glands at early pregnancy 
demonstrate that proliferation occurs at the terminal end buds (TEBs) of the ductal 
system in rats (Dulbecco et al., 1982) and from the TEBs and the ducts themselves 
in mice (Bresciani, 1971) suggesting the presence of pluripotent cells within the 
ductal branches. The high proportion of non-expressing cells in low expressors 
from line 7 would have had to arisen by deletion of the transgene in >50% of the 
mammary stem cells or within most of the cell lineages very early in mammary 
development. This seems very unlikely unless the transgene had integrated into a 
region within the genome that is a hotspot for recombination. 
In summary, while these studies would not reveal subtle changes in the 
structure of the transgene array, variable expression is probably not due to stochastic 
loss or rearrangement of the transgene array in different individual line 7 and 45 
mice. 
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7.4. Mosaic expression of BLG in the mammary gland 
BLG was expressed in a mosaic fashion in lines 7 and 45 
while 13-casein expression was uniform. This result argues against the possibility 
that mosaicism is caused by cycling of active and inactive domains due to hormonal 
regulation, as previously suggested for endogenous milk proteins in sheep and mice 
(Molenaar et al., 1992; Barash et al., 1994) or transgenes in mice (Faerman et al., 
1995). Mosaic expression of four endogenous mouse milk genes and for a whey 
acidic protein (WAP)-reporter fusion gene has been described during gestation in 
mice (Robinson et al., 1995). However, expression of all of the genes was observed 
throughout the mammary epithelium by day I of lactation. While the observations 
illustrated and described in chapter 5 do not rigorously rule out threshold effects 
due, for instance, to sub-optimal levels of lactogenic hormones leading to stochastic 
onset of milk protein gene expression, this possibility is unlikely. First, sections 
were taken from glands at a time (day II of lactation) when milk production is near-
maximal and all secretory cells are producing 13-casein. Second, line 14, harbouring 
the identical construct to that present in the highly variable line 7, shows stable 
expression throughout the gland. 
The patching of cells in which the transgene is active or inactive is 
suggestive of clonal expansion. Because no evidence was found of transgene loss or 
rearrangement, the results presented in this study suggest that events leading to 
epigenetic silencing of transcription occur stochastically in individual progenitor 
cells; these are then transmitted through cell division to daughter cells and give rise 
to the observed mosaic pattern of expression. The closest precedent for these 
observations is afforded by the striated coat colour patterns recorded by Mintz and 
collegues for a mouse mutant affecting the endogenous tyrosinase gene (Porter et 
al., 1991) or in animals harbouring tyrosinase fusion transgenes (Bradi et aL, 1991; 
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Mintz & Brad!, 1991). Robertson et al., (1995) have reported differing levels of 
heterocellular expression for a globin promoter-aHS-40 transgene among transgenic 
mouse lines and shown that the degree of silencing increases with age (Robertson et 
al., 1996). Although levels are fixed within lines, the underlying mechanism(s) may 
be similar, resulting in phenotypic differences that reflect the clonal origin of mosaic 
patches (phenoclones [Mintz, 19701). 
7.5. Position effect variegation: mechanisms of mosaic silencing 
PEV was first docummented by Muller in 1930 when he 
described a mosaic or variegated phenotype in the eye of Drosophila melanogaster. 
Variegation has fascinated and confounded investigators in the field since its 
discovery. PEV now applies to several phenomena (discussed below) but is most 
commonly observed in Drosophila when a chromosome rearrangement relocates a 
euchromatic endogenous gene locus close to a heterochromatic centromere or 
telomere. The translocation can result in the silencing of the locus in a variable 
proportion of cells, hence the variegation. Despite over 65 years of intensive study 
the phenomenon of PEV is still not adequately explained. However in the last few 
years there have been some exciting developments in the field. In attempting to 
dissect the cause of variegated expression research has focused on unstable gene 
structure or unstable gene expression. 
7.5.1. Somatic instability 
In 	Drosophila, surprisingly few genomic 
rearrangements (Rushlow et al., 1984; Tartof et al., 1984; Hayashi et a! 1990; 
Karpen & Spradling, 1990) or transposon insertions (Spradling & Rubin, 1983; 
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Daniels et al., 1986; Karpen & Spradling, 1992; Tower et al., 1993; Zhang & 
Spradling, 1993) exhibiting PEV have been analysed at the DNA level. Variegation 
of genes due to chromosome rearrangement (Henikoff, 1981; Rushlow etal., 1984; 
Hayashi et al., 1990) or insertion into subtelomeric regions (Levis, 1989; Karpen & 
Spradling, 1992) sometimes show evidence of altered copy number and structure of 
the variegating gene. However, these alterations are generally considered as 
insufficient to explain the dramatic alteration in phenotype. The lack of evidence for 
substantial alterations to the loci could be because the examples failed to exhibit 
sufficiently high levels of variegation and Southern blot analysis would not reveal 
altered molecules representing a small fraction of the total. Other studies (Spradling 
& Karpen, 1990; Karpen & Spradling, 1990; Spradling, 1993) however, have 
demonstrated detailed examples of DNA elimination (up to 39-fold reduction) 
occuring at a locus (yellow) exhibiting strong variegation. The authors argue that 
some DNA alterations are due to stochastic instability of juxtaposed heterochromatic 
sequences and that copy number reduction (under-representation) represents a 
subclass of variegating regions. Spradling (1993) suggests that somatic 
rearrangements of heterochromatic regions may serve as a process for the regulation 
of genes (e.g., rRNA genes) embedded within heterochromatin or as overall 
organisers of nuclear chromatin through development. 
7.5.2. Chromatin assembly model 
Until recently, unstable gene expression of 
endogenous genes relocated close to centromeric or telomeric heterochromatin had 
been attributed to a heterochromati n isat ion process. The heterochromatinisation 
model (Zuckerkandi, 1974; Sinclair etal., 1983; Locke etal., 1988; Grigliatti, 1991) 
proposes that multimeric protein complexes normally associated with 
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heterochromatin slide or spread along the chromosome past the 
heterochromatin/euchromatin breakpoint and into adjacent relocated euchromatin 
(Belyaeva & Zhimulev, 1991; Martin-Morris et al., 1993). In this model, mass-
action or self-assembly of heterochromatin-associated proteins (see chapter 6) cause 
stochastic condensation of the DNA at some stage in development resulting in the 
variable inactivation of genes between the centromere and the vicinity of the 
breakpoint (Tartof et al., 1984; Spradling & Karpen, 1990; Eissenberg & Elgin, 
1991; Grigliatti, 1991; Henikoff, 1992; Reuter & Spierer, 1992). Evidence for this 
model is provided by the cytological observation that euchromatin juxtaposed with 
heterochromatin appears to merge with the highly compacted chromocentre on 
Drosophila polytene chromosomes (Schultz & Caspersson, 1939; Prokofyeva-
Belgovskaya, 1939; Cole & Sutton, 1941; Zuckerkandi, 1974; Locke etal., 1988). 
Furthermore, the inactivation of the endogenous loci is directional; loci closest to the 
breakpoint are more strongly affected than those further away, implying a spreading 
of the silencing process from the heterochromatic centromere. The degree of 
variegation of a locus can be reduced by relocation away from heterochromatin 
(Dubinin & Sidorov, 1935; Panshin, 1935; Kaufmann, 1942; Judd, 1955). Therefore 
it is proximity of the locus to heterochromatin per Se, and not mutation of the locus 
due to translocation that is the cause of the variegated expression. 
Evidence, however, for the mass-action model has been lacking. If the 
silencing process does indeed spread from the centromere then why does it not 
continue to spread along the whole of the chromosome as is thought to occur in X 
chromosome inactivation? It has been proposed that there are "insulator or 
blocking" elements interspersed along the chromosome that prevent the infinate 
spread of the silencing (Tartof et al., 1984). However molecular evidence for the 
existance of these elements has not arisen (Kellum & Schedi, 1991) although a locus 
control region appears to insulate a transgene from variegated expression in mice 
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(Festenstein et al., 1996). Close inspection of chromosome regions associated with 
some PEV rearrangements demonstrate discontinuous compaction. This suggests 
that instead of uniform spread along the chromsosome a more local 
heterochromatinisation process takes place (Belyaeva & Zhimulev, 1991). 
Furthermore, two variegating loci within the same cell can show differential 
variegation, condensation and binding to heterochromatin protein 1 (HP1; Bishop, 
1992; Belyaeva et al., 1993). This argues against the idea that the silencing is 
caused by the binding of proteins that are uniformly distributed throughout the 
nucleus. Perhaps the most striking example of variegation that cannot be explained 
by this model is the dominant PEV induced by certain alleles of the brown (bw) 
gene. The brownD0m 1u (b w D) mutation results when a >2 Mb sequence of 
heterochromatin integrates within the hw gene. This can result in variegated "trans-
inactivation" of the wild-type bw homologue on the unaltered chromosome (Slatis, 
1955; see also 7.5.3.). 
7.5.3. DNA looping model 
Recently, two papers (Dorer & Henikoff, 1994; Sabl 
& Henikoff, 1996) reported that heterochroniatinisatiori of a transgene in Drosophila 
is not only dependent upon proximity to the centromere but also on the number of 
repeats present at the transgene locus; silencing increased in step with copy number. 
The most recent study (Sabi & Henikoff, 1996) using a Drosophila brown eye 
colour transgene has resulted in a different model from the classical heterochromatic 
spreading hypothesis to explain PEV. The transgene P(bw) was inserted 50-75 kb 
from heterochromatin. Initially this showed an intermediate level of variegation. 
Transgene duplication or inversion resulted in different levels of variegation; 
reversal of orientation resulted in almost no inactivation, duplication in reversed or 
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the same orientation increased inactivation while triplication resulted in almost 
complete extinction of expression. It is hard to reconcile these observations with the 
model for a heterochromatinisation process spreading along the chromosome. 
Instead, the authors suggest a pairing-looping mechanism, whereby somatic pairing 
involving middle repetitive elements can lead to looping and sequestration of 
euchromatic genes into a heterochromatic compartment. In separate studies, 
homology-dependent silencing of bwD  and bw is dependent on pairing of the 
chromosomes (Dreesen et al., 199 1) and the position of the bwD  allele relative to the 
centromere; variegation is suppressed when bwD  is translocated further from the 
centromere (Talbert et al., 1994) and enhanced when bwD is closer to the centromere 
(Henikoff et al., 1995). Cytological studies demonstrate that the insertion of a large 
block of heterochromatin into bw causes the allele and its wild-type homologue (due 
to chromosome pairing) to be moved into a heterochromatic region of the nucleus 
(Csink & Henikoff, 1996; Dernburg et al., 1996). These observations have led to 
the idea that the nucleus may be compartmentalised into regions that are permissive 
for gene transcription (in which euchromatin is located) and regions that are non-
permissive for gene transcription (and in which heterochromatin is located) [see also 
Karpen, 19941. In addition, sub-regions of euchromatin may be packaged into 
condensed chromatin structures or domains that prevent access to transcriptional 
activators (Locke et al., 1988; Grigliatti, 1991; Wallrath & Elgin, 1995). 
Transcriptionally permissive and non-permissive domains may be regulated by 
macromolecular complexes that mediate changes in chromatin structure via 
nucleosome positioning (reviewed by Kingston et al., 1996). Once established, the 
non-permissive transcriptional state can be maintained through successive cell 
divisions during mitosis, as is the case with the silent mating-type locus in yeast 
(Loo & Rine, 1995) and X chromosome inactivation in female eukaryotic cells 
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(Lyon, 1991; Brown & Willard, 1994), resulting in clones of expressing and non-
expressing cells. 
7.6. A model for transgene silencing in lines 7 and 45 
While the mechanism responsible for BLG transgene 
silencing in some mammary cells but not in others remains to be elucidated, the 
phenomenon of PEV in Drosophila affords an informative parallel. The 
experiments described in this study argue that a similar process may occur in mouse. 
First, in both mouse lines exhibiting mosaic BLG expression the transgene array is 
integrated in the vicinity of the centromere while, in the stably-expressing line, the 
transgene locus was located some distance from the centromere. Second, gene 
variegation in Drosophila can extend over 50-60 polytene bands (1-2 Mb) from a 
rearrangement breakpoint (Demerec, 1940; Hartmann-Goldstein, 1967; Weiler & 
Wakimoto, 1995). While no precise measure can be provided, estimates from FISH 
chromosomal spreads suggest that the transgene insertion of line 7 is some 4-5 Mb 
from centromeric heterochromatin. This is broadly consistant with the situation 
found in Drosophila, particularly if relative genome sizes are taken into account 
(Mus musculus = 3.3 Gb, Drosophila melanogaster = 165 Mb; Carden, 1994). 
Third, the recent experiments by Henikoff and colleagues indicate that 
heterochromatinisation in Drosophila is not only dependent on proximity to the 
centromere but also on the number of repeats present at the transgene locus. In this 
study lines 7 and 45 both display mosaic expression and both have some 20 copies 
of the transgene, while the stably expressing line 14 contains only <5 copies. 
Furthermore, Mehtali et al., (1990) described increased extinction of transgene 
activity (as judged by reporter gene expression and DNA methylation 
measurements) with increased copy number. Mosaic expression was reported for a 
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transgene integrated into the heterochromatic portion of the Y chromosome 
(Practcheva et al., 1994) while heterochromatic features of an unusually large (1.1 
Mb) 3-g1obin transgene integrated into a peritelomeric region were also observed 
(Manuelidis, 1991). It is therefore plausible to suggest that both integration site and 
number of transgene copies predispose to the mosaic expression phenotype. 
A link between heterochromatinisation and variegation in lines 7 and 45 has 
yet to be demonstrated. In Drosophila the degree of variegation is remarkably 
sensitive to the presence or absence of the Y chromosome (Karpen & Spradling, 
1990). This is probably because Drosophila only has four autosomes. The 
heterochromatic Y chromosome is thought to act as a "sink" for heterochromatin-
associated proteins; the presence of the Y chromosome drains the availability of 
heterochromatin-associated proteins from the variegating locus, the absence of the Y 
chromosome releases more heterochromatin-associated proteins. It would be 
interesting to test if a similar strategy would work in mice by using XO female mice 
harbouring the BLG transgene. Would this reduce the range of expression levels, 
lower the mean and increase the degree of variegation (number of non-expressing 
cells) within line 7? Major satellite DNA comprises up to 10% of the genome in 
Mus which is equivalent to —330 Mb. The X chromosome represents 6.18% of the 
total genome (Evans, 1996) which is —204 Mb. Therefore this experiment would 
remove more than one third of the heterochromatin. This may act as a significant 
release of heterochromatin-associated proteins that could affect BLG expression 
within line 7. An alternative strategy to investigate the possibility of a 
heterochromatic protein complex at the BLG locus would be to fractionate 
fragmented chromatin by adsorption to CREST, M32 or M31 antibodies that 
recognise heterochromatin-associated proteins. The extent of differential 
representation of transgene DNA in the bound and unbound fractions should 
correlate with expression levels. 
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To examine the possibility that the mosaic patterns reflect clonal expansion 
from committed progenitor cells (and determine whether there is a link between X 
chromosome inactivation and epigenetic silencing of euchromatic loci) it would be 
valuable to cross line 7 mice to animals harbouring an X-linked lacZ transgene (Tan 
et al., 1994). The coincidence of p3-gal and BLG expression would argue for clonal 
expansion. 
Three heterochromatic silencing mechanisms could cause variegated 
expression of the BLG transgene locus. Firstly, as has been classically described for 
PEV in Drosophila, the BLG locus could be silenced due to heterochromatin-
associated proteins spreading from the centronlere (Fig. 39A). 
A. Position-effect 'variegation (PC-'V) 
... 
Ill. Local: centt-oniere-dependent 
krJi 	 II 
€. L.ocal: ceritromere- I ndcpc nde n t 
I, 	 . ... 
Fig. 39. Models for BLG silencing (heterochromatinisation) 
Open circle, centromere; plain line, euchrornatin; stipled boxes, transgene array; hatched boxes, 
heterochromatin 
This could be tested by double chromosome in situ hybridisation mapping of 
endogenous genes in the vicinity the BLG integration locus (e.g., GHR and IL7R) 
and examining whether these genes also exhibit variegated expression. Secondly, 
the BLG locus could be silenced because of its proximity to the centromere (Fig. 
39B). However, instead of heterochromati n -associated proteins spreading from the 
IEEI 
centromere, this model predicts that pairing of the transgene locus with 
heterochromatic regions is facilitated by proximity, leading to transfer into a 
heterochromatic domain within the nucleus. Thirdly, the BLG locus could be 
silenced because of the repeat structure of the transgene array and the silencing 
process is independent of the position of the locus relative to the centromere (Fig. 
39C). If heterochromatin -associated proteins are involved in silencing of the BLG 
locus then current literature would suggest that the second mechanism is the most 
likely cause of silencing in lines 7 and 45. The second and third mechanisms could 
be distinguished between by generating more transgenic lines with different copy 
numbers and integration sites and determine if there is a relationship between copy 
number, position relative to the centromere and transgene variegation. 
7.7. PEV: A ubiquitous phenomenon? 
The phenomenon of PEV has stimulated and held the interest 
of geneticists since its discovery. It represents one of a variety of diverse, yet 
related processes. These include X-chromosome inactivation in female mammals 
(see chapter 6), silencing of euchromatic genes in the vicinity of X-autosome 
translocation junctions in mice (Cattanach, 1974) or genes adjoining the Xq27 locus 
in human fragile-X syndrome (Laird, 1987), genetic imprinting in human disease 
(Scrable et al., 1989; Hall, 1990; Nicholls, 1993), endogenous and transgene 
silencing in plants (Matzke & Matzke, 1995; Martienssen & Richards, 1995), the 
control of mating type in Saccharomyces cerevisiae (Laurenson & Rine, 1992; 
Rivier & Rine, 1992; Loo & Rine, 1995) and processes involved in heritable 
silencing of developmentally regulated genes (Eissenberg et al., 1995; Orlando & 
Paro, 1995; Elgin, 1996). A crucial feature of PEV and related processes is that the 
states of silencing are stored as heritable chromatin structures instead of a feedback 
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loop of regulatory proteins that diffuse from place to place. The study of PEV and 
heterochromatin structure may provide useful models for understanding the 
molecular basis of general mechanisms involved in the genetic control of 
chromosome domains. 
7.8. Implications for mosaic transgene expression 
Mosaic expression of transgenes in mice is not uncommon 
(see chapter 1) and has implications for investigations utilising gene addition 
technology. For instance, in gene expression studies the pattern of transgene 
expression would give a less than complete picture of the pattern of expression of 
the endogenous gene. In medical research, gene addition is now being tested as a 
means of causing tissue specific cell ablation in the treatment of brain tumours 
(Culver et al., 1992), or in the study of the consequences of the loss of thyroid 
hormone production without surgery in mice (Wallace et al., 1994). Variegated 
expression in such experiments would prevent 100% ablation and therefore result in 
variable numbers of cells remaining. Similarily, the genetic manipulation of animal 
organs for transplant purposes might be prejudiced by unpredictable transgene 
expression (Cozzi & White, 1995). In biotechnological applications, such as the 
production of proteins of biomedical interest in the milk of transgenic livestock 
(Clark et al., 1987; Archibald et al., 1990; Wright et al., 1991), mosaic expression 
will reduce the yield of product. Prescreening on the basis of chromosomal 
localisation and copy number could potentially avoid the need for large scale 
breeding experiments to verify the stability of expression, while the use of large 
transgene constructs (e.g., based on bacterial or yeast artificial chromosomes) would 
be expected to hinder DNA looping between repeat motifs (if this does indeed 
contribute to PEV) and yield stable expression patterns. 
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Since this project was completed other colleagues have reported variable 
expression within transgenic lines (Drs B. Binas and T. Burdon, pers. comm.; Drs S. 
Morley and J.J. Mullins, pers. comm.) suggesting that the phenomenon may not be 
uncommon. Particularly intriguing is the possibility that some endogenous genes 
within the mammalian genome, especially those close to heterochromatic regions 
(e.g., immunodeficiency, centromeric instability, facial anomalies syndrome [ICF; 
Gimelli et al., 1993] and faciocapulohumeral muscular dystrophy [Zatz et al., 1995]) 
or present as tandem duplications at a single locus, may be susceptible to the type of 
mosaic silencing described here. Recently, chromosome rearrangements located 4-
400 kb (5' or 3') from genes have been associated with some human (e.g., SOX9 / 
campomelic dysplasia and autosomal sex reversal; PAX6 I aniridia) and mouse 
(steel locus / female sterility) genetic disorders (reviewed by Milot et al., 1996; 
Bedell et al., 1996). For example, detailed molecular analysis of two aniridia 
(absence of iris) human pedigrees have demonstrated that the disorder is associated 
with chromosome rearrangements greater than 85 kb downstream of the PAX6 gene 
(Fantes et al., 1995). Although a link between the aberrant phenotypes and the 
genomic rearrangements has yet to be established, it is tempting to speculate that the 
rearrangements cause relocation of the affected loci into transcriptionally non-
permissive chromatin domains. It would appear that our understanding of gross 
chromosomal architecture will be as critical in our understanding of gene regulation 
as our understanding of local cis-acting elements. 
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Variance: average of the squared distance of observations (sample values e.g. BLG 
expression levels) from the mean 
Mean: sum of all the values divided by the number of values 
Standard Deviation (s.d.): square root of the variance (same measurement as the 
variance but on the same scale as the mean) 
Coefficient of variation: (s.d. / mean) x 100 (the s.d. as a proportion of the mean) 
Correlation coefficient: a measure of the degree to which the two variables (e.g. 
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ABSTRACT 	Mice carrying an ovine )3-lactoglobulin 
(BLG) transgene secrete BL(; protein into their milk. To 
explore transgene expression stability, we studied expression 
levels in three BLG transgenic mouse lines. Unexpectedly, two 
lines exhibited variable levels of transgene expression. Copy 
number within lines appeared to be stable and there was no 
evidence of transgene rearrangement. In the most variable 
line, BEG production levels were stable within individual mice 
in two successive lactations. Backcrossing demonstrated that 
genetic background did not contribute significantly to vari-
able expression. Tissue in situ hybridization revealed mosa-
icism of transgene expression within individual mammary 
glands from the two variable lines; in low expressors, discrete 
patches of cells expressing the transgene were observed. 
Transgene protein concentrations in milk reflected the pro-
portion of epithelial cells expressing BEG mRNA. Further-
more, chromosomal in situ hybridization revealed that trans-
gene arrays in both lines are situated close to the centromere. 
We propose that mosaicism of transgene expression is a 
consequence of the chromosomal location and/or the nature 
of the primary transgene integration event. 
-Lactoglohulin (BLG) is a major ovine milk protein. The 
function of BLG is unknown, though the crystal structure of 
bovine BLG is consistent with a role in vitamin A transport (I). 
We previously reported that mice carrying a sheep BLG 
transgene secrete BLG into their milk (2); BLG regulatory 
regions can direct expression of biomedical proteins into the 
milk of transgenic mice and sheep (3-5). In this context, it is 
important that transgene expression is stable. Unstable trans-
gene expression has been described previously: Palmiter et al. 
(6) reported that the level of herpes simplex virus thymidine 
kinase expression could vary by more than an order of 
magnitude among progeny of the same founder. Although 
other transgene insertions express to variable degrees within 
individual cell lines or transgenic mouse lines (refs. 7-19; M. 
Mchtali and RU, unpublished data). there has been no 
common explanation for the instability of expression. Unstable 
expression may be due to strong selection against the trans-
gene, for instance by the failure of sperm fertility engendered 
by testicular thymidine kinase expression (7. 8) or by the 
toxicity of high-level hepatic expression of plasminogen acti-
vator (9). A transgene inserted into the X chromosome (10) or 
an X-autosome translocation (20) generates mosaic expression 
due to stochastic X chromosome inactivation. Silencing has 
also been observed when the transgene integrates into repeat 
sequence or satellite DNA (11, 12), whereas different levels of 
transgene expression between animals of the same lineage 
have been attributed to strain-specific modifier genes (13-15). 
The publication costs of this article were defrayed in part by page charge 
payment. This article must therefore he hereby marked -advertisement" in 
accordance with 18 U.S.C. §1734 solely to indicate this fact. 
Mosaic patterns of expression were also observed in trans-
genie animals bearing intestinal fatty-acid binding protein 
fusion transgenes (16). Here, mosaicism was attributed to a 
deficit of cis-acting elements in the transgene. Mosaic expres-
sion patterns were also observed in mice carrying different 
tyrosinase fusion transgenes (17-19); these reports suggested 
that the striated coat color was an inherent property of the 
transgene. 
To address the stability of transgene expression, we exam-
ined three transgenic mouse lines harboring an intact BLG 
gene. In line 14, BLG expression levels were stable, whereas in 
lines 7 and 45. BLG levels varied significantly. We examine the 
nature of this variable expression and show that it reflects 
variegated patterns of transgene expression within the mam-
mary gland. We demonstrate that variable expression is inde-
pendent of genetic background and is a property of the 
transgene locus. 
MATERIALS AND METHODS 
Mice, Sampling, and Milk Protein Analysis. Transgenic 
lines 7. 14. and 45 (2) were maintained by systematic crossing 
to C57BL/6 X CBA F 1 hybrid mice. Litters were standardized 
to five pups per mother at birth. Milk and tissue samples were 
collected from 6- to 8-week old transgenic mice (hemizygous 
for the transgene array) at day ii of lactation. Backcross 
experiments used CBA and C57BL/6 mice (Harlan Olac, 
Bichester, U.K.). Transgenic mice were identified by a PCR 
assay (21). Milk collection and SDS/2ffi PAGE analysis of 
milk proteins were performed as described (22). 
DNA Analysis. Genomic mammary DNA was obtained from 
frozen tissue by standard procedures. EcoR I-digested DNA 
samples (10 zg) were electrophoresed and transferred to 
Zetaprobe (Bio-Rad) membranes. BLG and glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) probes were gel puri-
fied. A mouse total genomic DNA probe was prepared from 
nontransgenic mammary tissue. BLG. GAPDH, and mouse 
genomic DNA probes were labeled with [a- 32PIdCTP using a 
commercial labeling system (Multiprime. Aniersham). Follow-
ing hybridization, results were quantified using a Molecular 
Dynamics Phosphorlmager. 
RNA Analysis. Frozen mammary tissue was homogenized in 
2 ml RNAzol B (Biogenesis Ltd.) and total mRNA extracted. 
Samples (II) j.tg) were electrophoresed on 1.5 denaturing 
Mops/formaldehyde agarose gels, transfered, and hybridized 
with BLG and GAPDH probes. 
Tissue in Situ Hybridization. Pstl fragments from the BLG 
(424 bp; ref. 23) and -casein (440 hp: ref. 24) eDNA, 
Abbreviations: BLG. -lactog!obulin; FISH, fluorescence in situ hy-
bridization; FITC, fluorescein isothiocyanate; c.v., coefficient of vari-
ation. 
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respectively, were suhcluned into pGEM-4Z in both orienta-
tions. dUTP[S]-labeled single-stranded antisense probes and 
control sense probes were synthesized by in vitro transcription 
using standard procedures (25). Mammary tissue was collected 
from hemizvgous mice at day 11 of lactation and processed for 
in si/it hybridization (26). 
Chromosome Fluorescence in Si/ti Hybridization (FISH). 
Lymphocyte cells from mouse spleens were cultured in RPM! 
164() medium with 1W? fetal calf serum and 5)) p g/nil lipo-
polysaccharide, at a density of I X 10 cells/nil for 45 hr at 
37°C. These cells were used for Giemsa banding and karyo-
typing of chromosomes (27). Genoniic ovine BLG clone 
pSSItgXS (2) was nick-translated with hiotin-I6-dUTP (28) 
and used to assign transgenes to specific metaphase chromo-
somes from hemizygous line 7. 14. and 45 mice using avidin-
fluorescein isothioevanate (FITC) (29). Digital images were 
obtained with a Bio-Rad confocal microscope. Double-color 
FISH used BLG and mouse major satellite DNA (30) probes 
(see Fig. 4 legend for details) and results were visualized as 
described (31). 
RESULTS 
Lines 7 and 45 Exhibit Variable Expression of BLC. Lines 
7 and 14 harbor an identical 16 kb BLG transgene. whereas line 
45 carries an II kb 3' truncated transgene: the 3' truncation 
does not affect the transcription unit nor transgene function 
(2). Hemizygous transgcnic female mice were mated, milk 
collected at day 11 of lactation, and BLG protein levels 
determined. 
The ranges of BLG expression levels were different among 
the three lines (Fig. 1). Line 14 expressed BLG in a stable 
fashion with only 3.5 mg/nil separating the lowest and the 
highest expressor. However. BLG levels in milk of line 45 
animals ranged from 16 to 30 mg/rn!, whereas in line 7 there 
was a 8-fold difference between the lowest and highest expres-
sors (3 to 23.9 mg/nil). Table I shows the standard deviations 
(SDs) and coefficients of variation (c.v.) for I3LG protein 
expression in the three hues. As expected. lines 7 and 45 had 
larger SD values than line 14. The c.v. for line 45 was similar 
to that of line 14, but this reflects its higher average expression 
level and also it possible upper limit to protein production. We 
conclude that the particular transgene insertion locus in line 7 
determines variation in expression levels of BLG protein, for 
the identical transgene resulted in stable expression in line 14 
animals. 
To establish whether variation occurred at the steady-state 
rnRNA level, quantitative Northern blot analyses using BLG 
and control (GA PDH) hybridization probes were performed. 
BLG niRNA levels were more variable in lactating gland from 
animals of lines 7 and 45 than in line 14 animals (Table I ). The 
correlation coefficients for protein and RNA levels were 0.44. 
0.54. and 0.54 for lines 14 (ti = 9). 45 (n = 9) and 7 (,z = 8, after 
the exclusion of one outlier), respectively. The results show 




BLG levels (mg/ml) 
Mo. I. BLG expression level profiles in milk collected from line 7 
14, and 45 hemizvgous mice. 
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relationship between protein and RNA was similar in all three 
lines. 
Variable Expression Is Not Due to Rearrangement of the 
Transgene Locus. We were concerned that variable expression 
might he due to modifications to the structure of the transgene 
locus. Therefore, we performed Southern blot analysis on 
DNA prepared from lactating mammary tissue. Lines 7 and 45 
carried 25 and 17 transgene copies, respectively, whereas line 
14 harbored 2 copies (32). In all samples. the BLG probe 
identified a single major 4.3-kb hand with no evidence of 
variations in banding patterns to suggest rearrangement of the 
transgenc arrays. Quantitative hybridization using probes cor-
responding to ovine BLG and to total genomic DNA revealed 
that the trans gene copy number was indistinguishable within 
lines, even among mice from line 7 exhibiting the full spread 
of BLG levels. All lines had similar c.v. values (Table I) and 
this contrasts with the protein and RNA data in which the SD 
and c.v. values differed considerably for the three lines. 
Furthermore, the c.v. values for protein and RNA in line 7 
exceeded that for DNA. While these analyses would not reveal 
subtle changes in the structure of the transgene array, we 
surmise that variable expression is not due to stochastic loss or 
rearrangement of the transgene array in different individual 
line 7 and 45 mice. 
BLG Expression Does Not Vary Between Lactations. To 
determine whether expression levels exhibit temporal variation 
within individual line 7 animals, milk BLG protein levels were 
measured in 28 individuals at day II of two successive lacta-
tions (Fig. 2.4). The close correlation between I3LG levels 
measured in two lactations argues that individual levels are 
fixed by day 11 of the first lactation. 
Variable Expression Is Not Due to Genetic Background. 
The transgenic mice studied were of it C57BL/6 X CBA hybrid 
background. Variable transgene expression among line 7 mice 
might he due to segregation of alleles of a modifier gene(s). We 
therefore hackerossed transgenic animals from line 7 to 
C5713L/6 and CBA animals for three generations: milk sam-
ples were collected at day I 1 of lactation and the levels of BLG 
determined (Fig. 213). 
The variance and mean BLG levels were not significantly 
different between the third hackcross C57 population and the 
mixed CBA/C57 population (P > 0.05). Although variance 
and mean values were significantly different between the third 
hackeross CBA and CBA/C57 populations (I' 0.05), the 
difference in the range of expression levels was small. We have 
sincegcnerated data from fourth generation hackcross animals 
(96.9ci C57. ,i = 14: 96.94 CBA. ii = 13) and confirm that 
variance values for both backgrounds are again similar to the 
original CBA/C57 population (P > 0.115). There was also no 
clear trend in BLG expression levels through sublines within 
each hackcross: for example, it parent expressing II mg/ml 
gave rise to daughters with expression levels of 5 mg/mi and 
22 mg/ml. 
It is predicted that the presence of single or multiple 
modifier loci would he revealed by major alterations in both 
the variance and mean values for expression levels over three 
generations. Because no such alterations were observed by the 
fourth hackcross, we conclude the variable expression of the 
transgene within line 7 is not due to heterogenity of genetic 
background. 
Mosaic Expression of BLG in the Mammary Gland. We 
wished to determine whether levels of BLG expression were 
reflected in differential expression of the transgcne in the 
tianiniary epithelium. In situ hybridization studies were per-
lormed on abutting tissue sections collected at day 11 of 
lactation from individuals of lines 7, 14, and 45. Endogenous 
13-cascin mRNA was detected throughout the mammary epi-
thcliurn in all three transgenic lines, demonstrating that all 
secretory epithelial cells of the gland have the capacity to 
express a milk protein gene (Fig. 3 B. I). and F). Sections from 
Genetics: Dobie el al. 	 Proc. Nail. Acad. Sci. USA 93 (1996) 
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Table 1. BLG expression levels and copy numbers within three transgenic lines 
Protein 
	
Line 	 . 	SD 	 cv. 	 RNA c.v. 	 DNA c.v. 
7 	 9.5 4.9 	 52% (a = 30) 	 47% (a = 9) 	 36% (a = 18) 
14 6.6 ± 1.1 17% (a = 28) 13% (a = 9) 41% (n = 13) 
45 	 23.7 ± 3.9 	 16% (a = 28) 	 26% (a = 9) 	 42% (a = 13) 
i. mean; c.v. = 100 x SD/x: n, number of mice. BLG protein i values are absolute values (mg/ml); 
the c.v. measurements for BLG protein were the same if calculated from absolute values or those 
normalized for the endogenous protein albumin (data not shown). RNA and DNA values are measured 
in arbitrary units following normalization (within a line) to endogenous GAPDH mRNA or total DNA 
determined by separate hybridizations to the GAPDH and total genomic probes; for this reason, mean 
values for RNA and DNA are not comparable between different lines and are not shown. 
low-expressing line 7 individuals showed small clusters of cells 
strongly expressing BLG mRNA, surrounded by nonexpress- 
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Ftc;. 2. I3LG expression levels in milk of line 7 animals: conseeutie 
lactations and effect of genetic background. (A) BLG levels in milk 
collected at day 11 of lactation in two successive lactations. The 
average difference between the first and second lactations was 2 (± 
0.4) mg/ml. (B) BLG levels in line 7 (C57BL/6 / CBA) animals 
backerossed to the two parental strains. The CBA/C57 group is mice 
of C57BL/6 x CBA background (50% genetic contribution from each 
parental strain): CBA 1-3 and C57 1-3 are mice of three successive 
crosses to each parental strain (parental genetic background contri-
butions are 75%. 87.5%. and 93.75%. respectively).  
pattern of expression with small regions of cells negative for 
BLG mRNA (Fig. 3C). The proportion of positive cells in any 
one section correlated with the level of BLG in the milk: higher 
expressors had a greater proportion of cells positive for 
transgene mRNA. Line 14 was distinctly different because 
BLG expression was present in all the epithelial cells exam-
ined, matching the pattern of -casein niRNA expression (Fig. 
3 E and F). In lines 7 and 14, the introduced transgene is 
identical, arguing that mosaic expression is due to the location 
and/or nature of the transgene array. Line 45 also exhibited 
mosaic expression of BLG, although less so than in line 7 (Fig. 
3G). This may reflect the higher average expression level in 
line 45; individuals from line 7 and 45 with the same levels of 
BLG protein exhibited a similar degree of mosaicism. Al-
though this analysis does not permit precise quantitation of 
per-cell expression levels, the results suggest that variations in 
the level of BLG protein and mRNA expression in line 7 and 
45 individuals appear to be due to variations in the proportion 
of mammary epithelial cells expressing the transgcne. 
The Transgene Locus Lies Near a Centromere in Lines 7 
and 45. Variegated expression of endogenous genes (33) and 
transgencs (34) has been described in Drosophila and linked to 
proximity to the centromere. To determine the subchromo-
sornal localization of the BLG transgencs, we applied in situ 
hybridization to chromosome spreads prepared from animals 
of different transgenic lines. (i-handing and karyotyping in 
conjunction with FISH using a BLG probe demonstrated that 
the transgene arrays had integrated into chromosomes 15 (line 
7), 7 (line 14). and 5 (line 45). Further, the BLG locus had 
integrated midarm in line 14 (Fig. 4a) but was close to the 
centromere in lines 7 and 45. To refine the localization of the 
transgene array relative to the centromere. we used a BLG 
probe in conjunction with a major satellite (196) probe that 
predominantly decorates centromeric regions. In all line 7 
spreads, the BLG locus was close to but out with the centro-
mere (Fig. 4b). A crude estimate from 56 chromatids indicated 
that the array lies within the 3.5% of the chromosome proximal 
to centromeric heterochromatin. In line 45 the resolution of 
the experiment made the array appear to be within major 
satellite DNA (Fig. 4c, chromosome arrow). However, the 
transgene signal was observed as clearly separate from major 
satellite DNA in interphase nuclei where the chromosomes are 
decondensed (Fig. 4c, nucleus arrow). By quenching BLG 
signals, it was clear that integrated arrays were not associated 
with major translocations of this satellite DNA. 
DISCUSSION 
The introduction of transgenes to the mouse germline by 
pronuclear injection of DNA usually results in tandemly 
repeated and head-to-tail arrays at a single random site within 
the genome. Though the transgene insertion site can clearly 
have an influence upon tissue-specificity and level of expres-
sion, it has often been assumed that expression of the trans-
gene, once integrated, is stable within a transgenic line. 
However, processes have been described, such as the "RIP"  
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FIG. 3. In situ, hybridization analysis of BLG and -casein mRNA expression patterns in mouse m,Irnmar\ tissue. (A and B) Hybridization of 
BLG and -casein prohesto tissue from a low-expressinglinc 7mouse (4mg/mI). ((and I.)) BLG, (J-casein. high-expressing line 7 mouse (17 mg/ml). 
(E and F) BLG. !3-casein, line 14 mouse (8 mg/nil). (U) Line 45 mouSe (25 mg/mI). (H) Control, hybridization with a f3-casein sense probe. line 
7 mouse (17 mg/ml). (Bar = 0.5 mm.) 
phenomenon in Neurospora (35) and cosuppression in plants 
(36). that result in transgene silencing and variegated expres-
sion. We therefore entered into a study of transgene expression 
stability using three mouse lines that express the ovine BLG 
gene selectively within the lactating mammary gland. Only one 
expressed the transgene in a stable manner, whereas wide 
variations in the individual level of BLG expression were 
observed among individuals of the other two lines. 
In the most variable line (line 7). expression levels are fixed 
within the individual. Further, the genetic background of this 
line does not play a significant role in this variation. In this 
pedigree, as well as in a second line (line 45). mammary tissue 
in situ hybridization experiments revealed mosaic expression of 
the transgene. In contrast, all the secretory cells within trims-
genic glands expressed the gene for an endogenous milk 
protein (0-casein). arguing against niosaicism due to cycling of 
active and inactive domains under hormonal control (37): 
recently, uniform expression of four endogenous milk proteins 
was observed throughout the mouse mammary epithelium by  
day I of lactation (38). While our observations do not rigor -
ously rule out threshold effects due to suboptimal levels of 
lactogenic hormones leading to stochastic onset of milk protein 
gene expression, we think this unlikely. First. sections were 
taken from glands at a time when milk production is near-
maximal and all secretory cells are producing (3-casein. Sec -
ond. line 14, harboring the identical construct to that present 
in the highly variable line 7, shows stable expression through-
out the gland. 
We believe that the patching of cells in which the transgene 
is active or inactive is most consistent with clonal expansion. 
Our results suggest epigenetic silencing of transcription occurs 
stochastically in individual progenitor cells, which is then 
transmitted through cell division to daughter cells, giving rise 
to mosaic patterns of expression. The closest precedent for our 
observations is afforded by the striated coat color patterns 
recorded by Mintz and colleagues (17. 18) in animals harboring 
tyrosinase fusion transgenes. All lines appeared to reproduce 
the striped pattern of expression, and animals either fully- 
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sequences by chrtirnosoiiial FISH to nctaphoe ehromoonies. (a) 
Chromosomes from hemizygous line 14 mice were stained (red) using 
propidium iodide. Biotinylated BLG probe (arrow) was visualized 
indirectly using avidin-FITC (green). (h) Chromosomes from homozy-
gous line 7 mice were stained (blue) with 4',6-diamidino-2-
phenylindole (DAPI). The BLG probe incorporated digoxigenin-1 1-
dUTP and the major satellite DNA probe incorporated hiotin-16-
dtJTP. The BLG probe (arrow) was detected with rhodamine 
conjugated anti-digoxigenin and Texas red conjugated anti-sheep 
(red). The major satellite probe was detected using successive layers 
of avidin-FITC. hiotinylated anti-avidin, and avidin-FITC (green). 
Each chromatid of metaphase chromosome 15 can he seen labeled 
with the BLG signal in this example. (c) Chromosomes and one 
interphase nucleus from hemizvgous line 45 mice: procedures were as 
for 6 except that the fluorochrome labeling systems were reversed for 
the BLG probe (arrow) and the major satellite probe. 
pigmented or unpigmented were not reported: this contrasts 
with our observations that a lransgene insertion can give rise 
both to animals in which the transgene is predominantly silent 
and to animals in which the transgene is expressed in the 
majority of target cells. Robertson ci al. (39) have reported 
differing levels of expression in red blood cells for a glohin/lac 
Z construct among transgenic mouse lines: underlying mech- 
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nisnis maybe similar, resulting in phenotypic differences that 
I .tlect the clonal origin of mosaic patches (phenoclones: ref. 
The phenomenon of position-effect variegation in Drosoph-
i affords an informative parallel. Chromosomal rearrange-
inent that relocates an endogenous gene locus close to the 
cntromere can result in silencing of the locus in a variable 
roportion of cells (33). Silencing is attributed to chromosomal 
indensation or hetcrochromatinization brought about by 
roximity to the heterochromatic centromere. We argue that 
'.imilar process may occur in mouse. First, in both mouse lines 
\hihiting mosaic transgene expression, the array is integrated 
Iii the vicinity of the centromere, whereas in the stably-
- \pressing line the transgene is inserted some distance away. 
'ceond, gene variegation in Drosophila can extend over 50-60 
polytene hands (1-2 megahases) from a rearrangement break-
point (41). While no precise measure can he provided, our 
.Iirnates from FISH chromosomal spreads suggest that the 
.tnsgene insertion of line 7 is some 4-5 megabases from 
entromeric heterochromatin. This is broadly consistent with 
I he situation found in Drosophila, particularly if relative ge-
tomes sizes are taken into account. Third, Dorer and Henikoff 
(34) recently reported that lieterochromatinization in Dro-
aphila is not only dependent upon proximity to the centro-
mere but also on the number of repeats present at the 
ransgene locus. We note that both lines displaying mosaic 
c\pression harbor some 20 transgene copies, whereas the 
nably expressing line 14 contains only two copies. Hetero-
hromatic features of an unusually large (110(1 kb) -globin 
rinsgene integrated into a peritelomeric region were reported 
recently (42). Furthermore. Mehtali ci al. (43) described 
increased extinction of transgene activity (as judged by re-
porter gene expression and DNA methylation measurements) 
. ith increased copy number. It is therefore plausible to suggest 
hat both integration site and number of transgene copies may 
predispose to the mosaic expression phenotype: indeed. prox-
mity to repetitive DNA per se (either centromeric satellite 
DNA or repeat transgene copies) could he responsible for 
,triable expression. 
Our studies provide the first evidence for variegated expres-
ion of a transgene between individuals within a single trans-
cenic line. Such mosaic expression has implications for inves-
ligations using gene addition technology. Gene addition is now 
heing tested as a means of causing tissue specific cell ablation 
in the treatment of brain tumors (44), or in the study of the 
consequences of the loss of thyroid hormone production 
without surgery in mice (45). Variegated expression in such 
experiments would prevent 100 ablation and therefore result 
in variable numbers of cells remaining. Similarly, genetic 
manipulation of animal organs for transplant purposes (46) 
might he prejudiced by unpredictable transgene expression. In 
biotechnological applications, such as the production of pro-
teins of biomedical interest in the milk of transgenic livestock 
(3, 4), mosaic expression will reduce the yield of product. Since 
this project was completed, other colleagues have reported 
variable expression within transgenic lines (B. Binas and T. 
Burdon, personal communication: S. Morley and J. J. Mullins, 
personal communication) suggesting that the phenomenon 
may not be uncommon. Particularly intriguing is the possibility 
that some endogenous genes within the mammalian genome, 
especially those close to heterochrornatic regions [e.g., immu-
nodeficiency, centrorneric instability, facial anomalies (ICF) 
syndrome (47)] or present as tandem duplications at a single 
locus, may he susceptible to the type of mosaic silencing we 
describe here. 
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